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Abstract
Follicular development requires both proliferation and differentiation
of the cellular compartments of the maturing follicle. The role of
gonadotrophins, FSH and LH, is well accepted, but follicles exposed to the
same gonadotrophic stimulation undergo differing fates suggesting that
gonadotrophin action is subject to intraovarian modulation. Local regulators
may modulate proliferation or differentiation of a developing follicle, either
in their own right or by modulating gonadotrophin action. Alternatively
they may be concerned with intercompartmental communication, allowing
for a tighter linking of cellular populations and thereby facilitating co¬
ordinated follicular development. This thesis describes a study of the role of
local regulators in the modulation of gonadotrophin action.
It was found that in vivo FSH stimulated granulosa cell proliferation
and increased ovarian weight, but was incapable of stimulating granulosa
cells to proliferate in vitro. This suggests that the action of FSH in vivo is
mediated through another factor. However, in the presence of LH, FSH also
stimulated the expression of differentiated functions (progesterone and
oestradiol production) both in vivo and in vitro demonstrating a direct effect
of FSH. In the absence of LH or aromatase substrate, FSH induced the
potential for aromatisation but did not increase uterine weight, a marker of
oestradiol production. Therefore it is concluded that FSH is the primary
stimulus for follicular development but that LH is also required for co¬
ordinated follicular development.
There is a growing body of indirect evidence to suggest that factors of
FSH-stimulated granulosa cell origin may regulate adjacent
thecal/interstitial cells. Cytochrome P45017a (17-hydroxylase/Ci7-20 lyase)
in thecal/interstitial cells is a LH-responsive steroidogenic enzyme vital for
androgen production. To obtain direct evidence for FSH-stimulated
paracrine signalling in the ovary a rat thecal/interstitial cell culture system
was validated for the study of the control of androgen production. Using this
system and Northern hybridisation the control of androgen production by
xii
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gonadotrophins and granulosa cell derived factors was studied. The -2.0 kb
P45017a mRNA signal in ovarian total RNA from intact animals was dose-
dependently increased by treatment with recombinant human FSH (rh-FSH).
Treatment of hypophysectomised animals with rh-FSH did not consistently
alter ovarian P45017a mRNA levels, though in the presence of low levels of
LH, FSH increased P45017a mRNA expression. LH treatment alone also
increased P45017a mRNA levels. During culture for 48 h in serum-free
medium, basal androgen (androstenedione + androsterone) production by
thecal/interstitial cells from intact or hypophysectomised animals was
unaffected by treatment with rh-FSH in vivo but hLH-stimulated androgen
production by cells from intact animals only was enhanced ~2-fold. The
ability of rh-FSH treatment in vivo to increase hLH-responsive androgen
production in vitro by thecal/interstitial cells from hypophysectomised
animals was restored by r-LH treatment in vivo. Similarly, treatment of
thecal/interstitial cell cultures with conditioned medium from FSH-treated
granulosa cell cultures enhanced LH-responsive but not basal androgen
production. It is concluded that treatment of pituitary intact animals with
'pure' FSH modulates thecal/interstitial cell androgen production.
Granulosa cells but not thecal/interstitial cells possess FSH receptors, and
thecal/interstitial cells are principal ovarian sites of P45017oc expression.
Thus factors produced by FSH-stimulated granulosa cells must function as
paracrine signals in vivo. In hypophysectomised animals, absence of any
effect of FSH on these parameters of thecal/interstitial cell function
emphasises the relevance of paracrine signalling to modulation of LH action
rather than any direct regulation of thecal/interstitial function. Factors of
granulosa cell origin implicated in the paracrine control of androgen
production include IGF-I and inhibin. Both these factors had little or no effect
on basal androgen production but dose-dependently increased LH-
stimulated androgen production. These data suggest that the effects of FSH
in vivo on androgen production could be mediated by one of these factors.
In situ hybridisation of P45017a mRNA expression confirmed that this
enzyme was specific to thecal/interstitial cells and was absent from
granulosa cells. This observation confirms a basic requirement of the two
cell, two gonadotrophin mechanism of follicular oestrogen production. The
withdrawal of gonadotrophic support by hypophysectomy for up to 4 days
Abstract xiv
had no effect on P45017a mRNA expression suggesting that this
steroidogenic enzyme is constitutively expressed. Treatment in vivo with
DES, a synthetic oestrogen, decreased P45017a mRNA expression consistent
with previous observations that oestrogens inhibit androgen production.
Treatment with rh-FSH dose-dependently inhibited P45017a mRNA
expression in hypophysectomised animals implicating a factor of granulosa
cell origin in this down regulation of P45017a. Consistent with previous
observations LH stimulated the expression of P45017a mRNA, and FSH, in
the presence of a low dose of LH, increased P45017a mRNA expression.
These results again underline the modulatory role of FSH-stimulated
granulosa cell paracrine signalling on LH-stimulated androgen production.
To establish the paracrine role of inhibin, a system for the culture of
individual preantral follicles was used. After 5 days in culture with
homologous serum and FSH, follicles had grown to preovulatory size with a
commensurate increase in oestradiol secretion but not progesterone.
Immunoneutralisation of endogenous inhibin resulted in a significant
decrease in oestradiol secretion and an increase in progesterone
accumulation. Supplementation of antiserum treated follicles with
exogenous inhibin restored oestradiol secretion and reduced progesterone
accumulation. Aromatase substrate (androstenedione) levels were too low to
measure regardless of antiserum treatment. However, follicles treated with
inhibin antiserum in the presence of exogenous androstenedione also
exhibited oestradiol levels similar to untreated controls, while progesterone
accumulation remained elevated. Based on our previous observations it is
proposed that granulosa cell derived inhibin promotes thecal androgen
production and hence oestrogen production during preovulatory follicle
development. The antiserum-induced increase in progesterone accumulation
is most likely explained by reduced metabolism of C21 steroid substrate to
androgen in thecal/interstitial cells deprived of inhibin. It is concluded that
inhibin is a physiological modulator of follicular steroidogenesis which
exerts its effect at the level of theca cell androgen production.
In summary, FSH exerts primary control over follicular development
while LH supports and augments the regulatory function of FSH during
folliculogenesis. These results provide direct evidence that FSH can influence
LH-responsive thecal/interstitial androgen production in vivo and suggest
Abstract xv
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Chapter 1 Literature Review
1. Introduction
The mammalian ovary is a complex organ serving a dual function,
being responsible for the provision of fertilisable oocytes, and for the
secretion of steroids that regulate female sexual life. The ovary is composed
of two main functional units: the developing follicle and the corpus luteum.
Follicular development, ovulation and maintenance of corpora lutea are the
result of interactions between the hypothalamus, the pituitary and the
gonads, as well as the action of peptides and steroids within the ovary.
In the mature female, gonadotrophin releasing hormone, GnRH, is
released in a pulsatile manner by cells within the hypothalamus. GnRH
stimulates the secretion of luteinizing hormone, LH, and follicle-stimulating
hormone, FSH, by the pituitary. These hormones in turn stimulate the two
main cell types within the follicle, theca cells and granulosa cells, to develop.
Ovarian follicular development is orderly and progresses from primordial
through preantral to preovulatory stages. As the follicle grows it
differentiates, acquires new functional capabilities and is primarily
oestrogen-producing. The oestrogen produced has local regulatory functions
within the follicle and also exerts negative feedback on the hypothalamus
and pituitary. As oestrogen levels increase the negative feedback becomes
positive feedback resulting. in a midcycle LH surge which in turn
stimulates ovulation. Luteinization is characterised by progesterone
secretion and continues until luteolysis is initiated.
As well as endocrine regulation by FSH and LH, the developing follicle
is also likely to be subject to paracrine control. This type of regulation
involves one cell-type producing and secreting chemical messengers which
act specifically on neighbouring cell-types (Franchimont, 1986).
This thesis is primarily concerned with the paracrine regulation of
follicular development. The purpose of this review is firstly to provide a
background to the ovarian life-cycle and its endocrine control by
gonadotrophins, and secondly to outline current knowledge of the local




The ovaries are situated in the peritoneal cavity and are surrounded by
a bursa that completely encloses the ovary in rats and mice with very little
connection with the peritoneum. In pigs and sheep the bursa is open to the
peritoneum, and in humans it is virtually absent (Harrison, 1962). The ovary
itself is covered with a continuous smooth epithelium, called the surface
epithelium. During embryonic development, this epithelium proliferates to
give rise to the underlying cortex, in which the germ cells are embedded
(Franchi et al. 1962).
Oocytes originate outside the primitive gonad, probably from the
hindgut region of the embryo, and migrate as primordial germ cells to the
genital ridge resulting in the formation of the primitive ovary (Hardisty,
1978). During foetal life the germ cells in the ovary proliferate by mitosis to
form oogonia, and enter the first meiotic division. Once meiosis has begun
germ cells are termed primary oocytes and are arrested in diplotene of the
first meiotic prophase before spindle formation, and are unable to proceed
any further. Therefore the number of germ cells is fixed by birth (or just after
birth in the rat) and they are not replaced as they are released. Little is
known about the influence, if any, that the oocyte has on follicle
development; however it is essential because follicles do not form in their
absence (Buccione et al. 1990).
The majority of follicles (-90%) are non-growing throughout life and
are termed primordial follicles. Recruitment of primordial follicles initiates
dramatic changes in growth, structure and function. The growing follicles
are divided into five stages: primary, secondary, tertiary, Graafian and
atretic. As described above, the first three stages are gonadotrophin-
independent (Hirshfield, 1985) and thus appear to be regulated by
intraovarian mechanisms (Eshkol et al. 1970). After a follicle enters the
tertiary stage, continued growth and steroidogenesis is gonadotrophin-
dependent (Hisaw, 1947).
The primordial follicle is composed of a single layer of granulosa cells
and a single immmature oocyte arrested in the diplotene stage of the first
meiotic division. The primordial follicle is separated from the surrounding
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stroma by a layer of spindle-shaped cells with protoplasmic processes that
reach the basement membrane, providing a route for nutrient transfer. The
oocyte and granulosa cells have no vascular supply and thus exist in a micro-
environment enclosed by the basement membrane.
Cuboidal differentiation of the spindle-shaped cells followed by
successive mitotic divisions forms a multilayered zona granulosa. The oocyte
enlarges and secretes a glycoprotein-containing mucoid substance called the
zona pellucida that surrounds the oocyte and separates it from the granulosa
cells, forming a primary follicle (Philpott et al. 1987; Lira et al. 1990). The
oocyte stops growing, but still produces RNA and protein (Lintern-Moore &
Moore, 1979). Re-initiation of meiosis of the oocyte occurs spontaneously in
isolated oocytes from primary follicles (Eppig & Downs, 1984), therefore the
growth of the oocyte is associated with the development of the ability to
resume meiosis. Oocytes do not resume meiosis until just prior to ovulation
and thus would appear to be held in meiosis by granulosa-produced factors.
Cyclic AMP can maintain oocytes in meiotic arrest, therefore it is thought
that FSH-stimulated granulosa cells pass cAMP through gap junctions
(Eppig and Downs, 1984). Purine factors such as hypoxanthine, which is
found in high concentrations in follicular fluid, are also implicated by
maintaining high cAMP within the oocyte (Downs and Eppig, 1987; Downs
etal. 1989).
The secondary follicle is formed by further granulosa cell proliferation
and growth. Coincident with granulosa cell proliferation, stromal cells
outside the basement membrane differentiate and arrange in concentric cell
layers to form the theca interna adjacent to the basement membrane and the
theca externa which merge with the surrounding stroma. The secondary
follicle acquires an independent vascular supply which terminates in a
capillary bed at the basement-membrane. The granulosa cells and oocyte thus
remain avascular.
Tertiary follicle formation is accompanied by further hypertrophy of
theca cells and the appearance of a fluid-filled antrum among the granulosa
cells. The antral fluid consists of a plasma transudate and secretory products
of granulosa cells. In association with antrum formation the granulosa and
theca cells develop intercellular gap junctions (Albertini & Anderson, 1974)
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which allow cell-cell communication and synchronised co-ordination of
follicular function.
At this stage, the follicle rapidly increases in size under the influence of
gonadotrophins to form a Graafian follicle. The antral fluid increases in
volume and the oocyte, surrounded by the cumulus oophorus, assumes a
polar, eccentric position within the follicle (Gougeon, 1982). The mature
Graafian follicle is ready to release ova by ovulation.
Recruited primordial follicles either develop into dominant follicles
destined to ovulate or degenerate as a result of atresia (Byskov, 1978). As a
result of atresia the oocyte and granulosa cells die and are replaced by
fibrous tissue. In contrast the theca cells return to the pool of ovarian
interstitial cells (Erickson et al. 1985).
The ovary consists of other cell types other than the ones mentioned
above. The cortical stroma contains connective tissue, fibroblasts, blood and
lymphatic vessels, and macrophages as well as secretory cells known as
interstitial cells. This stroma provides the basic cellular matrix in which the
follicles are distributed. Macrophages constitute a major cellular component
of the interfollicular ovarian compartment and potentially modulate ovarian
function, acting in all likelihood through the secretion of regulatory cytokines
(Adashi, 1990). The androgen-producing cells of the interfollicular
compartment are heterogenous, and are classified into three classes
excluding the thecal/interstitial cells mentioned previously; (1) Primary
interstitial cells exist only for a short time during fetal life and have limited
steroidogenic capacity. They are not gonadotrophin-responsive and their
function is believed to involve the conversion of placental progesterone to
androgen (Erickson et al. 1985). (2) The ovary also contains androgen-
producing interstitial cells in the hilar region though their function is
unknown. (3) Secondary interstitial cells represent hypertrophied theca
interna remnants surviving the ongoing process of follicular atresia. They
settle in the region of the old follicle but otherwise are functionally




A principal function of the ovary is the secretion of sex steroids that
regulate female sexual life. The production of sex steroids in a co-ordinated
manner is essential for differentiation of the follicle and provision of a
fertilisable oocyte. The key steroidogenic enzymes and sex steroids involved
in ovarian biosynthesis are illustrated in Fig. 1.1.
Fig. 1.1. Pathways of steroid synthesis in the ovary.
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3.1.1 Cholesterol Uptake
All ovarian steroids are derived from cholesterol which tends to be
obtained from three sources: (1) pre-formed cholesterol circulating in blood
in the form of lipoproteins, (2) cholesterol synthesised de novo within the
ovary from acetylcoenzyme A, and (3) cholesterol liberated from cholesterol
esters stored within lipid droplets. The preferred source is derived from
uptake of plasma lipoprotein cholesterol (Carr et al. 1982) either as low
density lipoproteins (LDL) or high density lipoproteins (HDL). In humans
-—
LDL is the principal source whereas rats prefer HDL (Miller, 1988;
Gwynne & Strauss, 1982).
The mechanism by which cholesterol is taken up from HDL is relatively
unknown but is thought to involve an association with recognition sites
located on the plasma membrane (Ghosh & Menon, 1986), followed by
cholesterol release due to lipase activity. LDL is taken up by a receptor-
mediated process, and the lipoprotein degraded in lysosomes. Cholesterol is
transported to the inner mitochondrial membrane by cAMP-activated sterol
carrier protein (Gwynne & Strauss, 1982).
3.1.2 Ovarian Enzymes of Steroidogenesis
3.1.2.1 Cholesterol Side Chain Cleavage
The rate-limiting step in progesterone biosynthesis is the conversion of
C27 cholesterol to C21 pregnenolone by cleavage of the cholesterol side chain.
The reaction is catalysed by an enzyme complex located on the inner
mitochondrial membrane and consisting of cytochrome P450 side chain
cleavage (P450scc) and the electron transport proteins adrenodoxin and
/
adrenodoxin reductase (Waterman & Simpson, 1989). P450scc mRNA and
protein are found in both theca and granulosa cells of antral follicles,
consistent with the progesterone production capabilities of both cell types
(Zlotkin el al. 1986; Goldring et al. 1986; Hedin et al. 1987). Levels of P450scc
mRNA are low in small antral follicles, but increase during preovulatory
follicular development and reach a maximum during luteinisation (Goldring
et al. 1986; Goldschmit et al. 1989; McMasters et al. 1987). Granulosa cells of
the cumulus oophorus contain detectable levels of P450scc protein only after
ovulation, whereas mural granulosa cells contain detectable levels of
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P450scc protein throughout late preovulatory follicular development
(Zlotkin et al. 1986; Goldring et al. 1986; Hedin et al. 1987). The enzyme is
subject to regulation by gonadotrophins, via cAMP-dependent kinase, which
increase P450sco adrenodoxin and adrenodoxin reductase (Tuckey &
Stevenson, 1986). These stimulatory effects are enhanced by oestrogen
(Richards et al. 1987). Insulin-like growth factors also regulate levels of the
enzyme (Veldhuis et al. 1986a,Veldhuis et al.1986b; Veldhuis & Rogers, 1987).
3.1.2.2 3(1 HSD
The enzyme complex 3P-hydroxysteroid dehydrogenase/A5"4
isomerase (3[3-HSD) catalyses the conversion of A5-steroids to A4-steroids
and is found in both theca and granulosa cells of preovulatory follicles as
well as corpora lutea (Bogovich & Richards, 1984). The enzyme is
microsomal and utilises NAD+ as a co-factor (Miller, 1988). Ovarian reactions
catalysed by this enzyme include the conversions of pregnenolone to
progesterone, 17-hydroxypregnenolone to 17-hydroxyprogesterone, and
dehydroepiandrosterone to androstenedione. This reaction is not rate-
limiting in any way since ovarian cells are capable of converting large
amounts of pregnenolone to progesterone in the absence of any trophic
stimulation (Strauss & Miller, 1991). Despite this apparent constitutive
expression, gonadotrophins are able to stimulate 3P-HSD enzymic activity
(Hsueh et al. 1984).
3.1.2.3 17a-hydroxylase
17a-hydroxylase/Ci7-20"lyase (P45017a) is the enzyme vital for the
conversion of progestogens to androgens (Nakajin & Hall, 1981a; Nakajin &
Hall, 1981b; Nakajin et al. 1981). A single peptide is capable of both enzymic
activities (Zuber et al. 1986). Electrons for the reaction are supplied by
NADPH via P450 reductase for the first reaction, and via P450 reductase or
y
cytochrome bs for the second reaction (Takemori & Kominami, 1984; Jefcoate
et al. 1986). P45017a can utilise either pregnenolone (A5-progestogen) or
progesterone (A4-progestogen) as a substrate to produce either
dehydroepiandrosterone or androstenedione, respectively.
Literature Review 8
Ovarian P45017a expression has been shown to be restricted to theca
cells (the major androgen producing cells of the ovary) as shown byftlbrthern
y
blot and immunocytochemistry (Human: Voutilainen et al. 1986; Sasano et al.
1989a; Sasano et al. 1989b. Bovine: Rodgers et al. 1986a; Rodgers et al. 1986b;
Rodgers et al. 1987). Subtle increases in LH promote theca cell differentiation
leading to the induction of P45017a activity in developing follicles (Bogovich
et al. 1981). P45017a mRNA, protein content, and bioactivity increase
throughout theca cell differentiation while NADPH cytochrome P450
reductase remains constant throughout follicular development (Hedin et al.
1987). In mature graafian follicles, a surge in LH causes a sharp drop in
P45017a mRNA, protein content and bioactivity to levels below those seen in
small antral follicles (Hedin et al. 1987). In the rat they remain low
throughout the luteal phase and during pregnancy (Hickey et al. 1989). The
decline in P45017a activity accounts for the low levels of androgens and
consequently oestradiol produced by the corpus luteum despite the
abundance of aromatase enzyme during the second half of rodent
pregnancy. However, theca cells obtained after the LH surge are capable of
regaining their ability to produce androgens (Richards et al." 1986).
Cytochrome P45017oc is essential for androgen synthesis, and, hence, the
provision of aromatase substrates required for oestrogen synthesis. As well
as endocrine regulation by LH, thecal/interstitial cell P45017a activity is
likely to be subject to paracrine regulation by factors of granulosa cell origin.
This thesis will investigate the regulation of P45017a by both LH (directly)
and FSH (via granulosa cell-derived paracrine signalling).
3.1.2.4 17p-HSD
17(3-hydroxysteroid dehydrogenase is a loosely bound microsomal
enzyme responsible for the interconversion of androstenedione to
testosterone, and oestrone to oestradiol. The enzyme is constitutively
expressed in both theca and granulosa cells of the developing follicle, and




The aromatase enzyme complex is responsible for the conversion of
androgens to oestrogens, and consists of cytochrome P450 aromatase
(P450arom) and NADPH cytochrome P450 reductase, located in the smooth
endoplasmic reticulum. P450arom catalyses three successive hydroxylations
of the steroid A-ring, which are necessary for converting C19 androgens to Cis
oestrogens (Cole & Robinson, 1988). In the ovary aromatase activity has been
y
conclusively localised to the granulosa cell layer (Sasano et al. 1989a; Sasano
et al. 1989b). P450arom mRNA, protein content, and activity are increased in
preovulatory follicles compared to small antral follicles (Hickey et al. 1988)
due to the inductive effect of FSH (Steinkampf et al. 1987; Whitelaw et al.
1992). This induction of P450arOm mRNA, protein content, and activity is
enhanced by oestradiol (Hickey et al. 1988) though oestradiol is not essential
for the induction (Whitelaw et al. 1992). Other potential stimulators of
P450arom include IGF-I and cAMP analogues (Steinkampf et al. 1988), whilst
epidermal growth factor antagonises the stimulatory effects of these agents
(Steinkampf et al. 1988).
3.1.2.6 20a-HSD
20a-hydroxylase steroid dehydrogenase activity is found in granulosa
cells, and serves a primarily catabolic function: it catalyses the conversion of
progesterone to the inert 20a-hydroxyprogesterone (Davoren & Hsueh,
1986). It is found in increasing amounts in regressing rat luteal tissue
(Rodway & Kuhn, 1975), and is subject to negative regulation by prolactin
(Pupkin et al. 1966), while LH increases 20oc-HSD activity (Hsueh et al. 1984).
3.1.2.7 5a-Reductase
This enzyme is involved in steroid catabolism, and also generates the
potent androgen, 5a dihydrotestosterone (DHT), from testosterone. Its
cellular distribution is not well characterised though it does have a high
y
activity in the stroma (Eckstein & Lerner, 1977; Eckstein & Nimrod, 1977).
5a-reductase activity is inhibited by FSH (Payne et al. 1989), an effect
augmented by competitive substrates progesterone and testosterone, and the
non-competitive inhibitor, oestradiol. Stromal and granulosa cells are
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steroidogenically linked since 5a reduced androgens from stromal cells are
competitive inhibitors of granulosa cell aromatase (Hillier et al. 1980) and
thus act reciprocally to modulate oestrogen synthesis.
3.1.3 Co-ordination of Steroidogenesis
The co-ordination of steroidogenesis is essential for normal follicular
growth and maturation. The regulation of steroidogenesis is achieved by
cell-specific enzymic localisation. The key enzymes involved catalyse the
conversion of cholesterol to pregnenolone (P450scc)/ pregnenolone to
progesterone (3(3HSD), pregnenolone to androgens (P45017a) and androgens
to oestrogens (P450arOm)- LH regulates the first step in steroidogenesis by
controlling the conversion of cholesterol to pregnenolone, whereas FSH
controls the conversion of androgens to oestrogens.
Immunoreactive P450scc is found primarily in the theca interna cells of
the follicle, consistent with the requirement of this enzyme for thecal
androgen synthesis. In the corpus luteum immunoreactive P450scc is found
in both theca- and granulosa-lutein cells (Sasano et al. 1989b). There is little
3(3HSD in follicles but levels are high in the corpus luteum. These parallel
increases in P450scc and 3[3HSD are consistent with large levels of
progesterone production during the luteal phase of the cycle.
Immunoreactive P45017a is exclusively localised to theca interna cells of the
follicle and theca-lutein cells of the corpus luteum (Sasano et al. 1989b).
Immunoreactive P450arOm is localised in granulosa cells consistent with the
rise in oestrogen production before ovulation, and is localised in granulosa-
lutein cells of the corpus luteum.
The co-ordinated action of these localised enzymatic activities, under
the control of FSH and LH, facilitates normal oestrogen synthesis and
follicular development (Falck, 1959; Short, 1962; Ryan & Petro, 1966; Bjersing,
1967). Studies of the steroidogenic capacities of isolated granulosa and theca
cells led to the proposal of the two-cell, two-gonadotrophin theory of
oestrogen synthesis (Armstrong & Dorrington, 1979). This theory proposes
that in response to LH the thecal cells produce C19 steroids, these steroids
traverse the basement membrane and enter granulosa cells, and that FSH
stimulates granulosa cells to aromatise C19 steroids to oestrogens. The
oestrogens produced have a positive feedback effect on LH release (Yen,
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1986) and therefore upon their own production, and with each successive LH
pulse there is a surge in androgen and oestrogen levels found in the ovarian
vein (Baird et al. 1981). It is likely that there is local communication between
the thecal and granulosa cells to ensure that the provision of androgens is
sufficient for the required production of oestrogen.
As explained in more detail below gonadotrophins increase the activity
of steroidogenic enzymes, acting through adenylyl cyclase signalling to
regulate the transcription of genes encoding steroidogenic enzymes and
related proteins. Intracellular cAMP mediates positive regulation by LH of
P450sco P45017a and other components of these systems in theca cells, as
well as mediating the effects of FSH on P450arOm and 17(3HSD in granulosa
cells. The gonadotrophins differentially regulate enzyme levels using the
same second messenger due to the fact that the kinetics of mRNA responses
differ. This is due to different sensitivities to cAMP and also to the action of
local regulators. Similarly other genes under the transcriptional control of
cAMP, and their gene products may then modulate transcriptional control of
steroidogenic enzymes. Thus the co-ordinated regulation of steroid hormone
synthesis is achieved by enzymic localisation, and differential responses to
the concentration of cAMP and the temporal pattern of cAMP accumulation.
3.2 Endocrine Regulation of Ovarian Function
Ovarian follicular development is dependent upon the secretion of FSH
and LH from the anterior pituitary. These heterodimeric glycoproteins share
a common a-subunit consisting of 89 amino acids and two glycosylation
sites. The (3-subunit confers specificity to the hormones and they only share 7
amino acids of similarity; the FSH (3-subunit also has two glycosylation sites
compared to one for the LH (3-subunit. FSH has a molecular weight of 32.6
v/
kDa, while LH has a molecular weight of 34 kDa (Johnson & Everitt, 1988).
3.2.1 Control of Gonadotrophin Secretion
Ovarian function is controlled via the hypothalamo-pituitary-ovarian
axis involving complex feedback regulation (Knobil, 1980). FSH and LH are
secreted by gonadotrope cells in the anterior pituitary in response to
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stimulation by the neurosecretory product of neurons in the hypothalamus,
gonadotrophin—releasing hormone (GnRH). This factor is a decapeptide
produced by a small number of GnRH secreting neurons in the forebrain and
defined centres in the hypothalamus, most notably in the medial preoptic
area and the arcuate and paraventricular nuclei, where it is then transported
to terminals in the median eminence. GnRH is released in a pulsatile manner
from the median eminence into the portal system and binds to specific, high
affinity G-protein coupled receptors on the cell surface of the pituitary
gonadotropes (Clayton & Catt, 1981). Activation of the GnRH receptors
stimulates a calcium-dependent release of gonadotrophins from storage
granules,a.v) during states of enhanced gonadotrophin secretion there is
evidence for increased synthesis of a- and (3-subunits. LH is released from
intracellular stores in pulses in response to GnRH pulses, whereas FSH
release is dependent on its rate of synthesis, and thus is released more or less
continually (McNeilly, 1988). In addition to stimulating release of LH and
FSH, GnRH enhances pituitary responsiveness to subsequent stimulation by
GnRH. This 'self-priming' effect is achieved by increasing numbers of its
own receptor. All these actions of GnRH are mediated by a calcium-
dependent mechanism involving protein kinase C activation (Conn, 1989).
Several feedback control systems operate within the hypothalamo-
pituitary-gonadal axis to regulate the secretion of LH and FSH from pituitary
gonadotropes. These are superimposed on the pulsatile stimulatory action of
GnRH released from the median eminence and include inhibitory and
stimulatory inputs from the gonads to the pituitary and hypothalamus. The
overall effect of such feedback control is negative as illustrated by the fact
that FSH and LH levels increase in gonadectomised animals. Most of the
gonadal control of pituitary function is exerted by oestradiol acting at the
level of the hypothalamus as well as directly on the pituitary. When
circulating levels of oestradiol are low, FSH secretion is inhibited due to the
suppression of FSH (3-subunit mRNA transcription (Phillips et al. 1988).
Transcription of the a-subunit is also inhibited but LH levels remain constant
(Baird, 1991) due to the fact that most LH release is from intracellular stores.
Oestradiol may also exert stimulatory actions on gonadotrophin secretion by
acting in the hypothalamus to promote GnRH synthesis and release at the
time of the midcycle LH surge (Fink, 1988). At the same time oestradiol acts
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at the level of the pituitary to enhance GnRH sensitivity (Johnson & Everitt,
\S
1988) by increasing the number of GnRH receptors (Laws et al. 1990).
Although the major feedback regulation of gonadotrophin secretion is
mediated by the actions of oestradiol at the hypothalamic and pituitary
levels, an additional family of non-steroidal regulators have been proposed
to be involved. These proteins of ovarian origin are inhibin, activin and
follistatin. The evidence for the involvement of inhibin in the mediation of
the control of gonadotrophin synthesis is the most compelling; it selectively
suppresses. FSH synthesis and secretion by pituitary cells in vitro (Robertson et
al. 1986; Farnworth et al. 1988) at the level of the anterior pituitary (de Jong,
1987). Immunoneutralisation of inhibin leads to increased plasma FSH levels
and increased ovulation rates (Mann et al. 1989a; Rivier & Vale, 1989; Findlay
/ / V
et al. 1989; Wrathall et al. 1990; Brown et al. 1990). These effects are achieved
by reducing the GnRH-induced increase in FSH (3-subunit (Carroll et al.J v/
1989) by blocking the 'self-priming' effect on its own receptor (Braden et al.
1990; Busbridge et al. 1990; Wang et al. 1989). Activin stimulates FSH
secretion by cultured pituitary cells (Schwall et al. 1988; Mason et al. 1989), by
increasing FSH (3-subunit mRNA levels (Attardi & Miklos, 1990; Carroll et al.
1991), and injection of activin into rats increases plasma FSH levels (Rivier &
Vale, 1991). Follistatin suppresses pituitary FSH secretion (Ying et al. 1987;
DePaolo et al. 1991), and binds activin (Nakamura et al. 1990). Though activin
and follistatin exert effects alone in vitro on pituitary cells it is unlikely that
there is an in vivo endocrine role for these factors. Follistatin is probably
responsible for ensuring that activin intended to have local effects on the
gonads does not affect pituitary function.
3.2.2 Role ofFSH in the Regulation of Ovarian Function
As indicated by its name, FSH is the main promoter of follicular
maturation (Greep et al. 1942; Goldenburg et al. 1972; Goldenburg et al. 1973).
It is accepted that FSH receptors are exclusively localised to the granulosa
cells, though in the hamster there is evidence for FSH binding in the oocyte
(Oxberry & Greenwald, 1982). Therefore it is generally presumed that the
biological effects of FSH are exerted upon the maturation and function of
granulosa cells. The FSH receptor has been observed in the earliest stages of
follicle development and throughout the entire period of follicle
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development, though not in primordial follicles nor old corpora lutea (Camp
et al. 1991). FSH also stimulates production of its own receptor (Richards et
J
al. 1976; Ireland & Richards, 1978), which sensitises granulosa cells to further
stimulation by FSH.
The ability of FSH to orchestrate follicular growth and differentiation
depends on its ability to exert multiple actions concurrently. A major action
of FSH is to induce the formation of aromatase in the granulosa cell leading
to increased conversion of thecal androgen to oestrogen (Dorrington et al.
1975). This effect has been observed both in vivo (Armstrong & Papkoff, 1976)
-■
and in vitro (Moon et al. 1975). FSH has also been shown to increase
/
progesterone production (Hsueh et al. 1984).
In vivo or in vitro treatment with FSH has been shown to induce LH
y
receptors in granulosa cells (Erickson et al. 1979) and thus granulosa cells are
LH-responsive during the latter stages of follicular development. The ability
of FSH to induce LH receptors is augmented by the concomitant presence of
oestrogen (Rani et al. 1981). Furthermore this process may be amplified by
progesterone and androgen (Rani et al. 1981), LH itself (Ireland & Richards,
1978), and several growth factors (Knecht & Catt, 1983; Erickson et al. 1989).
Although oestrogen is an important mitogen for granulosa cells
V
(Penchartz, 1940), FSH also stimulates follicular growth by promoting
granulosa cell division in vivo (Gougeon & Testart, 1990; Roy & Greenwald,
1991). This effect of FSH cannot be reproduced in vitro (Hammond & English,
1987; Skinner et al. 1987; Dorrington et al. 1988), which suggests that this
effect of FSH is mediated by an intermediate in vivo.
Other important developments induced by FSH include the production
of proteoglycans which contribute to the formation of follicular fluid (Ax &
/
Ryan, 1979; Yanagishita et al. 1981); production of inhibin, activin and
follistatin which are probably involved in the feedback control of
gonadotrophin secretion and are possible local regulators of follicular
development (Bicsak et al. 1986; Hillier et al. 1989; Michel et al. 1990; Michel et
al. 1991); production of insulin-like growth factors (Oliver et al. 1989); and
also many morphological changes associated with granulosa cell
differentiation such as the production of gap junctions (Amsterdam &
Rotmensch, 1987).
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Studies of the effects of FSH on follicular development have had to take
account of the fact that pituitary FSH preparations inevitably contain a
significant degree of LH contamination. As such the interpretation of
experiments has been difficult. With the availability of recombinant (and
therefore 'pure') forms of FSH, it is possible to re evaluate the roles of FSH
and LH in follicular development. This thesis will present the results of a
study designed to determine the precise contribution of both FSH and LH to
normal follicular development.
3.2.3 Role ofLH in the Regulation ofOvarian Function
It is well known that LH enhances FSH-induced follicular development.
LH plays a major role in the control of androgen and progestogen synthesis
by thecal/interstitial cells during follicular development (Erickson et al.
1985), and stimulates the provision of androgens by thecal/interstitial cells
for aromatisation by granulosa cells. LH is therefore essential for normal
oestrogen production during follicular development. As the follicle grows,
its granulosa cells acquire LH receptors and respond to LH in a similar
manner to the way they respond to FSH (Hsueh et al. 1984). LH also
maintains the FSH-induced aromatase activity of granulosa cells (Wang et al.
1981).
\S
LH alone stimulates follicular growth (Greep et al. 1942) due to thecal
hypertrophy (Erickson et al. 1985). However, in conjunction with FSH, high
levels of LH trigger ovulation and the subsequent formation and
maintenance of corpora lutea (Greep et al. 1942; Lostroh & Johnson, 1966).
The resultant granulosa-lutein cells respond to LH by producing
progesterone (Moor, 1974). A major target for LH for the triggering of
ovulation is granulosa cells which produce plasminogen activators (Beers et
al. 1975), and prostaglandins that activate lysosomal enzymes (Bjersing, 1979)
which digest the follicular wall.
3.2.4 Intracellular signalling
Cellular responses to gonadotrophins and peptide factors are controlled
by a complex system of intracellular signalling pathways. Membrane-bound
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receptors receive and transduce the signal to generate an intracellular
signalling cascade.
3.2.4.1 cAMP intracellular signalling pathway
The signal transduction pathway of gonadotrophins consists of three
membrane-bound components; (1) the hormone receptor, (2) a guanine
nucleotide-binding regulatory protein (G-protein) and comprising an a-, |3-
and y-subunit, and (3) the catalytic subunit of the adenylate cyclase enzyme
(Johnson & Dhanasekaran, 1989; Leung & Steele, 1992). When FSH or LH
binds to its specific receptor, the hormone-receptor complex binds to the G-
protein. This stimulates the a-subunit to bind GTP which in turn causes the
[3- and y-subunits to dissociate from the complex. The remaining complex
then binds to the catalytic subunit of the adenylate cyclase enzyme, resulting
in the conversion of ATP to cAMP. The a-subunit contains intrinsic GTPase
activity, which serves to limit the response. In addition, binding of GTP to
the complex can lower the receptor affinity for the hormone and hence limit
the response. G proteins may be either stimulatory (Gs), which couple
stimulatory ligand receptors to adenylate cyclase, or inhibitory (Gj^), which
couple inhibitory ligand receptors to adenylate cyclase (Leung & Steele,
1992). Adenylate cyclase activity results in the accumulation of cAMP which
stimulates cAMP-dependent protein kinase A (PKA). This enzyme exists as a
tetramer of two regulatory subunits which bind cAMP, and two catalytic
subunits which possess phosphotransferase activity (Beebe et al. 1989).
Binding of cAMP to the regulatory subunits suppresses the
phosphotransferase activity, and therefore allows phosphorylation of protein
substrates which either immediately stimulate steroidogenesis or exert long
term effects on cAMP-regulated genes through control of transcription rates
(Kurten & Richards, 1989). It is likely that PKA stimulates a cAMP response
element binding protein (CREB) which binds as a dimer to an enhancer
element known to mediate cAMP responsive gene expression, the cAMP
response element (CRE), and thereby stimulates transcription from genes
under the regulation of a CRE (Montminy et al. 1990).
The FSH and LH receptors bear high sequence homology with each
other and thus they have similar molecular structures. They are large, single
chain polypeptides of with seven membrane spanning hydrophobic regions,
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separated by short stretches of hydrophilic amino acid residues (Johnson &
Dhanasekaran, 1989). The hormone recognition site of the receptor resides in
the long extracellular amino terminus. Glycosylation of the hormone-binding
domain of the receptor (Dufau et al. 1989; Minegishi et al. 1989) and the
ligand (Petaja Repo et al. 1991) is believed to be important for receptor-ligand
interaction. The LH receptor is a 75 KDa (Dufau & Kusuda, 1987), 90 KDa
(Keinanen et al. 1987), or a 92 KDa polypeptide (Roche & Ryan, 1989) whose
gene is capable of alternative splicing to generate diverse transcripts (Tsai-
Morris et al. 1990). It exists as a dimer of two identical hormone-binding
subunits associated by covalent interactions (Kusuda & Dufau, 1988).
Sequence analysis reveals a 26-residue signal peptide, a 341-residue
extracellular domain and a 333-residue region consisting of seven
transmembrane segments. The FSH receptor is a 75 KDa polypeptide with a
348-residue extracellular hormone-binding domain (Sprengel et al. 1990).
3.2.4.2 Protein kinase intracellular signalling pathways
Protein kinases are capable of catalysing the phosphorylation of
proteins. This covalent modification alters the equilibrium between active
and inactive forms of signal proteins, thereby enabling the cell to respond to
extracellular stimuli as well as its internal environment. Two major classes of
protein kinases are distinguished on the basis of the amino acids that they
preferentially modulate;
a) The tyrosine kinases mediate signal transduction for a variety of
growth factors such as epidermal growth factor (EGF/TGFa) (Feng et al.
1987) and insulin like growth factor (IGF-I) (Adashi et al. 1985a). The ligand-
binding region of the receptor is located on the extracellular portion of the
receptor, coupled to the intracellular tyrosine kinase. The receptors exist as
single polypeptide chains though in the case of IGF-I the receptor consists of
multiple subunits (Sibley et al. 1988). Binding of ligand activates the
intracellular tyrosine kinase, promoting phosphorylation of tyrosine residues
of proteins involved in cell development (Leung & Steele, 1992).
b) The serine/threonine kinases mediate signal transduction for
transforming growth factor P (TGFP) (Massague et al. 1992) and activin
(Mathews & Vale, 1991) and possibly other members of this family such as
inhibin. The ligand-binding region of the activin receptor is located on the
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very small extracellular domain of the receptor, coupled to the intracellular
serine/threonine kinase. This form of intracellular signalling is unusual and
has only been seen once before in animal cells, as the product encoded by the
developmental gene daf-1 in the nematode C. elegans (Georgi et al. 1990).
3.2.4.3 Phosphatidylinositol intracellular signalling pathways
This intracellular pathway mediates the actions of a number of local
regulatory factors that inhibit gonadotrophin-stimulated differentiation in
thecal/interstitial cells (Hofeditz et al. 1988) and immature granulosa cells
(Kasson et al. 1985; Shinohara et al. 1985) and promote gonadotrophin-
y
stimulated differentiation in luteal granulosa cells (Davis et al. 1989).
The key event in signal transduction is the hydrolysis, mediated by
phospholipase-C (PLC), of phosphatidylinositol biphosphate (PIP2), to yield
diacylglycerol (DAG) and inositol triphosphate (IP3) (Berridge, 1987a).
Subsequently, DAG activates PKC and undergoes cleavage to release the
prostaglandin precursor, arachidonic acid, while IP3 mediates the release of
sequestered intracellular calcium. PKC is involved in the control of ovarian
cell growth and differentiation by inhibiting gonadotrophin-stimulated
differentiation in thecal/interstitial cells (Hofeditz et al. 1988) and exerting
>/
development-related control over granulosa cell differentiation (Kasson et al.
y y
1985; Shinohara et al. 1985; Davis et al. 1989). Calcium is a ubiquitous second
messenger that interacts with specific protein kinases and binds to
calmodulin, which regulates many kinase activities as well as functioning as
an intracellular calcium receptor. One of the most important target proteins
of calcium is the cAMP phosphodiesterase, and activation of this enzyme by
calcium release provides a link between the cAMP and phosphatidylinositol
intracellular pathways. The forked signalling of IP3 and DAG and its local
regulation is important for the modulation of gonadotrophin-stimulated
ovarian follicular development and the activation of gene transcription by
local regulators (Berridge, 1987b).
3.3 Local Regulation of Ovarian Function
The observation that ovarian follicles exposed to comparable
gonadotrophic stimulation undergo variable fates suggests the existence of
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an intraovarian system that modulates the actions of gonadotrophins. The
existence of such a system would help to explain differences in rate and
extent of follicular development, initiation and arrest of meiosis, and
determination of follicular dominance versus atresia. Similarly, early stages
of gonadotrophin-independent follicular growth probably involve
intraovarian signalling.
Granulosa and theca cells respond to gonadotrophic stimulation by
producing a host of steroidal and non-steroidal regulatory factors capable of
exerting local control of follicular growth and development. Potential
regulatory factors include oestrogens, IGFs, inhibin and activin which will be
reviewed below. It is important to remember that the majority of actions that
these factors exert require the presence of gonadotrophins, and thus they
merely positively or negatively modulate gonadotrophin action at a local
level, and do not substitute for gonadotrophins. Most evidence for the role of
intraovarian regulators is indirect, and has been obtained from the use of
primary cell cultures. This thesis will, however, provide direct evidence for
the existence of paracrine signalling in the ovary.
3.3.1 Steroidal Regulation
3.3.1.1 Mechanism of Steroid Action
Steroid action is mediated by specific steroid receptors belonging to a
large family of nuclear hormone receptors which includes the thyroid
hormone receptor and the vitamin D3 receptor (Evans, 1988; Parker, 1988).
Using mutagenesis (Jenster et al. 1991) and generation of chimaeric receptor
proteins (Green & Chambon, 1989) these receptors have been characterised
as having three distinct functional domains.
The highly conserved DNA-binding domain is rich in cysteine residues
(Green & Chambon, 1986), which coordinate zinc ions to form two zinc
fingers (Evans & Hollenberg, 1988; Berg, 1990). The zinc fingers bind specific
short genomic DNA palindromic sequences called hormone response
elements (HREs) (Ham et al. 1988; Beato et al. 1989; Umes^*& Evans, 1989),
which act as enhancers (Ptashne, 1988). Binding of the steroid receptor to its
HRE leads to enhancement of transcription of the downstream gene, by
interacting with other transcription factors at the gene promoter and/or
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changing the chromatin structure so these other transcription factors may
bind (Beato, 1989). This domain can be considered as the 'active site' of the
receptor.
The carboxy-terminal steroid binding domain is less well conserved
and reflects the difference in structure of the various ligands (Evans, 1988).
This domain represses the transcriptional activation potential of the receptory y
in the absence of any ligand (Hollenberg et al. 1987; Webster et al. 1988) and
v/
is involved in dimerisation of occupied receptors (Fawell et al. 1990).
The N-terminal domain of these receptors is variable in size and
sequence, and is enigmatic as far as its precise function, though it is
necessary for full activity of the receptor (Bocquel et al. 1989; Lees et al. 1989).
Recent research suggests that this domain exerts an important influence on
on transcriptional modulation, by selectively activating different hormone-
regulatable genes (O'Malley & Strott, 1992).
Active hormone-receptor complexes bind as dimers, via their zinc
fingers, to their HREs and enhance transcription of hormone-responsive
genes (Beato, 1989). Inactive receptors are bound to several proteins
including heat shock protein 90 (hsp90) (Ziemiecki et al. 1986) which binds to
the DNA-binding domain (Smith et al. 1990) and prevents receptor activation
\y
in the absence of steroid (Cadepond et al. 1991) by preventing receptor
dimerisation (DeMarzo et al. 1991). Once the steroid ligand binds the
receptor is activated due to hsp90 dissociation (DeMarzo et al. 1991) and
\y
receptor dimerisation (O'Malley, 1990).
3.3.1.2 Androgens
Aside from serving as substrates for the aromatisation by granulosa
cells, androgens exert a variety of receptor-mediated effects at the level of the
Q granulosa cell (Hillier et al. 1977; Hillier &Ross, 1979). Androgens are capable
of promoting gonadotrophin-stimulated granulosa cell aromatase activity
(Hillier & deZwart, 1981). Thus androgens augment FSH-stimulated
aromatase activity not only by acting as a substrate, but also by exerting a
direct paracrine effect, resulting in the up-regulation of aromatase activity.
Androgens also promote progesterone synthesis (Armstrong & Dorrington,
1976; Lucky et al. 1977). Androgens enhance many other FSH-stimulated
effects such as the induction of LH-responsiveness (Shaw et al. 1989), inhibin
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production (Hillier et al. 1989; Michel et al. 1991) and plasminogen activator
secretion (Jia et al. 1990). However, high follicular concentrations of reduced
androgens such as dihydrotestosterone (DHT) may act as competitive
inhibitors of granulosa cell aromatase activity (Hillier et al. 1980).
In the absence of gonadotrophins, androgens promote follicular atresia
and antagonise oestrogen-supported ovarian weight gain in
hypophysectomised immature rats (Hillier & Ross, 1979; Leung &
Armstrong, 1979). Similarly in vitro or in vivo treatment with DHT abolishes
the ability of FSH to induce granulosa cell LH receptors (Farookhi, 1980). It
has been postulated that these and other effects may be due to an androgen-
receptor mediated decrease in the ovarian oestrogen receptor content.
These findings are in keeping with the observation that an increased
androgen : oestrogen ratio is associated with the morphologic features of
atresia. Although androgens undoubtably play regulatory roles at the level
of the thecal/interstitial cell, there is no published experimental information
to-date of any effects of androgens on thecal/interstitial cells. The function of
androgens in vivo is not certain, since administration of antiandrogens does
not disrupt rat oestrous cycles (Neumann et al. 1970), nor does it affect FSH-
responsiveness in rats (Zeleznik et al. 1979), and androgen resistant mice
undergo apparently normal cycles (Lyon & Glenister, 1974). However,
intraovarian androgen implants reduce progesterone secretion by granulosa
cells in vitro (Schomberg et al. 1978).
3.3.1.3 Oestrogens
Oestrogens, in addition to their multiple systemic effects, exert a variety
y
of critical actions at the level of the ovary (Goldenberg et al. 1972; Goldenberg
et al. 1973). Both granulosa and theca cells appear to be sites of oestrogen
action (Payne & Hellbaum, 1955; Bradbury, 1961). At the level of the
granulosa cell, oestrogens promote cellular division (Rao et al. 1978), exert a
direct antiatretic effect (Harman et al. 1975), and stimulate expression of
inhibin a- and (3-subunit mRNAs (Turner et al. 1989). In addition oestrogens
play important roles in the promotion of intercellular gap junction formation
(Merk et al. 1972), in the enhancement of antrum formation (Richards et al.
and in the augmentation of the oestrogen receptor content (Richards,
1980). Importantly, oestrogens also synergise with gonadotrophins at several
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levels, including the promotion of ovarian growth (Reiter et al. 1972), LH and
FSH receptor formation (Richards et al. 1979; Louvet & Vaitukaitis, 1976),
augmentation of FSH-induced inhibin production by cultured rat granulosa
cells (Bicsak et al. 1988), the enhancement of aromatase activity (Adashi &
Hsueh, 1982), and augmentation of FSH-stimulated progesterone production
(Ratoosh & Richards, 1985). The ability of oestrogens to augment aromatase
contributes to the exponential preovulatory rise in the circulating levels of
oestradiol. This form of self amplification may also play a role in establishing
follicular dominance. The augmenting actions of oestrogens on FSH-
stimulated parameters of granulosa cell function are believed to be mediated
at the level of cAMP generation or breakdown. Both in vivo and in vitro,
oestrogens amplify cAMP levels found in granulosa cells in response to FSH
(Richards et al. 1979).
However, oestrogens can also inhibit ovarian androgen production by
blocking the conversion of C21 progestogens to C19 androgens (Leung &
Armstrong, 1979; Magoffin & Erickson, 1981; Magoffin & Erickson, 1982a)
and thus oestrogen may be involved in suppressing thecal androgen
synthesis in response to the LH surge (Erickson et al. 1985). The exact
mechanism of oestrogen action in thecal/interstitial cells remains unclear.
This inhibitory action does not involve altered cAMP generation by theca/ s
cells (Hunter & Armstrong, 1987; Morley et al. 1989), and is probably due to
inhibition of P45017a (Magoffin & Erickson, 1982a). This thesis will address
the question of how oestrogens inhibit ovarian androgen production during
follicular development.
3.3.1.4 Catecholoestrogens
The enzyme, oestrogen-2-hydroxylase converts oestrogens to 2-
hydroxyoestradiol, a catecholoestrogen, in the ovary. Catecholoestrogens
have been detected in human and horse follicular fluid (Dehennin et al. 1984;
Spicer & Hammond, 1989b), and in porcine follicles the enzyme, oestrogen-2-
hydroxylase, is abundant in both theca and granulosa cells, although not in
corpora lutea (Spicer & Hammond, 1989b). 2-hydroxyoestradiol stimulates
basal production as well as augments FSH-induced synthesis of
progesterone by rat and pig granulosa cells, and augments androgen
aromatisation (Hudson & Hillier, 1985; Spicer & Hammond, 1987a; Spicer &
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Hammond, 1987b). 2-hydroxyoestradiol can also inhibit proliferation of
granulosa cells (Spicer & Hammond, 1989a). In pig thecal cells, 2-
hydroxyoestradiol can inhibit androgen production (Morley et al. 1989) by
reducing P45017a activity, in much the same way as oestrogens act. The
action of 2-hydroxyoestradiol is distinct from that of oestradiol though since
its potency is greater than that of oestradiol (Spicer & Hammond, 1987a).
These observations suggest that catecholoestrogens have a role in the local
control of follicular development.
3.3.2 Non-steroidal Regulation
Over recent years it has become clear that the ovary produces several
non-steroidal regulatory agents such as growth factors (e.g. IGF-I), cytokines
(e.g. TNFa), and developmental factors (e.g inhibin and activin). Although
originally identified for their effects on cellular proliferation, within the
immune system, and during embryogenesis and organogenesis (e.g. Roberts
et al. 1988), they have been shown to be capable of regulating the activity of
steroidogenic cells in the ovary. To be considered putative intraovarian
regulators such factors must meet the following criteria: (1) local production,
(2) local reception, and (3) local action. Ideally, a demonstration of the
indispensability of these factors in vivo for normal follicular development is
also necessary.
3.3.2.1 IGFs
Insulin-like growth factor-I (IGF-I) and its structural homologue, IGF-II,
are low molecular weight single-chain polypeptides that promote cellular
proliferation and differentiation in a variety of systems (Slack, 1989) and are
believed to play a role in cyclic ovarian follicular development (Giudice,
1992). The IGFs have a close homology with insulin (Froesch et al. 1985) and
these three factors cross react with each others' receptors (Rechler & Nissley,
1985). While the IGFs are produced by the liver under the control of growth
hormone (GH) (Slack, 1989) they are also produced by the ovary and exert
local actions (Adashi et al. 1985a; Giudice, 1992). In the rat (Hernandez et al.
1989; Oliver et al. 1989) and pig (Hammond et al. 1985; Hsu & Hammond,
1987a) the granulosa cells are the principal site of ovarian IGF-I gene
expression and protein synthesis. Porcine granulosa cell IGF-I production is
Literature Review 24
stimulated by FSH, LH, GH and oestradiol via the cAMP second messenger
pathway (Hsu & Hammond, 1987a; Hsu & Hammond, 1987b). IGF-I
production by porcine granulosa cells is also modulated by other growth
factors (Mondschein et al. 1988) and may also be inhibited by FSH
(Mondschein & Hammond, 1988). Receptors for IGF-I have been
demonstrated in rat (Adashi et al. 1986a), heep (Monget et al. 1989), pig
(Veldhuis & Furlanetto, 1985) and human (Gates et al. 1987) granulosa cells,
/
and in rat theca cells (Hernandez et al. 1988b). Expression of granulosa cell
IGF-I receptors is also stimulated by FSH, LH and GH in vivo and in vitro
(Adashi et al. 1988; Adashi et al. 1986a).
Having demonstrated local production and reception, the next
criterion to satisfy is that of local action. Although multiple ovarian actions
have been assigned to IGF-I, its main role is the amplification of
gonadotrophin action (Adashi et al. 1985a). IGF-I augments FSH-stimulated
progesterone production in cultured granulosa cells of several species (rat:
Adashi et al. 1985b; pig: Veldhuis & Furlanetto, 1985) by increasing P450scc
mRNA levels (Veldhuis et al. 1986a) and thus protein levels (Veldhuis et al.
1986b). FSH-stimulated oestrogen synthesis is augmented by IGF-I (Davoren
et al. 1985) accompanied by an increase in P450arom gene expression
(Steinkampf et al. 1988). Other FSH-stimulated differentiated functions that
are augmented by IGF-I include inhibin production (Bicsak et al. 1986), LH
receptor induction (Maruo et al. 1988) and proteoglycan synthesis (Adashi et
al. 1986b).
In purified rat thecal cell studies it has been demonstrated that IGF-I
alone does not stimulate androgen or progesterone synthesis (Magoffin et al.
1990). However, in the presence of LH, there is a synergistic increase in
thecal cell production of both androgen and progesterone without a change
in thecal cell sensitivity to LH stimulation (Magoffin et al. 1990). The
mechanism of this synergism probably involves effects of IGF-I on several
components of the LH-responsive signalling pathway. IGF-I also increases
LH receptor content of thecal cells both in the presence and absence of LH
(Cara et al. 1990) by increasing transcription and translation of the LH
receptor gene. In cultured human thecal cells the effect of IGF-I on thecal
androgen synthesis is greater than that of LH, though IGF-I synergises with
LH to increase androgen production also (Hillier et al. 1991b; Hillier et al.
Literature Review 25
1991c). Therefore IGF-I has the potential to exert paracrine control over
androgen synthesis as well as autocrine control in the granulosa cell, and
thereby coordinate follicular oestrogen synthesis.
The IGF-II gene is expressed by thecal cells (Hernandez et al. 1990b),
and in humans IGF-II is found in significant amounts in the follicular fluid
(Ramasharma et al. 1986). Similarly, granulosa cells produce IGF-II in vitro in
y
response to FSH, LH, GH and dibutyryl cAMP (Voutilainen & Miller, 1987).
These observations suggest a potential local role for IGF-II during follicular
development.
The hormonal actions of IGFs are subject to further modulation by the
local production of low-molecular weight binding proteins (IGFBPs) which
bind to IGFs during transport in the blood (Giudice, 1992). There are at least
six different IGFBPs, all of which are produced by different cell types at
various stages of development and have a variety of modulatory effects on
IGF action (Rosenfeld et al. 1990). Both stimulatory and inhibitory effects of
IGFBPs have been shown (Adashi et al. 1991), but most available evidence
suggests that IGFBPs negatively regulate IGF action and thus are
antigonadotrophic in nature. In a study of the expression of IGFBP-1, 2, 3
■>/
and 4 in the rat ovary (Nakatani et al. 1991b) it was shown that IGFBP-1 is
not found anywhere in the ovary in agreement with porcine studies
(Mondschein et al. 1990) but in contrast to the human granulosa cells
(Jalkanen et al. 1989). IGFBP-2 was expressed only in thecal/interstitial cells
in larger follicles, IGFBP-3 was found only in corpora lutea, and IGFBP-4 was
/
found only in granulosa cells of atretic follicles (Nakatani et al. 1991b;
Erickson et al. 1992a). In another study IGFBP-5 (Erickson et al. 1992b) was
localised to granulosa cells of atretic preantral follicles. Similarly in sheep
increased IGFBP expression is associated with atresia (Monget et al. 1989).
The thecal/interstitial cells are a prominent site of rat ovarian IGFBP-6 gene
expression (Rohan et al. 1993). The level of IGFBP transcript is inhibited by
FSH and DES, and IGFBP-6 has limited antigonadotrophic actions on rat
granulosa cell function (Rohan et al. 1993). The actions of IGFBPs observed so
far are similar to the effects of a specific antiserum to IGF-I and suggest a
complex level of control of ovarian function that requires more attention in
order to develop a fuller understanding.
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3.3.2.2 EGF/TGFa
Transforming growth factor a (TGFa), and a structural analogue,
epidermal growth factor (EGF), are single chain polypeptides of c. 50 amino
acids, that are capable of binding to an apparently common granulosa cell
EGF/TGFa receptor (Massague, 1983; Derynck, 1986). Not only do they
share the same receptor, but they are of equal potency in systems studied to-
date. The ovarian content of EGF/TGFa receptors is increased by FSH or LH
(St Arnaud et al. 1983). EGF does not appear to be expressed in the ovary
(Skinner & Coffey, 1988), but TGFa is expressed in thecal cells (Skinner &
Coffey, 1988).
At the ovarian level, EGF and TGFa exert regulatory effects on
granulosa cell proliferation and differentiation in a variety of species (May &
vf
Schomberg, 1989). EGF is a mitogen in vitro (Gospodarowicz & Bialecki,
1979; Skinner et al. 1987; May et al. 1987; Mondschein et al. 1988), though rat
granulosa cells are insensitive to this action of EGF (Gospodarowicz &
Bialecki, 1979). In rats, EGF inhibits FSH-stimulated oestradiol production7 / v/-
(Dorrington et al. 1987; Adashi et al. 1987), inhibin production (Bicsak et al.
1986), progesterone production (Dodson & Schomberg, 1987) and LH
receptor induction (Dodson & Schomberg, 1987). These effects are mediated
via a suppression of cAMP production (Adashi et al. 1987), though EGF is
also able to block the action of cAMP analogues (Adashi et al. 1987). In pigs
and humans the effects of EGF are similar (Steinkampf et al. 1988; Michel et
al. 1991) except that EGF enhances progesterone production (Tapanainen et
al. 1987; Urban et al. 1990), IGF-I and IGFBP production (Mondschein et al.
/,
1990), and increases FSH receptor number (May et al. 1987). TGFa has also
been shown to be an inhibitor of gonadotrophin-supported granulosa cell
differentiation (Skinner & Coffey, 1988).
EGF is an inhibitor of LH-stimulated thecal cell androgen biosynthesis
(Erickson & Case, 1983), which in turn leads to decreased follicular oestrogen
production. These observations suggest that EGF/TGFa may exert paracrine
effects at the level of the adjacent granulosa cell, as well as exerting autocrine
effects on thecal/interstitial cells. Thus TGFa of thecal/interstitial cell origin




Transforming growth factor [3 is a 25 KDa homodimeric protein,
originally identified for its ability to elicit a reversible phenotypic
•/
transformation of mammalian cells (Massague, 1985). TGFP exists in three
forms (TGF(3i, TGFP2, TGFP3) and is a member of a family of related proteins
that include inhibin, activin, and Mullerian duct inhibiting substance (MIS)
(Knecht & Catt, 1989), all of which are involved in embryonic development.
TGFp is produced by both granulosa cells (Kim & Schomberg, 1989; Bendell
& Dorrington, 1991) and theca cells (Skinner et al. 1987; Bendell &
Dorrington, 1988) of the ovary in most species, but pig granulosa cells do not
produce it (Kim & Schomberg, 1989). The regulation of TGFP production has
not been extensively studied to-date but it is known that oestradiol does
stimulate TGFP production by rat granulosa cells (Bendell & Dorrington,
1991).
The effects of TGFP on granulosa cells have been studied extensively in
both the rat and pig, but it has generally opposite effects in these two species.
In the rat, TGFP increases FSH-stimulated oestradiol (Ying et al. 1986; Bendell
& Dorrington, 1988), progesterone (Dodson & Schomberg, 1987) and inhibin
production (LaPolt et al. 1989), but has little effect in the absence of
gonadotrophin. It also increases EGF and LH receptor induction (Feng et al.
1986; Blair et al. 1988). These effects are partially due to enhanced cAMP
y y
accumulation (Knecht et al. 1986; Blair et al. 1988) but also lead to increased
y
amplification of the actions of cAMP (Knecht et al. 1987). In rats TGFP also
stimulates granulosa cell proliferation, both alone and in synergy with FSH
(Dorrington et al. 1988). Indeed the action of FSH on proliferation can be
blocked by immunoneutralising TGFP (Bendell & Dorrington, 1991).
In pigs the actions of TGFp are generally inhibitory. It inhibits FSH-
\X
stimulated inhibin production (Michel et al. 1991), progesterone synthesis
(Mondschein et al. 1988), and proliferation (Mondschein et al. 1988). It also
inhibits EGF-stimulated IGF-I production (Mondschein & Hammond, 1988)
and basal IGFBP secretion (Mondschein et al. 1990).
In rat thecal cells, TGFP potently inhibits LH-stimu' Ited androgen
synthesis (Magoffin et al. 1989; Hernandez et al. 1990a), but augments LH-
stimulated progesterone production (Magoffin et al. 1989). In the absence of
gonadotrophins there is little effect of TGFp unless IGF-I or insulin are
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present at the same time (Hernandez & Adashi, 1988). These observations
suggest potential autocrine and paracrine roles for TGF(3 during follicular
development in regulating both the effects of gonadotrophins and other
growth factors on granulosa and theca cells.
3.3.2.4 Inhibin and Activin
Mature inhibin is a 32 KDa heterodimeric protein that has been isolated
from follicular fluid as one of two forms consisting of an a-subunit and
either a (3a- or Pg-subunit (Ling et al. 1985; Miyamato et al. 1985; Rivier et al.
1985; Robertson et al. 1985; Vale et al. 1988; Ying, 1988). Treatment of
pituitary cell cultures with inhibin suppresses secretion of FSH, whereas
treatment with the P-subunit homodimer (Pa~Pa or Pa_Pb / called activin)
stimulates release of FSH (Tsonis & Sharpe, 1986).
The principal site of ovarian inhibin expression is the granulosa cells,
where all three inhibin subunits are produced (Meunier et al. 1988). In rats,
cows and sheep, the a-subunit is expressed in healthy follicles of all sizes,
but the p-subunits are only expressed in healthy antral follicles (Meunier et
al. 1988; Woodruff et al. 1988; Rodgers et al. 1989). The corpus luteum of these
species do not express inhibin (Woodruff et al. 1988; Rodgers et al. 1989;
Campbell et al. 1991), though in the case of the rat some inhibin a-subunit
expression is detected in newly formed corpus luteum (Meunier et al. 1988).
In the primate, Pe-subunit is expressed earlier in follicular development than
the other two subunits (Schwall et al. 1990). Primate corpora lutea do
however express inhibin subunits (Smith & Fraser, 1991). The theca cells of
rats and cows express only very low levelsAinhibin a-subunit (Meunier et al.
1988), but express neither of the other two subunits.
The inhibin subunits are encoded by separate genes (Mason et al. 1985;
/ y
Mason et al. 1986; Esch et al. 1987) whose expression is developmentally
regulated and induced by FSH (Woodruff et al. 1987; Woodruff et al. 1988;
Turner et al. 1989). The a- and Pb- subunit mRNAs are also inducible by in
vitro treatment with oestradiol (Turner et al. 1989). In vitro studies have
established that granulosa cell production of inhibin is stimulated by FSH in
rat (Bicsak et al. 1986), pig (Michel et al. 1991) and primate (Hillier et al. 1989),
while cow and sheep granulosa cells appear not to be responsive to FSH or
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LH (Henderson & Franchimont, 1981; Campbell et al. 1991). LH in low doses
stimulates inhibin production by mature granulosa cells (Bicsak et al. 1986)
and is inhibitory at high concentrations (Zhang et al. 1988). Inhibin
production is also subject to regulation by a variety of other steroidal (e.g.
androgen) and non-steroidal factors (e.g. IGF-I and TGF(3) as outlined
throughout this section. The bioavailability of inhibin and activin is
regulated by binding proteins for both factors (Krummen et al. 1993), most
notably follistatin (Nakamura et al. 1990) and a2-macroglobulin (Vaughan &
Vale, 1993).
As well as their endocrine functions, both inhibin and activin are
putative intraovarian regulators of ovarian function (Burger & Findlay, 1989;
Mather et al. 1992). The effects of these factors are mediated by cell surface
receptors (Mathews & Vale, 1991; Shinozaki et al. 1992). Intrabursal injection
of inhibin or activin in immature rats (Woodruff et al. 1990) showed tha'
inhibin stimulates follicular development and tritiated thymidine uptake
into granulosa cells, whereas activin caused atresia, and decreased granulosa
cell thymidine uptake. Progesterone production by^jraafian follicles in vitro
is not affected by addition of inhibin (Tsafriri et al. 1989b), though the
production of progesterone may be limited at a point other than inhibin
availability.
In rat granulosa cell cultures, inhibin has no effect at all (Hutchinson et
al. 1987), though a slight inhibition of FSH-stimulated cAMP generation has
been reported (Ying et al. 1986), which leads to a reduction in oestradiol and
progesterone production. Activin, on the other hand, stimulates granulosa
cell function. It enhances progesterone and inhibin production as well as
/ \S
FSH-induced aromatase activity (Hutchinson et al. 1987; Xiao et al. 1990), and
cAMP formation (Xiao & Findlay, 1991), LH receptor expression (Sugino et
al. 1988), and FSH receptor expression (Hasegawa et al. 1988; Nakamura et al.
1993). Activin alone stimulates basal inhibin secretion while not affecting
progesterone or oestradiol production. Activin also stimulates proliferation
of luteinized human granulosa cells (Rabinovici et al. 1990b) and inhibits
luteinized function in luteinizing cow granulosa cells (Shukovski & Findlay,
1990). Thus in granulosa cells, activin promotes early follicular development
but inhibits luteinization.
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In vitro regulation of theca cell androgen production by activin and
inhibin has been examined in the rat (Hsueh et al. 1987) and human (Hillier et
al. 1991b; Hillier et al. 1991c). In both species inhibin augments LH-
stimulated androgen production in vitro by thecal cells, whereas activin
inhibits LH-stimulated androgen production, while these two factors
antagonise each other when incubated together with LH. Therefore both
activin and inhibin exert potentially significant autocrine and paracrine
effects in the regulation of follicular function, though the indispensability of
either of these factors to normal follicular development has yet to be
demonstrated. This thesis presents evidence that locally produced inhibin is
crucial to normal follicular oestrogen synthesis.
3.3.2.5 Follistatin
Follistatin is a single chain peptide that suppresses FSH release from
pituitary cells, and exists in various forms of either 32 or 35 KDa in porcine
follicular fluid (Ueno et al. 1987), and 31, 35, or 39 KDa in bovine follicular
fluid (Robertson et al. 1987). These size variants are the products of
/
alternative splicing (Michel et al. 1990). Follistatin binds activin (Nakamura et
al. 1990) and thus antagonises many actions of activin. Follistatin has an
endocrine function as a suppressor of FSH secretion stimulated by GnRH or
activin (Robertson et al. 1987; Ueno et al. 1987; DePaolo et al. 1991), both by
inhibiting FSH release (Ying, 1989), and by reducing levels of FSH-(3 mRNA
(Carroll et al. 1989).
Expression of follistatin in the ovary is similar to the pattern of inhibin-
a; it is confined to granulosa cells of developing follicles from early antral
stages (Shimasaki et al. 1989; Nakatani et al. 1991a), with a maximum being
reached in the preovulatory follicle. Expression declines after the LH surge,
and is completely absent by the time of luteal regression (Nakatani et al.
1991a). Follistatin production by granulosa cells is stimulated by FSH or
PMSG (Shimasaki et al. 1989; Michel et al. 1990; Saito et al. 1991).
Follistatin inhibits aromatase activity and inhibin production, and
augments FSH-stimulated progesterone production (Xiao et al. 1990), but has
little effect on progesterone secretion by cultured preovulatory follicles
(Tsafriri et al. 1989b). These effects of follistatin seem to be mediated through
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a suppression of cAMP accumulation (Xiao & Findlay, 1991). There are no
published data of the effects of follistatin on thecal cell function to-date.
3.3.2.6 GnRH
Gonadotrophin-releasing hormone is a potential local regulator of
follicular development, as well as its primary function of stimulating
pituitary gonadotrophin secretion. GnRH has a large number of potential
roles in the modulation of ovarian function (Jones, 1989). GnRH has been
detected in sheep and cow ovaries (Aten et al. 1987), as well as the rat ovary
(Oikawa et al. 1990). Receptors for GnRH have been demonstrated on rat
granulosa and theca cells (Hsueh & Schaeffer, 1985; Maruo et al. 1985) and in
the granulosa cells of dominant follicles (Latouche et al. 1989). The recently
cloned GnRH receptor cDNA (Eidne et al. 1992) has enabled the expression
of GnRH receptor mRNA to be examined (Whitelaw et al. 1993). The GnRH
receptor mRNA was detected in the corpus luteum, and granulosa cells at
varying stages of follicular development, including some but not all primary
follicles. It was found to be expressed at an earlier stage than the LH
receptor. Treatment with FSH enhanced expression of the receptor. GnRH
causes a rapid increase in granulosa cell inositol triphosphate, diacylglycerol
and calcium (Davis et al. 1986) and therefore the action of GnRH is probably
mediated through the protein kinase C pathway. GnRH also affects cAMP
metabolism by reducing gonadotrophin-stimulated cAMP generation,
suggesting that the protein kinase A and C pathways are linked. Indeed
these two pathways appear to be antagonistic; granulosa cell differentiation
is stimulated through the protein kinase A system and inhibited through the
protein kinase C system (Shinohara et al. 1985; Shinohara et al. 1986).
Immature granulosa cells respond to GnRH by secreting fibronectin
(Dorrington & Skinner, 1986), decreasing FSH-stimulated progesterone,
oestradiol, and inhibin production (Suzuki et al. 1987), and also FSH-
stimulated LH receptor induction is inhibited (Maruo et al. 1985). Mature
granulosa cells respond to GnRH by increasing progesterone (Kawai &
Clark, 1985; Wang & Leung 1987; Wang & Leung, 1988), plasminogen
activator (Wang & Leung, 1986), and prostaglandin production (Kawai &
Clark, 1985; Kawai & Clark, 1986; Wang et al. 1989).
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The modulation of gonadotrophin action is not limited to the granulosa
cell compartment. GnRH treatment inhibits LH action (Hsueh & Jones, 1981)
on androgen biosynthesis. In contrast, GnRH treatment alone stimulates
progesterone and androgen production by cultured preovulatory follicles
(Popkin et al. 1983).
3.3.2.7 FGFs
Fibroblast growth factors j^re single chain heparin binding growth
factors (Burgess & Macaig, 1989) which are involved in embryonic
development. There are two classes of FGFs; acidic (aFGF) and basic (bFGF).
In the ovary they are recognised for their angiogenic properties and recent
studies have detected bFGF mRNA in cultured granulosa cells at all stages of
development (Grothe & Unsicker, 1989) and corpora lutea of cows (Stirling et
al. 1991), though expression of FGF mRNA is believed to occur
predominantly in endothelial cells (Koos & Olsen, 1989; Koos & Seidel, 1989).
FGF stimulates bovine granulosa cell proliferation (Neufeld et al. 1987), but
rat granulosa and theca cells do not proliferate in response to FGF
(Gospodarowicz & Bialecki, 1979).
Basic FGF exerts inhibitory effects on FSH-stimulated oestradiol (Baird
& Hsueh, 1986), inhibin (LaPolt et al. 1990b), and LH receptor induction
(Baird & Hsueh, 1986) by granulosa cells. It also inhibits LH-stimulated
androgen production by rat theca cells (Hurwitz et al. 1990). In contrast bFGF
stimulates plasminogen activator expression, progesterone production (Baird
& Hsueh, 1986), oocyte maturation and prostaglandin production (LaPolt et
al. 1990c). All these events are associated with ovulation and thus suggest
that FGF is involved in this process.
The angiogenic properties of FGFs implicate them in the process of
corpus luteum establishment after ovulation. Similarly, the vascularisation of
the thecal cell layer in the preovulatory follicle is likely to be subject to
paracrine regulation by FGFs (Gospodarowicz & Ferrara, 1989).
3.3.2.8 Cytokines
Direct actions of a number of monocyte- and macrophage-derived
cytokines such as the interferons, interleukins and tumor necrosis factor on
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ovarian function have been demonstrated recently (Adashi, 1990).
Macrophages, in particular, are known to constitute a significant cellular
component of the ovarian interfollicular compartment (Hume et al. 1984).
Interleukin-1 (IL-1), a polypeptide cytokine predominantly produced
and secreted by activated macrophages, has been shown to have a wide
range of biological activities as well as playing a role as an immunological
mediator. At the level of the ovary IL-1 suppresses the functional and
morphological luteinization of cultured porcine and murine granulosa cells
(Fukuoka et al. 1987; Fukuoka et al. 1989) and also inhibits LH-stimulated
androgen production by theca cells (Hurwitz et al. 1991); its anti-
gonadotrophic effect involving sites both distal and proximal to cAMP
generation. The ability of IL-1 to inhibit granulosa cell differentiation is
inversely related to its ability to promote granulosa cell growth (Fukuoka et
al. 1989). The gene expression of IL-1 is progesterone dependent (Cannon &
Dinarello, 1985); low levels of progesterone upregulate IL-1 gene expression
V
(Polan et al. 1988) whilst higher concentrations significantly inhibit IL-1
activity.
Tumor necrosis factor (TNFa), a 157 amino acid polypeptide, is capable
of attenuating the differentiation of cultured granulosa cells from immature
rats by virtual neutralisation of FSH action at sites proximal but not distal to
cAMP generation (Roby & Terranova, 1990). TNFa alters progesterone and
androstenedione (Roby & Terranova, 1990) but not oestradiol production.
This ability of TNFa to diminish the gonadotrophin supported accumulation
of progesterone by granulosa cells is largely due to attenuation of key
biosynthetic steps leading to progesterone production. Atretic granulosa
cells have been implicated as possible sites for TNFa gene expression (Roby
& Terranova, 1988), though granulosa cells enhance the release of IL-1 and
TNFa from co-cultured macrophages.
Although the relevance of cytokine factors has yet to be established, the
study of interactions between the immune system and the ovary is an area of
intense recent attention. Given the actions of just two immunoregulatory
peptides mentioned above, the immune cells of the ovary seem likely to be
involved in the regulation of its function.
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3.3.2.9 Other Factors
Apart from the local regulators mentioned previously in this section
there are many other factors that potentially qualify for a role in the
regulation of ovarian function. Many of the potential effects have only been
observed in vitro and more information is required before any speculation of
physiological significance is possible.
The theca and secondary interstitial cells are directly innervated by
adrenergic nerves though the significance of this innervation remains
unclear. Catecholamines stimulate androgen production by theca cells (Dyer
& Erickson, 1985), while noradrenaline causes a modest increase in basal
androgen production (Hernandez et al. 1988a).
Free inhibin a- (Knight et al. 1989) and (3-subunits (Robertson et al. 1992)
have been shown to have potential regulatory roles in ovarian follicular
development. Similarly, combinations of these inhibin subunits, as well as
splice variations, have been identified in follicular fluid (Miyamoto et al.
1986; Sugino et al. 1989; Sugino et al. 1992) and thus potentially have a
regulatory function in ovarian development.
Other factors implicated in the local regulation of ovarian function
include platelet derived growth factor (May et al. 1990), nerve growth factor
(Lara et al. 1990), components of the renin-angiotensin system (Lightman et
al. 1989), substance P (Dees et al. 1985), vasoactive intestinal peptide (Ojeda et
al. 1989), relaxin (Too et al. 1984), arginine vasopressin (Khan-Dawood &
Dawood, 1989), plasminogen activators (Knecht, 1988), and inhibitors (Ny et
al. 1985), extracellular matrix (Amsterdam et al. 1989) and many other factors
for which effects have been observed on ovarian function.
4. Coordination of ovarian function: The ovarian cycle
The development of cyclic, regular ovulatory ovarian cycles results
from regulated interactions of the hypothalamus, pituitary, and gonads as
described above. By a process of feedback to the hypothalamus and
pituitary, the ovary itself determines the length of the ovarian cycle. The
mammalian ovarian cycle consists of a repeated process of follicular
recruitment, selection, ovulation and corpus luteum formation then
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degeneration. The human menstrual cycle is usually divided into two
phases: a follicular, or proliferative, phase and a luteal, or secretory, phase.
The follicular phase is the part of the cycle when small follicles are
stimulated to grow in response to a rise in FSH levels and tonic LH levels.
The required number of follicles which begin to secrete oestrogen are
'selected', while the remainder become atretic. During this phase, tonic LH
levels are maintained while FSH levels fall in response to rising oestrogen
secretion by the dominant follicle(s). The transition to the luteal phase is
marked by a gonadotrophin surge, followed by ovulation some hours later.
The ovulated follicle becomes the corpus luteum, which in humans secretes
progesterone, oestradiol and inhibin. The life-span of the corpus luteum
during a non-fertilised cycle is the length of the ensuing luteal phase. After
the degeneration of the corpus luteum, gonadotrophin levels rise again and
another cycle begins.
The duration of the ovarian cycle and its constituent follicular and
luteal phases are different between species in both the absolute length of the
ovarian cycle and in the relative duration of its follicular and luteal
components. These differences, however, mask a fundamentally similar
organisation and result only from minor but significant modifications to a
basic pattern.
In humans and primates the follicular and luteal phases of the cycle are
approximately the same duration and gonadotrophin-dependent
development of small follicles does not begin until the degeneration of the
corpus luteum. This is probably due to oestrogen, inhibin and progesterone
production by the corpus luteum (Bassett et al. 1990; Baird, 1991), which
feeds back to suppress gonadotrophin secretion from the pituitary.
In other species such as pigs, cows and sheep, the luteal phase is
equivalent to the human, but their follicular phase is much shorter. The
corpus luteum of these species does not secrete oestrogen or inhibin
(Greenwald, 1979; Henderson & Franchimont, 1983; Mann et al. 1989b), and
thus FSH levels are much higher during the luteal phase, which allows
follicular development to occur despite the presence of a corpus luteum.
In species such as rats, mice and hamsters the corpora lutea do not
secrete progesterone and degenerate in 2-3 days unless coitus has occurred.
Follicular development in rats is triggered by a second FSH surge on the
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morning of oestrous, at about the same time as ovulation (Barraclough &
Wise, 1979). Therefore rats have a cycle of only 4-5 days. A functional luteal
phase can be induced by mating the female with an infertile male to induce
pseudopregnancy.
Rabbits and cats have permanent follicular phases, with repeated
waves of antral follicular development and atresia occurring until mating,
which triggers a LH surge, leading to ovulation and a luteal phase.
The differences in lengths of the two phases between species reflect
different ovarian cycles: Primates have menstrual cycles where the
endometrium is shed at the end of every luteal phase, and this endometrium
must be regenerated before the next ovulation in preparation for embryo
implantation. Thus the follicular phase is extended by suppressing
gonadotrophin-dependent follicular development until the corpus luteum
has degenerated.
4.1 Recruitment
Throughout life there is a continuous number of follicles that begin
gonadotrophin-independent growth in response to unknown cues. Follicles
do not respond to gonadotrophins until they have developed a theca cell
layer (Goldenburg et al. 1973). By antral stages of development these follicles
have granulosa cell FSH receptors and theca cell LH receptors (Oxberry &
Greenwald, 1982; Uilenbroek & Richards, 1979). After the LH surge in rats
and sheep the preovulatory follicle produces less oestradiol and inhibin
(Barraclough & Wise, 1979; Watanabe et al. 1990; Campbell et al. 1990) and
therefore FSH levels are allowed to peak for a second time (Butcher et al.
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1974; Pant et al. 1977; McNeilly, 1988). It is this FSH surge that is responsible
for the recruitment of the small antral follicles present in the ovary at that
time, and thus follicular development begins during the luteal phase of the
previous cycle. In primates the corpus luteum secretes oestradiol and inhibin
and therefore gonadotrophin levels are suppressed due to negative feedback
by these factors. It is only when the corpus luteum has degenerated that FSH
levels are allowed to rise and the next wave of small follicles is recruited.
Theca and granulosa cells proliferate in response to the gonadotrophins
and the theca cells produce androgens in response to the tonic LH levels. In
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the mid to late follicular phase most follicles will become atretic and only a
small number (species-specific) are destined to ovulate.
The recruited follicle contains a heterogenous population of granulosa
cells; mural granulosa cells are the most differentiated and express
steroidogenic enzymes (Goldschmit et al. 1989) and LH receptor (Oxberry &
Greenwald, 1982; Richards et al. 1987; Whitelaw et al. 1992); granulosa cells
surrounding the oocyte and lining the antrum are mainly proliferative
(Hirshfield, 1986) and they express greatest amounts of mRNA for IGF-I
(Oliver et al. 1989) which is implicated in the control of granulosa cell
proliferation. This gradient of differentiated function is probably due to the
greater access of mural granulosa cells to blood-borne FSH and other
regulatory factors from both the theca and blood.
4.2 Selection
In response to FSH, the steroidogenic capacity and inhibin production
of the developing granulosa cells increases. Throughout the follicular phase
the plasma concentrations of oestradiol and inhibin increase, and feedback to
the pituitary to suppress FSH levels. At this stage trophic support is
decreasing and the growing follicle responds to this decline in different
ways. Many of the follicles become atretic because they need higher levels of
FSH to maintain their development. The most advanced, dominant, follicles
with high gonadotrophin responsiveness continue to grow despite the
declining trophic support. An important factor in the selection of a dominant
follicle is a high rate of oestradiol synthesis for negative feedback to decrease
pituitary FSH production. Equally important is the role of local intraovarian
factors in mediating the effects of gonadotrophins at the level of the ovary,
and thus follicles exposed to the same gonadotrophin concentrations
respond differently. It should also be noted that the FSH-induced acquisition
of LH receptors on mature granulosa cells enables these cells to respond to
tonic levels of LH in the same way that they would respond to FSH. In this
way LH can stimulate intracellular cAMP accumulation and act as a
substitute for the lowered FSH levels.
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4.3 Ovulation
As the dominant follicle develops, it produces increasing amounts of
oestradiol, which eventually switch from negative to positive feedback
control of the pituitary. This leads to a massive surge of gonadotrophins, in
particular LH. The LH surge stimulates resumption of meiosis as well as
production of progesterone (Moor, 1974) and prostaglandins (Morioka et al.
1989; Wong et al. 1989) by the granulosa cells of the preovulatory follicle.
Progesterone promotes ovulation (Baranczuk & Fainstat, 1976; Greenwald,
1977; Tsafriri et al. 19(37) by interfering with collagen synthesis in the follicle
wall (Tjugum et al. 1984). Prostaglandins are also capable of inducing
ovulation (Strickland & Beers, 1976); an effect that is blocked by an inhibitor
/
of prostaglandin synthesis, indomethacin (Canipari & Strickland, 1986).
Prostaglandins increase blood flow to the follicle and increase vascular
permeability (Brannstrom & Janson, 1991) which increases the volume of the
follicular fluid. The last phase of preovulatory follicular growth is due to this
increase in follicular fluid volume (Brannstrom & Janson, 1991).
The major class of proteolytic enzymes produced by granulosa and
theca cells are plasminogen activators (Curry et al. 1989; Cajander, 1989)
which are produced in response to gonadotrophins (Galway et al. 1990) and
are maximal at the time of ovulation (Canipari & Strickland, 1985).
Expression of collagenases is also stimulated by human chorionic
gonadotrophin (hCG) (Reich et al. 1991). These enzymes degrade connective
tissue in the apical region of the follicle wall; ovulation may be blocked
partially by the administration of antibodies to plasminogen activator
(Tsafriri et al. 1989a). The gonadotrophin stimulation of plasminogen
production is mediated through prostaglandin synthesis (Canipari &
Strickland, 1986). Progesterone also augments this effect of gonadotrophins
(Ny et al. 1985).
Prior to ovulation, gap junctions between the oocyte and the cumulus
cells break down (Lindner et al. 1977), and the cumulus mass expands due to
the intercellular hyaluronic acid accumulation (Eppig, 1991). The oocyte then
re-initiates meiosis, possibly due to the removal of inhibitory factors such as
cAMP or purines produced by the granulosa cells. The prostaglandin-
induced increase in vascular permeability sustains a positive intrafollicular
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pressure and provides the driving force for extrusion of the oocyte. A
gradual reduction in the tensile strength of the follicular wall eventually
leads to its complete rupture; the flow of follicular fluid and vascular
transudate then carries the cumulus-enclosed oocyte out of the follicle on to
the ovarian surface.
4.4 Corpus Luteum
After extrusion of the oocyte, the follicle cpllapses, the basement
membrane fragments (Yoshinaga Hirabayashi et al. 1990) and the cells of the
follicle wall fill the antrum, to form the corpus luteum. The new structure is
invaded by blood vessels due to the release of angiogenic factors such as
bFGF (Findlay, 1986). The corpus luteum secretes progesterone, and in
primates it secretes oestradiol and inhibin as well (Savard et al. 1965;
McLachlan et al. 1987; Fraser et al. 1989). The function of this is to provide a
secretory endometrium capable of supporting pregnancy until the placenta is
developed enough to take over this role. Accordingly, the granulosa cells of
the former follicle cease proliferating, undergo hypertrophy and accumulate
cytoplasmic lipid droplets and large numbers of mitochondria; all
characteristics of steroid-secretory cells. This luteinization is the final stage of
differentiation for granulosa cells. The granulosa-lutein cells lose their FSH
receptors (Richards et al. 1976; Lee & Takahashi, 1977; Oxberry & Greenwald,
v/
1982; Camp et al. 1991) but remain LFI-responsive. The theca-lutein cells
remain LH-responsive and secrete progesterone. In rats and mice, another
pituitary hormone, prolactin, also stimulates luteal steroidogenesis (Hilliard,
1973), but its luteotrophic action is less clear in other species. The
steroidogenic capacity of the luteal cells is at its greatest at the beginning of
the luteal phase and declines therafter, although their LFI responsiveness
may increase (Fisch et al. 1989). However, progesterone concentrations
continue to rise during the luteal phase, probably due to the increasing
vascularisation of the corpus luteum during the first half of the luteal phase
(Niswender et al. 1976). During the second half of the luteal phase of at\)non-
fertile cycle, progesterone secretion by the corpus luteum falls until the
corpus luteum degenerates completely. The life-span of the corpus luteum is
fixed in different species; in sheep the luteal phase occupies most of the
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cycle, whereas in the rat there is no real luteal phase unless coitus takes place
(Barraclough & Wise, 1979). The degeneration of the corpus luteum is
independent of LH levels and is thought to be pre-programmed (Zeleznik,
1991). In the event of pregnancy chorionic gonadotrophin (CG) is secreted by
the placenta of some species such as the human. This hormone acts via the
LH receptor to rescue the corpus luteum and prolong its lifespan. The
greater half-life of CG compared to LH (Rizkallah et al. 1969) and slower
internalisation of CG-receptor complexes by luteal cells (Mock & Niswender,
1983) are believed to explain why LH cannot rescue the corpus luteum while
CG can via the LH receptor.
5. Summary
The start of the ovarian cycle is characterised by the growth of primary
follicles under gonadotrophic control. A rise in FSH stimulates the granulosa
cell layer to proliferate and express differentiated functions, including LH
receptor induction and production of inhibin and oestradiol. This oestradiol
and inhibin exerts negative feed back on the pituitary to decrease FSH
secretion. The decrease in trophic support leads to follicle degeneration in
the majority of cases. However, some follicles are "selected" and progress to
ovulation.
The fact that all follicles are exposed to comparable gonadotrophic
stimulation, and yet undergo variable fates, suggests the existence of
additional intraovarian modulatory systems that determine the fate of the
follicle. Both steroidal (e.g. oestradiol) and non-steroidal (e.g. inhibin and
IGF-I) regulatory factors of both granulosa and theca cell origin are
implicated in this system. These factors engage in subtle intraovarian
modulation of gonadotrophin-stimulated growth and differentiation, acting
either in their own right, or more often as positive or negative modulators of
gonadotrophin action. In this way the different cellular compartments of the
follicle may be linked in order to facilitate coordinated follicular growth. This
thesis concentrates on the paracrine actions of granulosa cell-derived inhibin
on thecal/interstitial cell androgen synthesis. By means of such a paracrine
mechanism the granulosa cells may regulate the adjacent thecal/interstitial
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cell function, and thus the supply of androgen substrate for granulosa cell
aromatisation during normal follicular oestrogen synthesis.
6. Structure of the Thesis
Gonadotrophins exert a primary endocrine regulation on follicular
development in the ovary. This endocrine control is believed to be subject to
a secondary local level of control by factors of ovarian origin. The two-cell,
two-gonadotrophin model of oestrogen synthesis requires FSH to stimulate
granulosa cell oestradiol production from androgens derived from LH-
stimulated theca cells. The major steroidogenic enzyme under FSH control
during oestrogen synthesis is granulosa cell P450arom/ while LH controls
thecal cell P45017a activity. The latter activity is vital for follicular androgen
production, and thus the provision of substrates for granulosa cell
aromatisation. This thesis describes the effects of gonadotrophins on aspects
of follicular growth and differentiation, then provides evidence for the
existence of a paracrine level of control of gonadotrophin action, and then
finally tests the hypothesis that inhibin is involved in such paracrine
signalling.
Firstly, the endocrine control of follicular development by FSH and LH
was investigated. Previous studies of the effects of FSH on follicular
development have used pituitary or urinary gonadotrophin preparations
containing finite amounts of LH contamination and thus interpretation of
data has been difficult. The availability of recombinant forms of
gonadotrophins has enabled experiments to be designed to dissect their
precise role in follicular development. Chapter 1 presents the results of a
study designed to determine the contributions of FSH and LH to normal
follicular growth and differentiation, using both in vivo and in vitro
techniques.
Secondly, the local control of gonadotrophin action on the ovary was
investigated. During the ovarian cycle the levels of LH remain constant
throughout except for a midcycle surge, whereas the levels of FSH are
variable throughout the cycle. In order for the thecal/interstitial cells to
respond appropriately to LH during the ovarian cycle, they presumably rely
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on paracrine signals from FSH-stimulated granulosa cells to modulate the
actions of constant levels of LH. Therefore, the actions of LH on
thecal /interstitial function (androgen synthesis) would appear to be
regulated by FSH via granulosa cell-derived paracrine signalling. Chapter 2
describes the validation of a thecal/interstitial cell culture system for the
study of the control of thecal androgen synthesis. Chapter 3 provides direct
in vivo evidence for FSH-activated granulosa-^ theca signalling in the ovary,
and also describes a study of the modulation of LH-stimulated thecal cell
androgen synthesis by gonadotrophins and putative regulatory factors of
granulosa cell origin. Chapter 4 presents the results from an in situ
hybridisation study to determine the control, by gonadotrophins, of thecal
cell P45017a mRNA expression, the enzyme that is essential for
thecal/interstitial androgen synthesis. Inhibin, because of its development-
related pattern of expression by FSH-stimulated granulosa cells and its
positive modulatory effects on LH-stimulated thecal androgen production, is
a potential paracrine signal in the growing follicle. The final chapter
describes the results from a study to test the effects of the removal of inhibin,
by immunoneutralisation, on rat ovarian follicles cultured in vitro.
Chapter 2. Relative Roles of Gonadotrophins
1. Introduction
Development of a follicle from the preantral to the preovulatory stage
requires both cell proliferation (Peters et al. 1975) and differentiation (Hsueh
et al. 1984). Preantral follicles contain relatively few, non-differentiated,
granulosa cells, whereas preovulatory follicles contain many more granulosa
cells which are morphologically and biochemically differentiated (Hirshfield,
1985). For normal follicular differentiation and oestrogen synthesis both FSH
and LH are clearly necessary (Fevold, 1941; Lostroh & Johnson, 1966),
however the precise role of each gonadotrophin in the control of cellular
proliferation and follicular development is not entirely clear.
The pituitary gonadotrophins, FSH and LH, have been available in a
'purified' form for over fifty years. Using purified ovine pituitary
gonadotrophins it was demonstrated that both FSH and LH were necessary
\s
for normal follicular development and steroidogenesis (Fevold, 1941; Greep
et al. 1942). However until the availability of recombinant (and therefore
'pure') forms of gonadotrophins it was not possible to design experiments to
dissect out the precise requirements for each gonadotrophin to stimulate
preovulatory follicular development and steroid synthesis in the ovary.
FSH stimulates growth of ovarian follicles in vivo (Greep et al. 1942) by
inducing proliferation of granulosa cells (Roy & Greenwald, 1991) and
directly causes granulosa cells to differentiate (Hsueh et al. 1984). This
differentiated state is expressed as development of steroidogenic activity,
mainly progesterone (Hillier et al. 1978; Richards et al. 1979) and oestradiol
(Dorrington et al. 1975; Moon et al. 1978), and the expression of LH receptors
(Zeleznik et al. 1974; Richards et al. 1976). LH alone has been reported to
stimulate limited follicular growth (Greep et al. 1942) due in the most part to
thecal hypertrophy (Erickson et al. 1985), probably caused by the atretic
actions of androgens (Hillier & Ross, 1979). In combination with FSH it
triggers ovulation and the subsequent formation and maintenance of corpora
lutea (Greep et al. 1942; Lostroh & Johnson, 1966). LH acts in the developing
follicle to stimulate thecal cell production of androgens (Erickson et al. 1985),
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which are substrates for oestrogen synthesis by granulosa cells (Hillier &
deZwart, 1982). As the follicle grows FSH stimulates granulosa cell LH-
receptor induction (Zeleznik et al. 1974; Richards et al.\976) and these cells
respond by producing more steroids (Hsueh et al. 1984). High levels of LH
induce ovulation and granulosa cell luteinization.
It has been reported that recombinant human FSH (rh-FSH) alone can
induce ovulation (Galway et al. 1990), though since the experimental animals
received exogenous oestrogen it is possible that oestrogen (probably not
normally produced in the absence of LH) may have affected the action of
FSH. It has also been demonstrated that follicular development and
aromatase activity are increased by rh-FSH (Mannaerts et al. 1991). The same
report showed that plasma levels of oestradiol are only increased by FSH in
the presence of a surrogate LH, hCG. This chapter describes a study
designed to determine the precise contribution of each gonadotrophin and
the paracrine factors under their control to normal follicular development
and oestrogen synthesis, using rh-FSH and LH in vitro and in vivo .
2. Materials and Methods
2.1 Animals
Intact or hypophysectomised (Charles River, Margate, Kent, UK.)
immature female Wistar rats were housed in a temperature and light-
controlled room. Animals were fed on proprietary rat food ad libitum and
hypophysectomised animals also received a 1% (w/v) dextrose solution (The
Boots Company Pic., Nottingham, UK.). Experimental groups (n>6) received
treatment with ovine FSH (NIADDK-o-FSH-16; FSH bioactivity 20 IU/mg,
LH bioactivity 0.04 x NIH-LH-S1), (National Institute of Arthritis,
Metabolism and Digestive Diseases, Bethesda, USA) given as four 12-hourly
subcutaneous (SC) injections (total dose 80 pg/animal); rh-FSH (GONAL-
F™, 13,096 IU FSH/mg), (Serono Laboratories UK Ltd, Welwyn Garden City,
Herts. UK) given as four 12-hourly SC injections (total dose 3-100 IU/animal)
and r-LH (13,108 IU LH/mg), (Serono Laboratories UK Ltd) given as four 12-
hourly SC injections (total dose 0.1-30 IU/animal). For comparison, other
groups of animals received human menopausal gonadotrophin (HMG)
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(Pergonal™, Serono Laboratories UK Ltd.) at a total dose of 40 IU of both LH
and FSH or a LH-containing gonadotrophin preparation as a single injection
(15 IU) of PMSG (Sigma, Poole, Dorset, UK). Where hCG was administered
in vivo, to mimic a LH surge, 20 IU hCG (Sigma) were injected
subcutaneously 12 h before killing the animals. Controls received injection
vehicle alone, which was phosphate buffered saline (PBS) containing 0.1%
(w/v) bovine serum albumin (BSA) (ICN Biomedicals, High Wycombe,
Bucks, UK). Some animals were also treated with diethylstilboestrol (DES)
(Sigma) using 1 x 0.3 cm silastic tubing capsules containing solid DES,
implanted SC under general anaesthesia in the throat region of the neck. All
animals were killed by carbon dioxide asphyxiation at 25 (intact) or 27
(hypophysectomised) days of age, 48 h after initiating treatment. Ovaries
were immediately removed and dissected free from fat and other extraneous
tissue.
2.2 Granulosa cell culture
Granulosa cells from preantral and early antral follicles were harvested
in culture medium by gentle puncture with a hypodermic needle. Cells were
then centrifuged at 1500 rpm for 10 min and resuspended in 1.0 ml of
medium. To disperse the cells and to eliminate clumps, the suspension was
drawn through a pipette tip several times, made up to 10 ml with medium,
and allowed to settle for 1 min. The cells remaining in suspension were then
centrifuged, resuspended and triturated again as before. An aliquot of the
cell suspension was removed and mixed with an equal volume of trypan
blue solution, and cells in this mixture were counted using a
haemocytometer. Viability was assessed based on the exclusion of the dye,
and was >40 %. Cells were cultured in 500 pi Medium 199 containing 25 mM
HEPES buffer, extra (2 mM) L-glutamine, penicillin (50 IU/ml) and
streptomycin (50 mg/ml) (all from Gibco Ltd, Paisley, Renfrewshire, UK)
with 0.1% (w/v) bovine serum albumin (BSA). Multiwell plastic dishes
(Linbro Space Savers, Flow Laboratories, Rickmansworth, Herts, UK) were
precoated with donor calf serum (Gibco) and washed twice with 1 ml
Dulbecco's phosphate buffered saline (DPBS; Oxoid) before use (Hillier &
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deZwart, 1981). The culture wells were inoculated with replicate 250 pi
portions of cell suspension containing 40,000 viable granulosa cells. The
granulosa cells were incubated for 48 h. In vitro treatments were with human
pituitary FSH (LER 8/116; FSH bioactivity 900 IU/mg, LH bioactivity 0.5
IU/mg), (generously donated by Prof L.E. Reichert, Jr.) at a final
concentration of 0.1-100 ng/ml; ovine LH (oLH) (NIADDK-oLH-26;
NIADDK-NIH, Bethesda, MD) at a final concentration of 0.1-10 ng/ml; a 10"4
M solution of testosterone (17(3-hydroxyandrost-4-en-3-one; Sigma) in
ethanol at a final concentration of 10"6 M; rh-FSH at a final concentration of
0.1-1000 ng/ml; rh-IGF-I (CGP-35M26, donated by Drs. H.H. Peter and K.
Scheibli, Ciba-Geigy) at a final concentration of 30 ng/ml; rh-activin-A
(Genentech Inc, San Francisco, CA) at a final concentration of 30 ng/ml; rh-
inhibin-A (Genentech Inc) at a final concentration of 30 ng/ml. The spent
culture medium was collected and stored frozen at -20 °C.
2.3 Measurement of DNA synthesis
Tritiated thymidine uptake was determined using the method of May et
al. (1988). After removing spent medium, the cell monolayer was washed
once with Dulbecco's PBS and incubated for a further 18 h at 37°C in 500 pi
fresh medium containing 1.0 pCi [methyl-3H]thymidine (1.5 Ci/mmol;
Amersham). The monolayers were then washed twice with ice-cold
Dulbecco's PBS and fixed by incubation for 20 min in 1.0 ml 5% (w/v)
trichloroacetic acid. After washing once with trichloroacetic acid and twice
with ice-cold methanol, the cells were dissolved in 500 pi 0.5 M NaOH. The
digest was then neutralised by addition of 500 pi 0.5 M HC1. The solution
was then aspirated and 3 ml scintillation cocktail (RIALUMA, Lumac LSC
b.v., Olen, Belgium) was added. The tritium content of the cultures were
measured by liquid scintillation spectrophotometry (RackBeta, LKB Wallac,
Turku, Finland).
2.4 Bromodeoxyuridine (BrdU) measurement
To study the effects of gonadotrophins on cell proliferation in vivo we
localised incorporated thymidine analogue, BrdU, using monoclonal
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antibodies. Three hours before they were killed, animals received a SC
injection of 0.1 ml BrdU at a concentration of Img/lOg animal in PBS
containing 0.1% BSA. After sacrifice ovaries were removed and dissected
free from fat and other extraneous tissue. Ovaries were fixed for one hour in
"3+1" (3 parts absolute ethanol and 1 part glacial acetic acid) followed by
overnight at 4°C in 4% (w/v) paraformaldehyde (Sigma) dissolved in PBS.
The tissue was then automatically processed overnight (Shandon Processor
2LE; Shandon Scientific Ltd, UK) through graded ethanol solutions, followed
by xylene, 1:1 xylene-paraffin, then paraffin wax. Prepared tissues were then
placed in moulds containing melted paraffin, which was then allowed to
solidify.
Slides were cleaned and coated to help tissue section retention. Firstly
slides were left overnight in chromic acid (9 parts 2 % potassium dichromate,
1 part sulphuric acid) (both Sigma). This was followed by a 5 h wash in
running water, then a rinse in distilled water and the slides were allowed to
air dry. Once the slides had dried they were twice dipped in a 2% (v/v)
solution of 3-aminopropyltriethoxysilane (TESPA) in acetone for 10 sec,
followed by two 10 sec washes in acetone. The slides were then rinsed in
distilled water then baked dry at 42 °C.
Using a standard rotary microtome (American Optical Corporation),
tissue was sectioned at 5pm thickness to produce a ribbon of sections. This
ribbon was floated on the surface of water in a water bath. Sections were
mounted by inserting a coated slide into the water bath near the sections at a
45 ° angle to the water surface, touching an edge of the ribbon to the slide and
slowly withdrawing the slide from the bath. Slides were placed in an oven
overnight at 40 °C to ensure sections had adhered to the slide.
Tissue sections were deparaffinised and rehydrated by immersing
slides in two changes of xylene for 10 min each time. The slides were then
passed sequentially, for 2 min each, through 100%, 100%, 90% (v/v), 75%
(v/v), 50% (v/v), and 30% (v/v) ethanol then 1 min in water, then slides
were washed three times in PBS. To each section was added 70 pi of anti-
BrdU antibody (IgG2a antibody and nuclease in tris buffered saline pH9
containing 1.0 % BSA, magnesium chloride and preservative) (Amersham
International pic, Buckinghamshire, UK) and slides were incubated for 2 h.
Slides were washed three times in PBS, and to each section was added 70 pi
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of peroxidase anti-mouse Ig<i (peroxidase conjugated antibody in PBS
containing 1.0 % BSA and preservative) (Amersham) and slides were
incubated for 30 min. Slides were washed three times in PBS and immersed
in diamino benzidine (DAB) staining solution for 10 min. After three washes
in water, sections were dipped in a cytoplasmic counterstain, light green.
Slides were then dehydrated through successively increasing alcohol
solutions ; 1 min in each of 30% (v/v), 50% (v/v), 75% (v/v), 90% (v/v) and
100% ethanol followed by 5 min in xylene. Coverslips were then mounted
using Eukitt (O. Kindler GmbH & Co, Freiburg, Germany) which was then
allowed to dry for 4 h.
2.5 Measurement of ovarian and uterine weight
Ovaries and uteri were dissected of all fat and extraneous tissue and
then weighed on an electronic balance (Cahn TA 4100; Cahn, Cerritos, CA).




Progesterone (4-pregnene-3,20-dione) was measured in culture media
by specific radioimmunoassay. The assay buffer was PBS/gelatin (0.05M
sodium phosphate, 0.15M NaCl, 0.1% gelatin). The antibody, anti-
progesterone-lla-hemisuccinate-BSA (R31/12), was provided by Medical
Research Council, Mill Hill. Antibody was used at a working dilution of
1:4,500. Cross-reaction of the antibody with oestradiol-17p, ICI 164,384,
ICI 164,275 or SCH 16423 was <0.01 % (Turner, 1992). Cross-reaction with
testosterone, 5a-dihydrotestosterone and 2-hydroxyoestradiol was 0.04 %,
0.05 % and 0.02 %, respectively. Tracer, [l,2,6,7-3H]-Progesterone (80-110
Ci/mmol, Amersham), was stored at -20 °C in ethanol, at a concentration of
10 gCi/ml. Before use this stock was diluted 1:400 in assay buffer to give
-10,000 cpm/500 pi. A standard curve covering the range of 0.04 to 5.1
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pmoles/tube progesterone (Sigma), made up in culture medium, was used.
Samples (5-100 pi) or standards (in 200 pi) were placed in tubes, and the
volume of samples was adjusted to 200 pi. Quality controls (0.26 and 2.7
pmoles/tube) were also included at the beginning and end of each assay.
Antibody (300 pi) and tracer (500 pi) were added, and tubes were incubated
for 3 h at room temperature. Tubes were placed on ice for 30 min before
addition of 200 pi dextran-coated charcoal (1.25 % (w/v) dextran/Xl 25 %
(w/v) charcoal in assay buffer) to separate bound and free progesterone.
Tubes were mixed and incubated for 10 min on ice, then centrifuged at 3000
rpm for 10 min at 4°C. Supernatants were decanted, 3 ml scintillation cocktail
(RIALUMA) was added, and bound tracer was measured by liquid
scintillation counting (RackBeta). The p-counter had a 36 % efficiency as
assessed by external standardisation. Standard curves were calculated using
a commercial computer program (AssayZap, Biosoft, Cambridge, UK).
Samples which were outside the detection limits were re-assayed at the
appropriate volume. The detection limit of the assay was within the range
0.05-0.06 pg/tube. Inter- and intra-assay coefficients of variation were <15%.
2.5.2 Oestradiol Radioimmunoassay
Oestradiol-l 7p was measured in culture media by specific
radioimmunoassay. The assay buffer was PBS/gelatin (0.05M sodium
phosphate, 0.15M NaCl, 0.1% gelatin). The donkey K3 anti-oestradiol-17-
hemisuccinyl-BSA antiserum was provided by Dr. G. Read, Tenovus
Institute, Cardiff. Antibody was used at a working dilution of 1:75,000. Major
cross-reactions were: oestradiol-17(3, 100 %; oestrone, <10% and <0.5 % for
all other steroids tested. Tracer, [125I]-Oestradiol-3-carboxymethylether, was
diluted in assay buffer to give ~12,000cpm/200pl. A standard curve covering
the range of 0.015 to 1.8 pmoles/tube oestradiol-17p (Sigma), made up in
culture medium, was used. Samples (5-100 pi) or standards (in 100 pi) were
placed in tubes, and the volume of samples was adjusted to 100 pi. Quality
controls (0.17 and 0.37 pg/tube) were also included at the beginning and end
of each assay. Antibody (200 pi) and tracer (200 pi) were added, and tubes
were incubated at room temperature for 3 h. Tubes were placed on ice for
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15min before addition of 500 pi dextran-coated charcoal to remove unbound
steroid. Tubes were mixed and incubated for lOmin on ice, then centrifuged
at 3000 rpm for 10 min at 4°C. Supernatants were decanted and bound tracer
was measured by y-counting (NE1600; Nuclear Enterprises, Edinburgh,
Scotland). Standard curves were calculated using a commercial computer
program (AssayZap). Samples which were outside the detection limits were
re-assayed at the appropriate volume. The detection limit of the assay was in
the range 0.015-0.018 pg/tube. Inter- and intra-assay coefficients of variation
were less than 15%.
2.5.3 Androstenedione Radioimmunoassay
Androstenedione in spent culture medium was determined by specific
radioimmunoassay. The assay buffer was PBS/gelatin (0.05M sodium
phosphate, 0.15M NaCl, 0.1% gelatin). The androstenedione antiserum was
rabbit anti-androst-4-ene-3,17-dione-7a-carboxyethylthioether-BSA (Hillier et
al. 1991b). Major cross-reactions were: androsterone 46.3 %; 5a-androstane-
3,17-dione 50 %; testosterone 37 %; and less than 0.5 % for all other steroids
tested. Tracer, [1,2,6,7 3H]-Androst-4-ene-3,17-dione, was diluted in assay
buffer to give -10,000 cpm/500 pi. A standard curve covering the range of
0.025 to 6.4 pmoles/tube androstenedione (Sigma), made up in culture
medium, was used. Samples (5-100 pi) or standards (in 200 |il) were placed in
tubes, and the volume of samples was adjusted to 200 pi. Quality controls
(0.08 and 2.4 pmoles/tube) were also included at the beginning and end of
each assay. Antibody (300 pi) and tracer (500 pi) were added, and tubes were
incubated at 37°C for 1 h then at 4°C for 1 h. Tubes were placed on ice before
addition of 200 pi dextran-coated charcoal (1.25 % dextranpi 25 % charcoal in
assay buffer) to separate bound and free steroid. Tubes were mixed and
incubated for lOmin on ice, then centrifuged at 3000 rpm for 10 min at 4°C.
Supernatants were decanted, 3ml scintillation cocktail (RIALUMA) was
added, and bound tracer was measured by liquid scintillation counting
(RackBeta). Standard curves were calculated using a commercial computer
program (AssayZap). Samples which were outside the detection limits were
re-assayed at the appropriate volume. The detection limit of the assay was in
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the range 0.03-0.04 pmoles/tube. Inter- and intra-assay coefficients of
variation were less than 15%.
2.6 Gonadotrophin levels in serum
2.6.1 Follicle stimulating hormone and Luteinizing hormone
Human FSH and LH in serum were measured by specific
immunoradiometric assay (Serono FSH MAIAclone™ and Serono LH
MAIAclone™). The 125I anti-FSH and -LH reagent consisted of fluorescein
and 125I labelled mouse monoclonal antibodies to the gpnadotrophini, <10 pCi
per vial in the FSH assay and <8 pCi per vial in the LH assay, in PBS
containing normal sheep serum, BSA, inert dye and 0.2 % (w/v) sodium
azide. The zero standard was bovine serum with 0.2 % (w/v) sodium azide.
A standard curve covering the range of 0.5 to 150mlU/ml of gonadotr ophin
per ml (FSH; 2nd irp 78/549. LH; 1st IRP 68/40) in bovine serum with 0.2 %
(w/v) sodium azide was used. Samples (100 pi) or standards (in 100 pi) were
placed in tubes. Serotest™ quality control (FSH; 7.13 U/l. LH; 6.86 U/l) was
also included at the beginning and end of each assay. The ^25I anti-
gonadotrophin reagent was added, and tubes were incubated at room
temperature for 1 h. 200 pi of MAIAclone separation reagent (sheep
antiserum to flyttrescein covaler tly bound to magnetic particles in Tris buffer
with BSA and 0.1 % (w/v) sodium azide) was added to each tube and tubes
were incubated for 5 min at room temperature. Particles were magnetically
separated for 2 min on a MAIA magnetic separator, the supernatant was
decanted and 500 pi of wash buffer (Tris buffer and 0.1 % (w/v) sodium
azide) was added, the tubes were vortexed and then allowed to separate
magnetically for a further 2 min. Supernatants were decanted and tubes were
measured by y-counting (NE1600). Standard curves were calculated using a
commercial computer program (AssayZap). Samples which were outside the
detection limits were re-assayed at the appropriate volume. The sensitivity of
the FSH assay was < 0.25 mlU/ml, while that of the LH assay was < 0.15
mlU/ml.
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2.7 Statistics
Statistical analysis was carried out using commercial software (CLR
ANOVA; Clear Lake Research Inc., Houston, TX., USA). Analysis of variance
with the Newman-Keuls test was used to analyse differences between
experimental and control observations. Differences assigned a P value of
<0.05 were regarded as statistically significant.
3. Results
3.1 Effect of gonadotrophins and DES on BrdU localisation in vivo
Bromodeoxyuridine uptake by proliferating cells was used to
determine the effects of gonadotrophins and DES on the proliferating
population of cells in the ovary. Basal proliferation in intact animals as
estimated by BrdU localisation was found to be low (Fig. 2.1A). The
administration of oFSH caused an increase in the number of antral follicles
and a large increase in proliferation in granulosa cells throughout these
follicles (Fig. 2.1C). Many thecal/interstitial cells appeared to be labelled
also. The administration of oFSH and hCG caused an increase in the number
of preovulatory follicles and a centripetal pattern of proliferation whereby
antral granulosa cells were mainly proliferating and only a few cells at the
granulosa-theca cell boundary were proliferating (Fig. 2.IE).
The administration of DES (Fig. 2.IB) increased basal levels of
proliferation though the effect of FSH (Fig. 2.ID) was no greater than in the
absence of DES. Again treatment with FSH/hCG caused preovulatory
follicles to exhibit a centripetal pattern of proliferation (Fig. 2.IF). The corpus
luteum showed no signs of proliferation (Fig. 2.1G) and the only BrdU
labelling was by blood vessels.
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Fig. 2.1. Bromodeoxvuridine labelling of rat ovaries in vivo showing dividing
granulosa cells. Three hours before they were killed animals received a subcutaneous
injection of 0.1 ml bromodeoxyuridine (BrdU) at a concentration of lmg/lOg body
weight in PBS containing 0.1% (w/v) BSA. Ovaries were removed, fixed and
incorporated BrdU was localised using monoclonal antibodies. Bar = 100p.m. A
Section from an untreated immature rat ovary showing low levels of BrdU
incorporation. C Section from an oFSH treated (total dose 80 pg/animal) rat ovary
showing increased BrdU incorporation due to FSH treatment. E Section from an
oFSH (total dose 80 pg/animal) then hCG treated (20 IU) rat ovary showing BrdU
incorporation predominately in antral granulosa cells in a centripetal pattern of
labelling. B Section from a DES treated immature rat ovary showing high levels of
BrdU incorporation due to DES treatment. D Section from a DES and oFSH treated
(total dose 80 pg/animal) rat ovary showing further increased BrdU incorporationdue to FSH treatment. F Section from a DES and oFSH (total dose 80 pg/animal)
then hCG treated (20 IU) rat ovary showing BrdU incorporation predominately in
antral granulosa cells in a centripetal pattern of labelling. G Corpus luteum showing
background incorporation of BrdU only at the site of blood vessels.
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3.2 Effect of gonadotrophins on granulosa cell proliferation and
differentiation in vitro
3.2.1 Thymidine uptake
Thymidine uptake (Fig. 2.2) was used as a measure of granulosa cell
proliferation in vitro. Animals were treated with FSH (to produce
differentiated granulosa cells), FSH+hCG (to produce preovulatory
granulosa cells) or injection vehicle alone (to produce non-differentiated
granulosa cells) in vivo and then these cells were treated in vitro with FSH or
LH with or without testosterone. Differentiated granulosa cells exhibited
basal levels of thymidine uptake approximately one half of levels observed
in non-differentiated granulosa cells, whilst preovulatory granulosa cells
have an even lower level of basal thymidine uptake. The addition of FSH or
LH in vitro approximately halved the thymidine uptake by non-
differentiated, differentiated or preovulatory granulosa cells. Likewise,
testosterone treatment in vitro also halved thymidine uptake by granulosa
cells at all stages of differentiation. Interestingly, FSH in the presence of
testosterone further decreased thymidine uptake by granulosa cells at all
stages of differentiation. However, LH only further decreased thymidine
uptake in the presence of testosterone by differentiated and preovulatory
granulosa cells whilst it had no measurable effect on non-differentiated
granulosa cells treated with testosterone.
Overall, a pattern was established whereby gonadotrophin treatment in
vitro decreased thymidine uptake by granulosa cells. Similarly granulosa
cells of increasingly differentiated state in vivo showed decreasing levels of
thymidine uptake in vitro.






















Fig. 2.2. Effects of gonadotrophins and/or testosterone on tritiated thymidine uptake
by non-differentiated (control), differentiated (FSH-treated) and preovulatory
(FSH/hCG-treated) granulosa cells. Granulosa cell cultures (40,000 viable cells per
well) were incubated for 48 h in serum-free medium containing hFSH (30 ng/ml),
oLH (30 ng/ml) and/or testosterone (l|iM). Tritiated thymidine uptake was
determined after 48 h of culture as described in section 2.3. Values are mean ± SE,
data are representative of 3 experiments. Asterisks denote significant inhibition by in
vitro treatment vs. corresponding control (C or T): *, P < 0.01.
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3.2.2 Progesterone production
Progesterone production in vitro (Fig. 2.3) was used as an indication of
granulosa cell differentiation. Non-differentiated, differentiated and
preovulatory granulosa cells were treated in vitro with FSH or LFI with or
without testosterone. Differentiated granulosa cells exhibited higher basal
levels of progesterone production than levels observed in non-differentiated
granulosa cells, whilst preovulatory granulosa cells had a much greater level
of basal progesterone production. The addition of FSH or LH increased
progesterone production by non-differentiated, differentiated or
preovulatory granulosa cells. Testosterone increased progesterone
production by differentiated and preovulatory granulosa cells. FSH or LH in
the presence of testosterone further increased progesterone production by
granulosa cells at all stages of differentiation. Granulosa cells from
preovulatory follicles were more responsive to LH+T than FSH+T in vitro.
There was no significant difference in the way that differentiated and non-
differentiated granulosa cells responded to gonadotrophin treatment in vitro
in the presence of testosterone.
The general pattern that was established showed that gonadotrophin
treatment in vitro increased progesterone production by granulosa cells.
Similarly granulosa cells of increasingly differentiated state in vivo showed
increasing levels of progesterone production in vitro.
3.2.3 Oestradiol production
Oestradiol production in vitro (Fig. 2.4) was used as a measure of
granulosa cell differentiation. Non-differentiated, differentiated and
preovulatory granulosa cells were treated in vitro with FSH or LH with or
without testosterone. In the absence of aromatase substrate, testosterone,
there was no measurable oestradiol production. Testosterone increased basal
levels of oestradiol production; differentiated and preovulatory granulosa
cells produced much higher levels of oestradiol than non-differentiated cells.
FSH in the presence of testosterone further increased oestradiol production
by granulosa cells at all stages of differentiation, especially by non-
differentiated granulosa




Fig. 2.3. Effects of gonadotrophins and/or testosterone on basal progesterone
synthesis by non-differentiated (control), differentiated (FSH-treated) and
preovulatory (FSH/hCG-treated) granulosa cells. Granulosa cell cultures (40,000
viable cells per well) were incubated for 48 h in serum-free medium containing
hFSH (30 ng/ml), oLH (30 ng/ml) and/or testosterone (lp.M). Progesterone in the
spent culture medium was determined by RIA; values are mean ± SE, data are
representative of 3 experiments. Asterisks denote significant stimulation by in vitro
treatment vs. corresponding control (C or T): *, P < 0.01; **, P < 0.05.















Fig. 2.4. Effects of gonadotrophins and/or testosterone on basal oestradiol synthesis
by non-differentiated (control), differentiated (FSH-treated) and preovulatory
(FSH/hCG-treated) granulosa cells. Granulosa cell cultures (40,000 viable cells per
well) were incubated for 48 h in serum-free medium containing hFSH (30 ng/ml),
oLH (30 ng/ml) and/or testosterone (l|iM). Oestradiol in the spent culture medium
was determined by RIA; values are mean ± SE, data are representative of 3
experiments. Asterisks denote significant stimulation by in vitro treatment vs.
corresponding control (C or T): *, P < 0.01.
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cells. LH in the presence of testosterone only increased oestradiol production
by non-differentiated granulosa cells.
Generally, gonadotrophin treatment in vitro increased oestradiol
production by granulosa cells. Similarly granulosa cells of increasingly
differentiated state in vivo showed increasing levels of oestradiol production
in vitro.
3.3 Effect of FSH and LH on granulosa cell proliferation and
differentiation in vitro
The dose-dependence of FSH (pituitary and rh-FSH) on thymidine
uptake (Fig. 2.5), progesterone (Fig. 2.6) and oestradiol production (Fig. 2.7)
was established in experiments on intact animals not treated with DES. Both
pituitary and recombinant FSH dose-dependently decreased thymidine
uptake (Fig. 2.5). Maximum responses ocurred in the presence of 30 ng/ml
pituitary FSH and 1000 ng/ml rh-FSH with the ED50 being ~3 ng/ml and
-20 ng/ml respectively. Both pituitary and recombinant FSH dose-
dependently increased progesterone and oestradiol production by granulosa
cells in vitro (Fig. 2.6 and 2.7). Maximum responsesoccurred in the presence
of 30 ng/ml pituitary FSH and 300 ng/ml rh-FSH with the ED50 being -3
ng/ml and -30 ng/ml respectively. LH at the doses tested had no significant
effect on any of the parameters measured. In all cases an approximately 10-
fold higher dose of rh-FSH than pituitary FSH was necessary to elicit a
similar level of response.
3.4 Effect of DES on granulosa cell proliferation and
differentiation in vitro
Results achieved in the presence or absence of DES were not
qualitatively different from each other except for the results observed with
non-differentiated cells. Untreated granulosa cells did not respond to LH,
whereas DES treatment in vivo rendered granulosa cells LH-responsive in
vitro (Table 2.1).
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In vitro treatment (ng/ml)
Fig. 2.5. Effects of pituitary hFSFl, rh-FSH and oLH on tritiated thymidine uptake by
non-differentiated granulosa cells. Granulosa cell cultures (40,000 viable cells per
well) were incubated for 48 h in serum-free medium containing pituitary hFSH (0.1-
100 ng/ml), rh-FSH (0.1-1000 ng/ml) or oLH (0.1-10 ng/ml). Tritiated thymidine
uptake was determined after 48 h of culture as described in section 2.3. Composite
data from 5 experiments are expressed as mean ± SE. Asterisks denote significant
inhibition by in vitro treatment vs. untreated control (C): *, P < 0.01.
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Fig. 2.6. Effects of pituitary hFSH, rh-FSH and oLH on progesterone production by
non-differentiated granulosa cells. Granulosa cell cultures (40,000 viable cells per
well) were incubated for 48 h in serum-free medium containing pituitary hFSH (0.1-
100 ng/ml), rh-FSH (0.1-1000 ng/ml) or oLH (0.1-10 ng/ml). Progesterone in the
spent culture medium was determined by RIA; Composite data from 5 experiments
are expressed as mean ± SE. Asterisks denote significant stimulation by in vitro
treatment vs. untreated control (C): *, P < 0.01.
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In vitro treatment (ng/ml)
Fig. 2.7. Effects of pituitary hFSH, rh-FSH and oLH on oestradiol production by
non-differentiated granulosa cells. Granulosa cell cultures (40,000 viable cells per
well) were incubated for 48 h in serum-free medium containing 1.0 p.M testosterone
(aromatase substrate) and pituitary hFSH (0.1-100 ng/ml), rh-FSH (0.1-1000 ng/ml)
or oLH (0.1-10 ng/ml). Oestradiol in the spent culture medium was determined by
RIA; Composite data from 5 experiments are expressed as mean ± SE. Asterisks
denote significant stimulation by in vitro treatment vs. untreated control (C): *, P <
0.01; **, P < 0.05.
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DES In vitro treatment Thymidine (% of C) Oestradiol (% of C)
+ C 100 ±8 100 ±6
+ LH (30 ng/ml) 63 ± 6 * 768 ±106 *
- C 100 ±3 100 ± 21
- LH (30 ng/ml) 108+15 134 + 21
Table 2.1. Effect of DES treatment in vivo on LH-induced thymidine uptake and
oestradiol synthesis in vitro. Granulosa cell cultures (40,000 viable cells per well)
were incubated for 48 h in serum-free medium containing 1.0 pM testosterone
(aromatase substrate) and oLH (30 ng/ml). Oestradiol in the spent culture medium
was determined by RIA. Tritiated thymidine uptake was determined after 48 h of
culture as described in section 2.3. Values are expressed as a percentage ± SE of
control values in vitro. Asterisks denote significant difference due to DES treatment:
*,P<0.01.
3.5 Effect of peptide growth factors on granulosa cell proliferation
and differentiation in vitro
3.5.1 Thymidine uptake
The effect of peptide growth factors on granulosa cell proliferation in
vitro was tested. Non-differentiated, differentiated and preovulatory
granulosa cells were treated in vitro with IGF-I, inhibin or activin.
Differentiated granulosa cells exhibited basal levels of thymidine uptake
approximately one quarter of levels observed in non-differentiated granulosa
cells, whilst preovulatory granulosa cells have an even lower level of basal
thymidine uptake (Fig. 2.8). Treatment with IGF-I or inhibin reduced levels
of thymidine uptake by granulosa cells at all stages of maturity; especially
non-differentiated cells. Activin also reduced non-differentiated granulosa
cell thymidine uptake dramatically, however, it reduced differentiated and
preovulatory granulosa cell thymidine uptake to even lower levels.
3.5.2 Progesterone production
The effect of peptide growth factors on granulosa cell progesterone
production in vitro was tested. Non-differentiated, differentiated and
preovulatory granulosa cells were treated in vitro with IGF-I, inhibin or
Relative Roles ofGonadotrophins 64
In vitro treatment
Fig. 2.8. Effects of IGF-I, inhibin and activin on tritiated thymidine uptake by non-
differentiated (control), differentiated (FSH-treated) and preovulatory (FSH/hCG-
treated) granulosa cells. Granulosa cell cultures (40,000 viable cells per well) were
incubated for 48 h in serum-free medium containing IGF-I, inhibin and activin (all
30 ng/ml). Tritiated thymidine uptake was determined after 48 h of culture as
described in section 2.3. Values are mean ± SE, data are representative of at least 2
experiments. Asterisks denote significant inhibition by in vitro treatment vs.
untreated control (C): *, P < 0.01; **, P < 0.05.
Relative Roles ofGonadotrophins 65
activin. Differentiated granulosa cells exhibit higher basal levels of
progesterone production than non-differentiated granulosa cells, whilst
preovulatory granulosa cells had an even higher level of basal progesterone
production (Fig. 2.9). Non-differentiated granulosa cell progesterone
production was increased by IGF-I or inhibin and was unaffected by activin.
Differentiated granulosa cell progesterone production was unaffected by
IGF-I, inhibin and only marginally increased by activin. Preovulatory
granulosa cell progesterone production was increased by IGF-I or inhibin,
but it was decreased by activin.
3.5.3 Oestradiol production
The effect of peptide growth factors on granulosa cell oestradiol
production in vitro was tested. Non-differentiated, differentiated and
preovulatory granulosa cells were treated in vitro with IGF-I, inhibin or
activin in the presence of 1.0 pM testosterone. Differentiated and
preovulatory granulosa cells exhibit higher basal levels of oestradiol
production in the presence of testosterone as an aromatase substrate than
non-differentiated granulosa cells (Fig. 2.10). Oestradiol production at all
stages of granulosa cell differentiation was unaffected by treat ment with
IGF-I or inhibin. Non-differentiated and differentiated granulosa cell
oestradiol production was increased (P < 0.05) by activin treatment, but
preovulatory granulosa cell oestradiol production was unaffected by the
presence of activin.
3.6 Effect of gonadotrophins on levels of oestradiol and
androstenedione in blood serum
The effect of recombinant gonadotrophins on steroid levels in rat serum
was tested. Table 2.2 shows the effect of rh-FSH, r-LH and gonadotrophin
preparations containing both FSH and LH activities (PMSG and Pergonal) on
the levels of oestradiol and androstenedione in the blood of
hypophysectomised immature rats. Recombinant human FSFI alone did not
increase the levels of either steroid in the blood. LH however, in the presence
of a fixed dose of FSH,dose-dependently increased the levels of both steroids
found in the blood. Similarly, FSH in

















Fig. 2.9. Effects of IGF-I, inhibin and activin on basal progesterone synthesis by
non-differentiated (control), differentiated (FSH-treated) and preovulatory
(FSFl/hCG-treated) granulosa cells. Granulosa cell cultures (40,000 viable cells per
well) were incubated for 48 h in serum-free medium containing containing IGF-I,
inhibin and activin (all 30 ng/ml). Progesterone in the spent culture medium was
determined by RIA; values are mean ± SE, data are representative of at least 2
experiments. Asterisks denote significant difference due to in vitro treatment vs.
untreated control (C): *, P < 0.01; **, P < 0.05.






Fig. 2.10. Effects of IGF-I, inhibin and activin on basal oestradiol synthesis by non-
differentiated (control), differentiated (FSH-treated) and preovulatory (FSH/hCG-
treated) granulosa cells. Granulosa cell cultures (40,000 viable cells per well) were
incubated for 48 h in serum-free medium containing containing IGF-I, inhibin and
activin (all 30 ng/ml) and 1.0 |lM testosterone (aromatase substrate). Oestradiol in
the spent culture medium was determined by RIA; values are mean ± SE, data are
representative of at least 2 experiments. Asterisks denote significant stimulation by in
vitro treatment vs. untreated control (C): **, P < 0.05.
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Treatment Oestradiol (pM) Andostenedione (pM) FSH (mlU/ml) LH (mlU/ml)
Expt 1 - C 50 0.5 <0.5 <0.5
FSH 72 50 0.46 654 <0.5
PERGONAL 1533 6.95 226 <0.5
Expt 2 - C 66 ND <0.5 <0.5
FSH 3 64 ND 46 <0.5
FSH 10 72 ND 141 <0.5
FSH 30 68 ND 123 <0.5
FSH 100 67 ND 394 <0.5
PERGONAL 997 ND 111 <0.5
Expt 3 - C <50 0.46 ±0.03 <0.5 <0.5
FSH 0 LH 1 <50 0.77 + 0.02 ** <0.5 <0.5
FSH 0 LH 10 <50 3.50 ±0.18 * <0.5 17 ±1.7
FSH 30 LH 0 <50 0.35 ±0.05 244 ± 43 <0.5
FSH 30 LH 1 346 ± 65 * 0.69 ± 0.06 ** 211 ± 16 <0.5
FSH 30 LH 10 1168 ± 42 * 6.26 ±0.19 * 258 ± 30 18 ± 1.3
FSH 72 LH 0 <50 1.15 ±0.04 * 392 ± 77 <0.5
FSH 72 LH 1 1236±134 * 1.68 ± 0.16 * 350 ±50 <0.5
FSH 72 LH 10 1850 + 454 * 7.55 ±0.27 * 347 ±115 15 ± 1.8
PMSG 1764± 128 * 19.33 ± 1.42 * <0.5 <0.5
Expt 4 - C 52 + 7 1.30 ±0.45 ND ND
FSH 30 LH 0 45 ±3 1.70 ±0.21 ND ND
FSH 30 LH 0.1 85 + 5 * 2.30 ±0.86 ND ND
FSH 30 LH 0.3 229 ± 1 * 1.66 ±0.21 ND ND
FSH 30 LH 1 250 ± 30 * 5.59 ± 3.00 * ND ND
FSH 30 LH 3 446 ± 41 * 6.31 ± 1.96 * ND ND
FSH 30 LH 10 750 ± 104 * 5.03 ± 1.10 * ND ND
FSH 30 LH 30 1059±151 * 10.20 ±5.17 * ND ND
PMSG 1111±124 * 7.20 ± 1.60 * ND ND
Table 2.2. Effects of administration of recombinant gonadotrophins in vivo on
oestradiol, androstenedione, rh-FSH and r-LH levels in plasma. Hypophysectomised
immature female rats were treated in vivo with injection vehicle alone, rh-FSH (total
dose 3-100 IU) and/or r-LH (total dose 0.1-30 IU), Pergonal (40 IU each of LH and
FSH) with four 12-hourly injections, or a single injection of PMSG (15 IU). After 48
h the animals were killed and blood was sampled from the posterior vena cava and
analysed by specific RIA (oestradiol and androstenedione) or specific IRMA (rh-
FSH and r-LH). Results are expressed as mean ± SE, n > 6. Asterisks denote
significant stimulation by in v/votreatment vs. corresponding control: *, P < 0.01; **,
P < 0.05. ND: Not Determined.
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the presence of a fixed dose of LH dose dependently increased
oestradiol and androstenedione levels found in the blood. The table also
shows the levels of rh-FSH and r-LH found in the blood after 48 h of
gonadotrophin treatment.
3.7 Effect of FSH on hypophysectomised rat ovarian and uterine
weight and granulosa cell aromatase activity.
The effect of rh-FSH, in the absence of any other gonadotrophic
stimulus, on ovarian weight, uterine weight and aromatase activity in vitro
was tested. Treatment with a fixed dose of rh-FSH approximately doubled
the ovarian weight of hypophysectomised immature rats while having no
measurable effect on uterine weight (Fig. 2.11). Treatment with Pergonal (40
IU of both FSH and LH) caused a further doubling of ovarian weight and a
~3-fold increase in uterine weight.
Basal oestradiol production in the absence of a substrate, testosterone,
was increased by FSH treatment in vivo and was further increased by
Pergonal treatment (Fig. 2.12). FSH-stimulated oestradiol production was
unaffected by in vivo gonadotrophin treatment. Basal and FSH-stimulated
aromatase activity (oestradiol production in the presence of testosterone)
was increased by rh-FSH treatment in vivo to levels similar to those found in
cells treated in vivo with Pergonal (Fig. 2.12).
The dose-dependence of rh-FSH action on ovarian and uterine weight
and aromatase activity was established in experiments on
hypophysectomised animals. Recombinant human FSH dose-dependently
increased ovarian weight while having no effect on uterine weight (Fig. 2.13).
Basal oestradiol production was increased by increasing doses of rh-FSH but
FSH-stimulated oestradiol production was unaffected. Likewise basal and
FSH-stimulated aromatase activity was dose-dependently increased by rh-
FSH treatment in vivo (Fig. 2.14).
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In vivo treatment
Fig 2.11 Effect of rh-FSH administration in vivo on ovarian and uterine weight.
Hypophysectomised immature female rats were treated in vivo with rh-FSH (total
dose 72 IU), Pergonal (40 IU each of LH and FSH) or injection vehicle alone with
four 12-hourly injections. After 48 h the animals were killed and the ovaries and
uteri were immediately removed and cleaned of all extraneous material. Results are
expressed as weight of a single ovary ± SE, or weight of uterine horn ± SE, n > 12.
Asterisks denote significant stimulation by in vivo treatment: *, P < 0.01.
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Fig 2.12 Effect of rh-FSH administration in vivo on aromatase activity.
Hypophysectomised immature female rats were treated in vivo with rh-FSH (total
dose 72 IU), Pergonal (40 IU each of LH and FSH) or injection vehicle alone with
four 12-hourly injections. Granulosa cell cultures (40,000 viable cells per well) were
incubated for 48 h in serum-free medium with or without 1.0 fi.M testosterone
(aromatase substrate) and/or hFSH (30 ng/ml). Oestradiol in the spent culture
medium was determined by RIA; Results are expressed as pmol oestradiol produced
per 1000 cells per h ± SE, n = 6. Asterisks denote significant stimulation by in vivo
treatment vs. corresponding control: *, P < 0.01.
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Fig 2.13 Effect of rh-FSH administration in vivo on ovarian and uterine weight.
Hypophysectomised immature female rats were treated in vivo with rh-FSH (total
dose 3-100 IU), Pergonal (40 IU each of LH and FSH) or injection vehicle alone
with four 12-hourly injections. After 48 h the animals were killed and the ovaries
and uteri were immediately removed and cleaned of all extraneous material. Results
are expressed as weight of a single ovary ± SE, or weight of uterine horn ± SE, n > 6.
Asterisks denote significant stimulation by in vivo treatment vs. corresponding
control: *, P < 0.01.
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Fig 2.14 Effect of rh-FSH administration in vivo on aromatase activity.
Hypophysectomised immature female rats were treated in vivo with rh-FSH (total
dose 3-100 IU), Pergonal (40 IU each of LH and FSH) or injection vehicle alone
with four 12-hourly injections. Granulosa cell cultures (40,000 viable cells per well)
were incubated for 48 h in serum-free medium with or without 1.0 |aM testosterone
(aromatase substrate) and/or hFSH (30 ng/ml). Oestradiol in the spent culture
medium was determined by RIA; Results are expressed as pmol oestradiol produced
per 1000 cells per h ± SE, n = 3. Asterisks denote significant stimulation by in vivo
treatment vs. corresponding control: *, P < 0.01.
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3.8 Effect of LH on hypophysectomised rat ovarian and uterine
weight and granulosa cell aromatase activity.
The effect of r-LH, in the presence of a fixed dose of rh-FSH, on ovarian
weight, uterine weight and aromatase activity in vitro was tested.
Recombinant LH in the presence of rh-FSH (total dose 30 IU) increased
ovarian weight at total doses above 3 IU, and increased uterine weight at
total doses above 0.1 IU r-LH (Fig. 2.15). Basal and FSH-stimulated oestradiol
production was increased by increasing doses of r-LH (Fig. 2.16). However,
basal and FSH-stimulated aromatase activity (oestradiol production in the
presence of testosterone) was unaffected by increasing doses of r-LH in vivo
(Fig. 2.17).
4. Discussion
These data provide evidence that FSH is required for normal follicular
development, though it is unlikely that this is entirely a direct effect of the
hormone. For normal follicular differentiation and oestrogen synthesis both
FSH and LH are necessary, as previously suggested by the two-cell, two-
gonadotrophin theory of follicular oestrogen synthesis (Armstrong &
Dorrington, 1979). These actions of gonadotrophins are subject to local
regulation by factors of both granulosa and thecal cell origin.
In the absence of gonadotrophins, follicular growth can continue to the
preantral stage (Hirshfield, 1986). The present study demonstrated that FSH
is capable of stimulating the rate of granulosa cell proliferation in vivo,
especially in antral follicles. It was observed in animals treated with FSH and
hCG, to induce preovulatory follicle development, that granulosa cells
abutting the basement membrane no longer incorporated detectable levels of
BrdU, whereas antral granulosa cells were labelled. This centripetal pattern
was more striking as follicular size increased. It is possible that the mural
granulosa cells have left the cell cycle and have become differentiated.
Indeed mural granulosa cells express a higher level of LH receptor mRNA, a
marker of differentiation, than antral
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Fig 2.15 Effect of rh-LH administration in vivo on ovarian and uterine weight.
Hypophysectomised immature female rats were treated in vivo with rh-FSH (total
dose 30 IU) plus r-LH (total dose 0-30 IU), Pergonal (40 IU each of LH and FSH) or
injection vehicle alone with four 12-hourly injections. After 48 h the animals were
killed and the ovaries and uteri were immediately removed and cleaned of all
extraneous material. Results are expressed as weight of a single ovary ± SE, or
weight of uterine horn ± SE, n > 6. Asterisks denote significant stimulation by in vivo
treatment vs. corresponding control: *, P < 0.01.
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Fig 2.16 Effect of rh-LH administration in vivo on aromatase activity.
Hypophysectomised immature female rats were treated in vivo with rh-FSH (total
dose 30 IU) and r-LH (total dose 0-30 IU), Pergonal (40 IU each of LH and FSH) or
injection vehicle alone with four 12-hourly injections. Granulosa cell cultures
(40,000 viable cells per well) were incubated for 48 h in serum-free medium with or
without hFSH (30 ng/ml). Oestradiol in the spent culture medium was determined by
RIA; Results are expressed as pmol oestradiol produced per 1000 cells per h ± SE, n
= 3. Asterisks denote significant stimulation by in vivo treatment vs. corresponding
control: *, P < 0.01.
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Fig 2.17 Effect of rh-LH administration in vivo on aromatase activity.
Hypophysectomised immature female rats were treated in vivo with rh-FSH (total
dose 30 IU) and r-LH (total dose 0-30 IU), Pergonal (40 IU each of LH and FSH) or
injection vehicle alone with four 12-hourly injections. Granulosa cell cultures
(40,000 viable cells per well) were incubated for 48 h in serum-free medium
containing 1.0 p.M testosterone (aromatase substrate) and/or hFSH (30 ng/ml).
Oestradiol in the spent culture medium was determined by RIA; Results are
expressed as ymol oestradiol produced per 1000 cells per h ± SE, n = 3. Oestradiol
production appears to be substrate limited since incubating cells with 1.0 |J.M
testosterone (500 pmoles) can only produce a maximum of 500 pmoles oestradiol. In
this experiment 8 pmoles/h over a period of 48h is equivalent to about 400 pmoles
oestradiol from 500 pmoles of substrate.
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granulosa cells (Whitelaw et al. 1992). This is consistent with a general
principle of biology that proliferation and differentiation are inversely
related. These results suggest that while early follicular growth is
gonadotrophin-independent, later stages are subject to gonadotrophic
regulation. Gonadotrophins affect follicular growth by altering the
proportion of proliferating granulosa cells in large follicles. Cyclic hormonal
fluctuations may thus regulate the number of follicles that will ovulate and
ensure that the number of granulosa cells that will luteinize is adequate to
form a corpus luteum capable of sustaining pregnancy.
FSH does not stimulate granulosa cells to proliferate in vitro which
suggests that in vivo the growth stimulatory effects of FSH are mediated
through another factor(s). FSH does however stimulate granulosa cells to
express differentiated functions such as progesterone and oestradioly
synthesis (Hsueh et al. 1984). FSH with or without hCG treatment in vivo
stimulated differentiation and thereby increased the number of cells leaving
the cell cycle. In other words, cells from increasingly mature follicles contain
decreasing proportions of proliferating cells and increasing proportions of
cells expressing differentiated functions. Similarly, in vitro gonadotrophin
treatment increased the proportion of differentiated cells and inversely
decreased the number of proliferating cells. Thus gonadotrophins do not
seem to directly affect proliferation, but rather stimulate cells to differentiate
and thereby indirectly decrease the proliferative activity of a cell population.
Androgens, as well as acting as an aromatase substrate for oestradiol
synthesis enhance FSH stimulated progesterone and oestradiol synthesis in
immature rat granulosa cells (Armstrong & Dorrington, 1976; Duleba et al.
1984) and mature rat granulosa cells (Zeleznik et al. 1979). These results are
verified by our finding that testosterone enhances FSH-stimulated
progesterone production by granulosa cells of all stages of maturity in vitro.
These effects of androgens, can be blocked with an anti-androgen (Zeleznik et
al. 1979) and are therefore thought to be specific for the steroid. The
mechanism of these effects of androgens is unknown, though enhanced
cAMP production is involved (Hillier & deZwart, 1982). The fact that anti-
androgen treatment blocks these androgen effects suggest that they are
receptor-mediated, which lends support to the existence of an androgen
receptor (Schreiber & Ross, 1976). Testosterone also enhances LH-responsive
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granulosa cell steroid production in vitro consistent with previous findings
(Nimrod & Lindner, 1976). It is however unclear why the presence of
testosterone should have blocked any LH-responsive decrease in
proliferation without affecting LH-induced progesterone production by the
same cells (figs. 2.2 and 2.3). It appears that the enhancement of LH-
responsiveness in immature granulosa cells by DES in vivo is negated by the
effects of testosterone in vitro. The parallel situation occurs in vivo where
testosterone treatment blocks DES-stimulated ovarian weight gain in
hypophysectomised immature female rats (Hillier & Ross, 1979). The
significance of these observations, if any, is unclear.
v
Oestrogens increase ovarian weight in hypophysectomised rats (Louvet
et al. 1975) though there are few reports of the growth-promoting effects of
oestrogens on granulosa cells in vitro . It has been reported that
thecal /interstitial cells are required for oestradiol to induce granulosa cell
DNA synthesis (Bley et al. 1991), thereby implicating factors of
thecal/interstitial origin in the mediation of this effect of oestradiol (Bendell
& Dorrington, 1991). In vivo, DES enhances granulosa cell proliferation as
assessed by BrdU incorporation, which is consistent with a requirement for
thecal/interstitial derived signalling for oestrogen effects on cellular
proliferation. The demonstration that DES promotes the induction of LH-
responsiveness in immature granulosa cells which normally are unable to
respond to LH (Table 2.1) supports the findings of previous studies
(Goldenburg et al. 1972; Richards et al. 1979). This induction of LH receptor
occurs in the presence of only very low levels of gonadotrophins and
therefore seems to be a gonadotrophin-independent effect. The physiological
implications of this finding are difficult to understand.
The effects of FSH on proliferation seem likely to be mediated by local
regulators since FSH in vitro is unable to stimulate proliferation as it does in
vivo. Rat granulosa cells seem to be resistant to further stimulation of
proliferation in vitro and thus there have been few published studies of the
effects of locally produced factors on rat granulosa cell proliferation in vitro
(Gospodarowicz & Bialecki, 1979; Orly et al. 1984) The reason for this
resistance is not clear, but it is likely that the lack of a system capable of
providing adequate support for rat cellular proliferation in vitro is the main
cause. As stated above oestrogens enhance the responsiveness of granulosa
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cells to a thecal/interstitial-derived mitogen. It seems that granulosa cell
growth is a tightly regulated event requiring complex interactions between
locally produced factors derived from both ovarian cell types. The effects of
IGF-I, inhibin and activin on granulosa cell thymidine uptake observed in
this study are most probably due to the induction of granulosa cell
differentiated functions by these factors rather than direct effects on cell
proliferation. This conclusion is emphasised by the fact that any significant
effects of the factors on thymidine uptake occurred in immature cells that
were presumably induced to differentiate in vitro by these factors. Likewise,
IGF-I is known to stimulate granulosa cell proliferation in granulosa cells of
other species (Adashi et al. 1985a), yet it failed to stimulate thymidine uptake
in our system.
Interestingly, oestradiol production in vitro by cells of all stages of
maturity was not affected by IGF-I or inhibin (Fig. 2.10). However, both these
factors increased progesterone production by immature and preovulatory
cells, but not differentiated granulosa cells (Fig. 2.9). This indicates that
inhibin and IGF-I increase P450scc selectively without affecting P450arom
activity. Activin had only a small stimulatory effect on non-differentiated
and differentiated granulosa cell oestradiol production in vitro (Fig. 2.10)
while it only increased progesterone production by differentiated granulosa
cells (Fig. 2.9). Treatment with FSH plus hCG did not significantly affect
oestradiol production but progesterone production was decreased, though
not to non-differentiated levels (Fig. 2.9). These data illustrate that aromatase
activity and progesterone production are differentially regulated throughout
follicular maturation and suggest that the complex regulation of
steroidogenesis during development may involve one or more of these
factors.
FSH enhances granulosa cell aromatase activity, resulting in increased
conversion of androgens to oestrogens (Dorrington et al. 1975), but in the
absence of androgen substrate granulosa cells are incapable of producing
oestrogens (Fig. 2.4). Since aromatase substrate is produced in the
thecal/interstitial cell under the influence of LH (Fortune & Armstrong,
1977), both FSH and LH are thought to be essential for oestrogen
biosynthesis (Armstrong & Dorrington, 1979). This two-cell, two-
gonadotrophin theory of oestrogen synthesis has been verified by the use of
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recombinant gonadotrophins to dissect out the precise contributions of
gonadotrophins to normal oestradiol production. By measuring steroid
levels in the blood of immature hypophysectomised rats treated with
recombinant gonadotrophins this study has shown that FSH is unable to
increase blood oestradiol levels in the absence of LH. However in the
presence of a fixed low dose of LH then FSH dose-dependently increases
oestradiol. Likewise in the presence of a fixed low dose of FSH then LH
dose-dependently increases oestradiol. Androgen accumulation in rat
plasma follows a similar pattern of gonadotrophic stimulation. In fact FSH
dose-dependently increases androgen production in the presence of LH.
Since thecal/interstitial cells are the only ovarian cell type capable of
producing androgens (Fortune & Armstrong, 1977), and granulosa cells the
only ovarian cell type capable of responding directly to FSH (Dorrington et
al. 1975), this data suggests that some communication occurs between FSH-
stimulated granulosa cells and androgen producing thecal/interstitial cells.
FSH alone is capable of stimulating follicular growth as indicated by
dose-dependent increases in ovarian weight. It was also demonstrated that
in the presence of a fixed dose of FSH, LH is also capable of increasing
ovarian weight, though this is most probably due to thecal cell hypertrophy
rather than follicular development (Erickson et al. 1985), caused by the atretic
actions of androgens (Louvet et al. 1975). In keeping with the two-cell theory
of follicular oestrogen production, FSH alone is incapable of eliciting any
increases in uterine weight (which correlates well with oestradiol
measurements in rat serum), and therefore cannot induce oestradiol
production alone. However, in the presence of a fixed dose of FSH, LH
causes uteri to balloon and thus uterine weight increases in a dose-
dependent manner. From these results it is evident that both FSH and LH are
necessary for follicular oestrogen synthesis. Though recombinant FSH can
only induce the potential for aromatisation, oFSH can actually increase
oestradiol production alone (Fig. 2.4). This difference is undoubtably due to
LH contamination which indicates that very low levels of LH are sufficient to
support FSH-stimulated oestrogen synthesis. FSH therefore is the primary
stimulus to follicular oestrogen synthesis since it stimulates aromatase
activity, but LH is also essential to provide support for FSH by supplying
aromatase substrate.
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In conclusion, FSH is the main stimulus for follicular growth and
differentiation of granulosa cells, though the actions of FSH are mediated by
locally produced factors. These data also suggest that low levels of LH are
adequate for normal follicular maturation and LH plays a fadlitatory role in
this process. The aim of the rest of this thesis is to investigate paracrine
mechanisms that modulate gonadotrophin action on the ovary during
normal follicular development and oestrogen synthesis.
Chapter 3. Validation of a Thecal/Interstitial Cell
Culture System
1. Introduction
The previous chapter described a study designed to determine the
precise contribution of FSH and LH to normal follicular development and
steroidogenesis. Having gained an insight into the individual effects of FSH
and LH during follicular development it was the aim of this project to
determine how the effects of each gonadotrophin are modulated at the level
of the gonad. In particular the aim was to determine how thecal cell function
(androgen synthesis) is affected by gonadotrophins and locally modulated.
This chapter describes the validation of a model culture system for the study
of rat thecal/interstitial cell steroidogenesis in vitro based on an existing
method developed by Magoffin and Erickson (Magoffin & Erickson, 1982b).
Androgen production in response to LH was used as a marker for hormonal
responsiveness during the validation of this system.
In all mammals, thecal/interstitial cells, under primary hormonal
control by LH (Bogovich & Richards, 1982), are the site of synthesis of
androgens, essential substrates for oestrogen biosynthesis (Erickson et al.
1985). The first convincing evidence that the ovary produced androgens was
provided when it was discovered that ovaries grafted to the ears of male
castrate mice stimulated atrophic seminal vesicles and prostates to return to
their normal states (Hill,1937; Parkes, 1950). These findings were interpreted
as evidence that the ovary secreted a male hormone into the circulation. It
was subsequently reported that the masculinisation effect was independent
of the adrenal gland (Deanesly, 1938), and that androgenic activity appeared
to be associated with the theca interna of the follicles. Over 20 years later,
work with explants of prostatic tissue (used as a marker of androgen
synthesis) and ovarian fragments in the anterior chamber of the eye of a rat
demonstrated that the theca interna and interstitial cells were the source of
/
ovarian androgens (Falck et al. 1962). The final proof was provided by the
use of biochemical techniques (Ryan & Petro, 1966; Rice & Savard, 1966), to
discover that the theca interna and secondary interstitial tissue synthesise
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androgens de novo. Since the mid-sixties much research has been devoted to
understanding the significance of ovarian androgen production and how this
process is regulated. It is clear that the primary hormonal control of
androgen biosynthesis is by LH (Bogovich & Richards, 1982), but different
follicular populations of thecal/interstitial cells respond differently to the
same LH stimulus and thus it is also clear that there must be a secondary
intrafollicular level of regulation.
Despite the importance of ovarian androgens, as described above, and
hence the central role of thecal/interstitial cells in reproductive processes,
the hormonal regulation of thecal/interstitial cell differentiation and
function is poorly understood. The primary reason for this is that
thecal/interstitial cells are embedded in connective tissue which makes it
difficult to isolate them from granulosa cells and other contaminants. This
chapter describes the validation of a primary serum-free cell culture model
for thecal/interstitial cells that are capable of being hormonally stimulated to
express differentiated functions.
2. Materials and Methods
2.1 Animals
Intact or hypophysectomized 21-day old female rats were purchased
from Charles River UK Limited (Margate,Kent). All animals were killed by
carbon dioxide asphyxiation at 25 (intact) or 27 days (hypophysectomized) of
age. Ovaries were immediately removed for isolation of thecal/interstitial
cells.
2.2 Isolation and culture of thecal/interstitial cells
The isolation of thecal/interstitial cells was based on a previously
reported method (Magoffin & Erickson, 1982b), with the main difference
being that ovaries were depleted of granulosa cells before enzymic digestion
to release thecal cells. All visible ovarian follicles were first punctured using
a 27 G hypodermic syringe needle to eliminate as many granulosa cells as
possible. Residual ovarian tissue was then rinsed in culture medium before
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enzymic digestion by incubation for 30 min at 37°C in fresh medium
containing 0.1% (w/v) collagenase CI. histolyticum type II (Sigma) and 0.01%
DNase (Sigma). The medium was Medium-199 (Gibco) containing Earle's
salts, 25 mM HEPES buffer, penicillin (50 IU/ml), streptomycin (50 mg/ml)
and additional (2.0 mM) L-glutamine, supplemented with 0.1% (w/v) BSA.
Complete dispersal into a single-cell suspension was achieved by repeated
pipetting at the end of this incubation. The cells were sedimented by
centrifugation (5 min at 800 x g), resuspended in 2ml of fresh culture
medium containing 5.0% (v/v) donor calf serum (Gibco) and counted in a
haemocytometer. Cell viability, determined by staining with trypan blue,
was consistently >90%.
Multiwell plastic culture dishes (Linbro Space Savers™ from Flow
Laboratories, Rickmansworth, Herts, UK.) were inoculated with replicate 0.5
ml portions of thecal cell suspension (40,000 cells) in culture medium
containing 5.0% donor calf serum (DCS). Pre-incubation in serum-
containing medium to allow cell anchorage and recovery from the enzymic
dispersal procedure was for 24 h at 37°C in a humidified atmosphere of 5%
CC>2/95% air. After removing the serum-containing medium and washing
the cell monolayers with 1.0 ml pre-warmed (37 °C) PBS, each culture well
received 0.5 ml serum-free medium with or without human LH (LER-1972,
5179 IU LH/mg, 2.5 IU FSH/mg) (generously donated by Dr. L.E.Reichert
Jr.) at concentrations between 0.1 and 30 ng/ml. In some experiments, rh-
inhibin-A (Genentech Inc), rDNA-human inhibin 90/522, rDNA-human
inhibin 91/624, 1st International standard for porcine inhibin (86/690) (all at
concentrations from 0.1 to 30 ng/ml); human follicular fluid (92/696),
collected from patients undergoing oocyte removal after FSH stimulation, at
a concentration of 5.5% (all from National Institute for Biological Standards
and Control, Potters Bar, Hertfordshire); rh-IGF-I ( 0.1 to 30 ng/ml); rh-FSH
at concentrations between 25 and 100 ng/ml, or rh-activin-A (30 ng/ml)
were also added to the cultures. All treatments were done in triplicate.
Incubation was normally for 48 h at 37°C, after which the medium was
collected and stored frozen at -20 °C for subsequent analysis of androgen
content by RIA, as described below. During the time-course experiment
incubation was for 24 h, 48 h or 72 h.
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2.3 Discontinuous density centrifugation
In order to produce a population of thecal/interstitial cells devoid of
granulosa cell contamination, residual ovary cell suspensions were
Fig. 3.1. Purification of ovarian thecal/interstitial cells by discontinuous Percoll
centrifugation. Dispersed residual ovary was centrifuged through Percoll (5 = 1.055).
The thecal/interstitial cells were collected by aspiration and then washed before
culture.
purified by discontinuous density centrifugation based on a previously
published method (Magoffin & Erickson, 1988^. First, 1 ml of 44% Percoll
(Sigma; d = 1.13 g/ml) in Medium-199 (containing Earle's salts, 25 mM
HEPES buffer, penicillin (50 IU/ml), streptomycin (50 mg/ml) and
additional (2.0 mM) L-glutamine, supplemented with 0.1% (w/v) BSA) was
pipetted into a sterile 12 x 75 mm Falcon centrifuge tube (Becton Dickinson &
Co, Lincoln Park, NJ). Two ml of a Percoll solution adjusted to a specific
gravity of 1.055 were carefully layered on top of the 44% solution. Dispersed
residual ovary^as described above) were carefully layered on top of the d =
1.055 Percoll solution. The cells were centrifuged at 400 x g for 20 min at 4°C.
The thecal/interstitial cells were collected by aspiration from the d = 1.055
layer (Fig. 3.1). The cells were washed in Medium-199 and the pellet
resuspended in 2ml of fresh culture medium containing 5.0% (v/v) donor
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calf serum (Gibco) and counted in a haemocytometer. Cell viability,
determined by staining with trypan blue, was consistently >90%. Cells were
cultured as described above. The equation used to calculate the dilutions
necessary to achieve a final d of 1.055 is as follows;
d - 0.1dx - 0.9
Vo = V
do -1
Where: Vo = volume of Percoll (ml)
do = 8 of Percoll (1.130 g/ml)
dx = 5 of Medium-199 (1.058 g/ml)
V = volume required for final working solution (ml)
and d = 8 required for final working solution (g/ml).
2.4 Steroid Radioimmunoassays
2.4.1 Oestradiol Radioimmunoassay
Oestradiol-17(3 was measured in culture media by specific RIA as
described in Chapter 2, section 2.5.2.
2.4.2 Androstenedione Radioimmunoassay
Androstenedione in spent culture medium was determined by specific
RIA as described in Chapter 2, section 2.5.3.
2.4.3 Androsterone Radioimmunoassay
Androsterone in spent culture medium wast determined by specific
RIA. The assay buffer was PBS/gelatin (0.05M sodium phosphate, 0.15M
NaCl, 0.1% gelatin). The androsterone antiserum was rabbit anti-
androsterone-3-hemisuccinyl-BSA (Hillier et al. 1981). Major cross-reactions
were: androsterone 100%; 5«tandrostane-3,17-dione 175%; androstenedione
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5%; and less than 0.5% for all other steroids tested. Tracer, [9,11-3H]-
Androsterone, was diluted in assay buffer to give ~10,000cpm/500^jl. A
standard curve covering the range of 0.025 to 6.4 pmoles/tube androsterone
(Sigma), made up in culture medium, was used. Samples (5-100 Jal) or
standards (in 200 jtll) were placed in tubes, and the volume of samples was
adjusted to 200 jal. Quality controls (0.08 and 2.4 pmoles/tube) were also
included at the beginning and end of each assay. Antibody (300 ^tl) and
tracer (500 ^Ul) were added, and tubes were incubated at 37°C for 1 h then at
4°C for 1 h. Tubes were placed on ice before addition of 200jbl dextran
charcoal (1.25% dextran, 1.25% charcoal in assay buffer) to separate bound
and free steroid. Tubes were mixed and incubated for lOmin on ice, then
centrifuged at 3000 rpm for lOmin at 4°C. Supernatants were decanted, 3 ml
scintillation cocktail (RIALUMA) was added, and bound tracer was
measured by liquid scintillation counting (RackBeta). Standard curves were
calculated using a commercial computer program (AssayZap). Samples
which were outside the detection limits were re-assayed at the appropriate
volume. The detection limit of the assay was in the range 0.03-0.04
pmoles/tube. Inter- and intra-assay coefficients of variation were less than
15%. Steroid production rates are expressed as picomoles of androsterone
per culture/48 h.
2.5 Statistics
Statistical analysis was carried out using commercial software (CLR
ANOVA). Analysis of variance with the Newman-Keuls test was used to
analyse differences between experimental and control observations.
Differences assigned a P value of <0.05 were regarded as statistically
significant.
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3. Results
3.1 LH-dependent androgen production by rat thecal/interstitial
cells in vitro
Androgen production in response to hLH was used as a marker for
thecal/interstitial cell hormonal responsiveness during the validation of the
cell culture system. Treatment with hLH in vitro elicited a dose-related
increase in androgen production by non-Percoll treated cultured
thecal/interstitial cells (Fig. 3.2) with significant (P < 0.01) stimulation at a
lowest dose of 1 ng/ml. Maximum response occurred in the presence of hLH
at a concentration of 10 ng/ml, with an ED50 of ~3 ng/ml. Cultured
thecal/interstitial cells produced roughly similar amounts of
androstenedione and androsterone. Results were therefore combined and
expressed as total androgen production.
Thecal/interstitial cells isolated from hypophysectomised animals
produced similar amounts of androgen to cells from intact controls and
showed similar sensitivity and responsiveness to hLH in vitro (Fig. 3.3).
3.2 Demonstration of thecal/interstitial cell purity
In order to demonstrate the purity of the thecal/interstitial cell cultures,
residual ovary dispersates were further purified using discontinuous Percoll
density gradient centrifugation. Thecal/interstitial cells isolated from intact
animals and further purified using the Percoll gradient exhibited levels of
basal and LH-stimulated androgen production similar to those produced by
thecal/interstitial cells from intact animals that underwent no further
purification (Fig. 3.4).
Treatment of cultured thecal/interstitial cells in vitro with hLH at
concentrations up to 30 ng/ml did not significantly increase oestradiol
production (Fig. 3.5) but did dose-dependently increase androgen
production. Androgens are a substrate for granulosa cell oestradiol
production (Erickson et al. 1985) but this experiment illustrates the lack of
granulosa cell aromatase activity in the cultures.
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Fig. 3.2. LH-responsive androgen production in vitro by thecal/interstitial cells from
the ovaries of intact female rats. Thecal/interstitial cell cultures (40,000 viable cells
per culture well) were incubated for 48 h in serum-free medium containing
increasing doses of hLH (0.03 to 30 ng/ml). Androstenedione+androsterone
accumulation in spent culture medium was determined by RIA. Composite data from
5 experiments are expressed as mean ± SE.
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Fig. 3.3. LH-responsive androgen production in vitro by thecal/interstitial cells from
the ovaries of intact female rats and hypophysectomized female rats.
Thecal/interstitial cell cultures (40,000 viable cells per culture well) were incubated
for 48 h in serum-free medium containing increasing doses of hLH (0.03 to 30
ng/ml). Androstenedione+androsterone accumulation in spent culture medium was
determined by RIA. Composite data from 2 experiments are expressed as mean ±
SE. There was no significant difference in LH-responsive androgen production by
thecal/interstitial cells from the ovaries of intact or hypophysectomised animals.
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Fig. 3.4. Effect of Percoll density gradient purification of thecal/interstitial cells from
the ovaries of intact animals. Dispersed cells were either centrifuged through Percoll
(5 = 1.055) and the thecal/interstitial cells were collected by aspiration, or dispersed
thecal/interstitial cells were cultured directly. Thecal/interstitial cell cultures (40,000
viable cells per culture well) were incubated for 48 h in serum-free medium
containing hLH (10 ng/ml). Androstenedione+androsterone accumulation in spent
culture medium was determined by RIA. Data from a representative experiment are
expressed as mean ± SE (n = 3). There was no significant difference in LH-
responsive androgen production by thecal/interstitial cells from the ovaries of intact
or hypophysectomised animals or Percoll purified thecal/interstitial cells.
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Fig. 3.5. Lack of LH-responsive oestradiol production in vitro by thecal/interstitial
cells from the ovaries of intact female rats. Thecal/interstitial cell cultures (40,000
viable cells per culture well) were incubated for 48 h in serum-free medium
containing increasing doses of hLH (0.03 to 30 ng/ml).
Androstenedione,androsterone and oestradiol accumulation in spent culture medium
was determined by RIA. Composite data from 5 experiments are expressed as mean
± SE. There was no significant stimulation of oestradiol accumulation by LH.
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Treatment of cultured thecal/interstitial cells in vitro with rh-FSH at
concentrations up to 100 ng/ml did not significantly increase androgen
production (Fig. 3.6), confirming the lack of intrinsic LH-like activity of the
rh-FSH preparation as well as illustrating the lack of any FSH responsive
androgen production in vitro due to stimulation by granulosa cell derived
factors. Similarly FSH can stimulate granulosa cell production of
progesterone (Hillier et al. 1978), a substrate for thecal/interstitial cell
androgen production (Lishinsky & Armstrong, 1983).
3.3 Time course of androgen production
To establish the optimal culture period to study the control of androgen
production, a time course of androgen accumulation by thecal/interstitial
cell cultures was established. Thecal/interstitial cells cultured for up to 72 h
in the absence of any treatment showed increasing androgen accumulation
over the time period (~4-fold increase). In the presence of hLH at a
concentration of 10 ng/ml the increase was more dramatic (~8-fold) during
the total time period (Fig. 3.7). The highest rate of LH-stimulated androgen
production was between 24 h and 48 h, after which the rate declined.
Therefore 48 h was chosen as the best time period to study the control of
androgen production by thecal/interstitial cells in vitro.
3.4 Effect of recombinant human inhibin on thecal/interstitial cell
androgen synthesis
To test the influence of a putative paracrine factor on thecal/interstitial
androgen synthesis in this system, cells were cultured with rh-inhibin-A in
the presence and absence of hLH. Recombinant human inhibin-A (30 ng/ml)
alone did not measurably affect the low basal androgen production by
thecal/interstitial cells from intact animals. However rh-inhibin-A (30
ng/ml) augmented LH-stimulated androgen production ~3-fold (Fig. 3.8).






Fig. 3.6. Lack of FSH-responsive androgen production in vitro by thecal/interstitial
cells from the ovaries of intact female rats. Thecal/interstitial cell cultures (40,000
viable cells per culture well) were incubated for 48 h in serum-free medium
containing increasing doses of rh-FSH (25 to 100 ng/ml).
Androstenedione+androsterone accumulation in spent culture medium was
determined by RIA. Data from a representative experiment are expressed as mean ±
SE (n=3). There was no significant stimulation of androgen accumulation by FSH.
























Control LH (10 ng/ml)
In vitro treatment
Fig. 3.7. Time course of androgen accumulation in vitro by thecal/interstitial cells
from the ovaries of intact female rats. Thecal/interstitial cell cultures (40,000 viable
cells per culture well) were incubated for 24 h, 48 h or 72 h in serum-free medium
containing hLH (10 ng/ml). Androstenedione+androsterone accumulation in spent
culture medium was determined by RIA. Composite data from 2 experiments are
expressed as mean ± SE.
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Fig. 3.8. Effect of inhibin on LH-responsive androgen production in vitro by
thecal/interstitial cells from the ovaries of intact female rats. Thecal/interstitial cell
cultures (40,000 viable cells per culture well) were incubated for 48 h in serum-free
medium with and without hLH (10 ng/ml) and/or rh-inhibin-A (30 ng/ml).
Androstenedione+androsterone accumulation in spent culture medium was
determined by RIA. Composite data from 6 experiments are expressed as mean ±
SE. Significant differences due to inhibin are indicated (P < 0.01).
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This culture system was also validated using five other inhibin
preparations as part of an International study of rh-inhibin (Fig. 3.9).
Recombinant DNA-human inhibin 90/522 (J) and a coded duplicate (M) (30
ng/ml) both produced a 7.2-fold increase in LH-stimulated androgen
synthesis. Recombinant DNA-human inhibin 91/624 (K) elicited an 11.2-fold
increase. A coded duplicate of this preparation (L) elicited a 10.8-fold
increase in androgen synthesis. The 1st International standard for porcine
inhibin (86/690; N) elicited a 5.4-fold increase in LH-stimulated androgen
synthesis. Human follicular fluid (92/696; P) at a concentration of 5.5% (v/v)
increased LH-stimulated androgen synthesis nearly 10-fold. A dose
response to these inhibin preparations is shown in Fig. 3.10.
3.5 Effect of recombinant human IGF-I on thecal/interstitial cell
androgen synthesis
Cells were cultured with rh-IGF-I in the presence and absence of hLH
to test the influence of this factor on thecal/interstitial androgen synthesis in
this system. Recombinant human IGF-I (30 ng/ml) alone approximately
doubled the levels of basal androgen production by thecal/interstitial cells
from intact animals. In the presence of hLH (10 ng/ml), rh-IGF-I (30 ng/ml)
increased LH-stimulated androgen production by nearly 50% (Fig. 3.11).
3.6 Effect of recombinant human activin on thecal/interstitial cell
androgen synthesis
Thecal/interstitial cells were cultured with rh-activin-A in the presence
and absence of hLH to test the effect this factor has on androgen synthesis in
the culture system. Recombinant human activin-A (30 ng/ml) alone did not
measurably affect the low basal androgen production by thecal/interstitial
cells from intact animals. Likewise rh-activin-A (30 ng/ml) did not
measurably affect LH-stimulated androgen production (Fig. 3.12).
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Fig. 3.9. Effect of inhibin on LH-responsive androgen production in vitro by
thecal/interstitial cells from the ovaries of intact female rats. Thecal/interstitial cell
cultures (40,000 viable cells per culture well) were incubated for 48 h in serum-free
medium with and without hLH (10 ng/ml) and/or rh-inhibin-A. The inhibin
preparations were: Genentech rh-inhibin-A; rDNA-human inhibin 90/522 (J and M);
rDNA-human inhibin 91/624 (K and L); 1st international standard for porcine
inhibin (86/690; N) and human follicular fluid (92/696; P).
Androstenedione+androsterone accumulation in spent culture medium was
determined by RIA. Composite data from 2 experiments are expressed as mean ±
SE. Significant differences due to inhibin are indicated (*P < 0.01).
Thecal Cell Culture 100
Inhibin (ng/ml)
Fig. 3.10. Effect of inhibin on LH-responsive androgen production in vitro by
thecal/interstitial cells from the ovaries of intact female rats. Thecal/interstitial cell
cultures (40,000 viable cells per culture well) were incubated for 48 h in serum-free
medium with and without hLH (10 ng/ml) and/or rh-inhibin-A (3 - 100 ng/ml). The
inhibin preparations were: Genentech rh-inhibin-A; rDNA-human inhibin 90/522 (J
and M); rDNA-human inhibin 91/624 (K and L) and 1st International Standard for
Porcine Inhibin (86/690; N). Androstenedione+androsterone accumulation in spent
culture medium was determined by RIA. Composite data from 2 experiments are
expressed as mean ± SE.
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Fig. 3.11. Effect of IGF-I on LH-responsive androgen production in vitro by
thecal/interstitial cells from the ovaries of intact female rats. Thecal/interstitial cell
cultures (40,000 viable cells per culture well) were incubated for 48 h in serum-free
medium with and without hLH (10 ng/ml) and/or rh-IGF-I (30 ng/ml).
Androstenedione +androsterone accumulation in spent culture medium was
determined by RIA. Composite data from 5 experiments are expressed as mean ±
SE. Significant differences due to IGF-I are indicated (P < 0.01).




Fig. 3.12. Effect of activin on LH-responsive androgen production in vitro by
thecal/interstitial cells from the ovaries of intact female rats. Thecal/interstitial cell
cultures (40,000 viable cells per culture well) were incubated for 48 h in serum-free
medium with and without hLH (10 ng/ml) and/or rh-activin-A (30 ng/ml).
Androstenedione +androsterone accumulation in spent culture medium was
determined by RIA. Composite data from 2 experiments are expressed as mean ±
SE. There were no significant differences due to activin.
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4. Discussion
The immature rat ovary contains a population of active androgen-
producing cells which are localised in the theca and the secondary interstitial
\J \/
gland (Falck et al. 1962; Fortune & Armstrong, 1977). The results reported in
this chapter have yielded a simple and reproducible system for culturing
these androgen-producing cells in a purified form. Importantly the cells are
hormonally responsive in serum-free culture and express differentiated
functions in response to physiological concentrations of LH.
The ovarian androgens are of major physiological importance for
oestrogen biosynthesis (Dorrington et al. 1975), follicular progesterone
production (Armstrong & Dorrington, 1976), atresia (Hillier & Ross, 1979)
and the onset of puberty. This study shows that isolated thecal/interstitial
cells from intact and hypophysectomised animals are able to dose-
dependently respond to physiological concentrations of LH in serum-free
medium with the expression of normal differentiated functions. The two
major androgens produced by rat thecal/interstitial cells in this system are
androstenedione (an aromatisable C49 androgen) and androsterone (a non-
aroma tisable 5a-reduced androgen). Both these androgens are detected in
roughly equal amounts by RIA indicating similarly high levels of 5a-
reductase and P45017a activities in this model culture system.
A potentially significant disadvantage of thecal/interstitial cell cultures
is the presence of granulosa cell contamination. Granulosa cells would be
expected to secrete a variety of steroid and peptide hormones that can
stimulate or inhibit thecal cell functions and therefore their presence can
make the interpretation of experimental results difficult. To ensure the
thecal/interstitial cells used for culture were as pure as possible we adopted
a discontinuous Percoll gradient to separate thecal/interstitial cells from
contaminating granulosa cells. A solution of Percoll with the specific gravity
adjusted to 1.055 g/ml allows the majority of thecal/interstitial cells to
sediment, but at the same time the granulosa cells (which possibly contain
more cholesteryl esters in their cytoplasm) and other less dense cell types
would float. To remove the red blood cells a 44% Percoll layer was placed at
the bottom of the tube. However, Percoll separation did not noticeably
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increase the purity of the thecal /interstitial cell cultures as measured by
androgen production and as such this method was discontinued. We
demonstrated a lack of oestrogen production by rat thecal/interstitial cells in
vitro in response to increasing doses of LH and androstenedione, an
1/
aromatase substrate (Erickson et al. 1985). In the same culture there was a
concomitant dose-dependent increase in LH-responsive androgen
production. It would be expected that FSH would increase granulosa cell
progesterone accumulation (Hillier et al. 1978), a substrate for
thecal/interstitial cell P45017a (Lishinsky & Armstrong, 1983), and therefore
increase androgen production. Therefore the finding that there was no
measurable change in basal androgen production in response to increasing
doses of FSH was interpreted as a lack of significant granulosa cell
contamination.
A consequence of culturing ovarian thecal/interstitial cells is that they
may spontaneously luteinize in culture. An in vivo characteristic of rat
thecal/interstitial cells is the loss of P45017a expression around the time of
ovulation, resulting in a switch from androgen to progesterone production
by thecal/interstitial cells (Bogovich et al. 1986; Richards et al. 1986). By pre¬
incubation in 5% DCS we avoid this hazard and are able to maintain LH
responsive androgen production for at least 72 h. The greatest rate of
androgen production occurred between 24 h and 48 h, after which androgen
production began to decline. Therefore a 48 h culture period was chosen as a
suitable time period for the study of the control of androgen production by
thecal/interstitial cells.
It has been previously reported that peptide growth factors such as
inhibin (Hsueh et al. 1987) and IGF-I (Adashi et al. 1985a) may have a
modulatory role in the control of androgen synthesis by thecal/interstitial
cells. In our studies inhibin has no effect alone but does enhance LH-
stimulated androgen synthesis up to 3-fold. This effect was verified using 5
different inhibin preparations during an international collaborative study of
the proposed international standard for recombinant DNA-derived human
inhibin. IGF-I alone approximately doubled basal androgen synthesis and
increased LH-stimulated androgen synthesis by up to 50%. These results
show that thecal/interstitial cells in this culture system are capable of
responding to putative local modulators of androgen synthesis.
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In conclusion, this chapter describes the validation of a culture system
employing rat thecal/interstitial cells that respond to LH in a manner similar
to the in vivo situation where androgen synthesis is increased in response to
LH. The results presented in this chapter indicate that the culture of
immature rat thecal/interstitial cells is suitable for use as an in vitro bioassay
for rh-inhibin-A. In particular the cell culture system is a powerful tool for
the study of paracrine modulation of thecal/interstitial cell androgen
production. The next chapter utilises this culture system to investigate the
regulation of thecal/interstitial cell function by potential paracrine factors of
granulosa cell origin.
Chapter 4. Regulation of Androgen Synthesis
1. Introduction
In the previous chapter a thecal/interstitial cell culture was validated
for the study of the control of androgen prodution. This chapter describes an
investigation of the intrafollicular regulation of LH-stimulated
thecal/interstitial cell androgen synthesis utilising the cell culture system
and Northern hybridisation. Thecal/interstitial cells, under the endocrine
control of LH, are major sites of androgen biosynthesis in the ovary.
Cytochrome P450C17a (17-hydroxylase/Cl7-20 lyase) in these cells is the LH-
responsive steroidogenic enzyme vital for androgen synthesis (Bogovich &
Richards, 1982), and hence the provision of aromatase substrates required for
estrogen synthesis in FSH-stimulated granulosa cells (Erickson et al. 1985).
The principal function of the ovary is the regular production of
fertilisable oocytes. In order to accomplish this, a continual supply of
primordial follicles must be recruited to begin growth and development.
During the process of follicle growth a fraction of the growing follicles are
selected to become dominant preovulatory follicles; the remainder undergo
atresia. As they grow to preovulatory size, the dominant follicles secrete
increasing amounts of oestradiol, which at the appropriate time triggers the
preovulatory surge of LH and ultimately ovulation. There is a large body of
literature that supports the fact that thecal cells play an essential role in these
processes of follicle growth, selection, atresia, and oestradiol biosynthesis.
During follicular growth and development the presumptive theca cells
differentiate in an orderly and tightly controlled manner resulting in the
sequential acquisition and loss of functional capabilities. These changes
require the expression of a characteristic pattern of genes unique to the theca
cell in a development-related manner. As the primordial follicle develops
through preantral stages the theca cells express the genes for LH receptors,
cholesterol side chain cleavage and 3(3-hydroxysteroid dehydrogenase
resulting in the capacity to respond to LH and produce progesterone but not
androgens (Bogovich & Richards, 1982). When a follicle becomes selected to
ovulate, physiologically low concentrations of LH present in the follicular
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phase of the cycle stimulate growth and development of small antral follicles
to the preovulatory stage (Richards et al. 1980; Bogovich et al. 1981). As the
teJfcs
antral follicles grow to preovulatory size the theca^express functional
/
P450C17a and shift from progesterone producing to primarily androgen
producing cells (Bogovich & Richards, 1982; Richards & Hedin, 1988). After
ovulation the theca cells stop expressing P450C17a and lose the ability to
produce androgens (Bogovich et al. 1986). As well as endocrine regulation
by LH, thecal/interstitial P450C17a activity is likely to be subject to
paracrine regulation by factors produced by granulosa cells. In vitro studies
implicate diverse steroidal (e.g. oestradiol) and non-steroidal regulatory
factors (e.g. inhibins and activins) in such a system but direct experimental
evidence is lacking that paracrine signalling operates in vivo (Hillier, 1991a;
Hillier, 1991b).
Previous attempts to demonstrate paracrine signalling in the ovarian
follicle in vivo have generally been hampered by the unavailability of
suitably pure forms of exogenous FSH with which to experiment (Fevold,
1941). Most pituitary or urinary FSH preparations available to-date have
contained finite amounts of LH such that their injection into experimental
animals activates thecal cell function via direct stimulation of the LH
receptors that are constitutively present on thecal/interstitial cells, possibly
obscuring any FSH-activated paracrine signal emanating in granulosa cells.
The recent availability of rh-FSH expressed in Chinese Hamster Ovary cells
offers a unique opportunity to test the follicular paracrine hypothesis, since
this form of FSH can be produced completely devoid of LH. This chapter
presents direct evidence from the use of rh-FSH that thecal/interstitial
androgen synthesis is subject to paracrine regulation by granulosa cells in
vivo.
2. Materials and Methods
2.1 Animals and in vivo treatments
All animals and in vivo treatments have been previously described in
Chapter 2, section 2.1. Some animals were also treated with rh-growth
hormone (rh-GH; 4 IU in 20 mg mannitol, 1.0 mg sodium chloride and PBS)
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(Serono Laboratories UK) given as four 12-hourly injections at a total dose of
400 mlU.
2.2 Analysis ofmRNA
2.2.1 Extraction, Purification and Quantitation of Total Cellular RNA
Total RNA was extracted from cultured thecal/interstitial cells
according to the method of Chomczynsky and Sacchi (Chomczynski &
Sacchi, 1987). Medium was removed from thecal/interstitial cell cultures and
cells were lysed on ice with "solution D" (4M guanidinium thiocyanate
[Fluka, Glossop, Derbyshire], 25mM sodium citrate, 0.5% [w/v] sarcosyl,
lOOmM (3-mercaptoethanol; 200 pi/well). The cell lysate was transferred to
polypropylene tubes (Falcon 2059, Becton Dickinson), and an additional 100
pi of solution D was added to each well, and pooled with the initial lysate.
Alternatively, frozen tissue (whole ovaries or isolated thecal/interstitial or
isolated granulosa cells) was homogenised in ice-cold solution D in corex
tubes (Corning, New Jersey, USA.). To the RNA-containing solutions were
added one tenth of a volume of 2M sodium acetate (pF14), one volume of
water-saturated phenol and one fifth of a volume of chloroform:isoamyl
alcohol (49:1 v/v) , tubes being capped and shaken between
additions. Tubes were shaken vigorously for lOsec after the last addition,
and placed on ice for 15 min. Tubes were then centrifuged at 10,000 x g for 20
min at 4°C to separate the phases. The aqueous (top) phases were transferred
to fresh tubes, taking great care to leave behind the protein present at the
interface, and an equal volume of cold isopropanol was added. Tubes were
left at -20°C for at least lh to allow the RNA to precipitate. Precipitated RNA
was recovered by centrifugation at 10,000 x g for 20 min at 4°C. The
supernatants were poured off, pellets were dissolved in 300 pi solution D,
and transferred to microcentrifuge tubes. RNA was reprecipitated with an
equal volume of isopropanol at -20°C for at least lh, and then recovered by
centrifugation at 13,000 x g for 10 min at 4°C. RNA pellets were washed with
70% (v/v) ethanol and allowed to dry by leaving tubes open at room
temperature, before being dissolved in 30 pi of 0.5% (w/v) SDS.
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Concentration and purity of RNA preparations were determined by
spectrophotometry. A small aliquot of each preparation was diluted with
water, and transferred to a spectrophotometer cuvette. The purity of an RNA
sample was calculated from the ratio of the absorbance of the solution at
260nm (A260) t° its absorbance at 280nm (A28o)- A ratio of 2.0 indicated
optimal purity. Any samples with an A260;A280 ratio of less than 1.5 were re-
extracted with an equal volume of phenohchloroform and reprecipitated
with 0.1 volume of 3M sodium acetate and 2.5 volumes of ethanol at -20 °C
for at least lh, then recovered by centrifugation, taken up in 0.5% SDS as
before, and scanned in the spectrophotometer once again. Concentration of
RNA samples was calculated from the A26O A solution containing 40 pg of
RNA/ml has an A26O of 1-0- A26O values of samples were therefore
multiplied by 40 pg/ml, and corrected for the dilution factor to give the
concentration of RNA in the original sample. One tenth of a volume of 3M
sodium acetate and 2.5 volumes of ethanol were added to the samples, and
they were stored at -70 °C until required.
2.2.2 Electrophoresis and Northern Blotting
Equal amounts of total RNA from each sample were centrifuged at
13,000 x g for 10 min, washed with 1ml 75% (v/v) ethanol, and pellets were
allowed to dry at room temperature. RNA was redissolved in 4.4 pi 0.5%
(w/v) SDS by heating to 65°C for 10 min. Buffer (15.6 pi) was added to a final
concentration of 20mM 3-(N-morpholino) propanesulphonic acid (MOPS), 5
mM sodium acetate, 1 mM EDTA, 50% formamide, 18% formaldehyde, and
50 pg/ml ethidium bromide, and samples were heated to 60°C for a further 5
min, to denature RNA, and placed immediately on ice. Two microlitres of
dye (25% [w/v] Ficoll 400 [Pharmacia], 0.25% bromophenol blue, ImM
EDTA) was added, samples were vortexed briefly, and centrifuged for 5 sec,
to bring the samples to the bottom of the tubes. Samples were immediately
loaded onto gels containing 1.5% (w/v) agarose, 6.6% (v/v) formaldehyde in
running buffer containing 20 mM MOPS, 5 mM sodium acetate, 1 mM EDTA
(pH7.0), and subjected to electrophoresis using a commercial horizontal gel
electrophoresis tank (Bio-Rad Laboratories Ltd, Hemel Hempstead,
Hertfordshire), in running buffer. After electrophoresis, gels were
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photographed under ultraviolet transillumination to check integrity and
even loading of RNA, and to measure migration of RNA molecular weight
standards and ribosomal RNA. RNA was partially hydrolysed by soaking
gels in 0.05 M NaOH for 20 min, to improve RNA transfer. Gels were then
soaked for 45 min in 20 x SSC (3M Nad, 300 mM sodium citrate [pH7.0]),
before RNA was transferred overnight to uncharged nylon membranes
(Hybond-N, Amersham) by capillary blotting. RNA was fixed to Northern
blots by exposure to ultraviolet radiation (260nm) for 5 min.
2.2.3 Preparation of Plasmids
Plasmid containing cDNA encoding the rat Cytochrome P450C17a (17-
hydroxylase/Cl7-20 lyase) (Fevold et al. 1989) was generously donated by Dr.
J. Ian Mason, University of Texas Southwestern Medical Center, Dallas,
Texas.
Plasmid containing cDNA encoding the rat 18S ribosomal RNA was
also used in this study (Erikson et al. 1981).
2.2.3.1 Transfection
Plasmids were transfected intoE. coli strain JM109 (Promega), which
were rendered competent for transfection by the following procedure. Cells
were streaked on M-9 plates containing thiamine-HCl (42 mM Na2HPC>4, 22
mM KH2PO4, 20 mM NH4CI, 9 mM NaCl, 2 mM MgSC>4, 1 mM thiamine-
HCl, 100 pM CaCl2,1.5% [w/v] agarose, 0.2% [w/v] glucose) and incubated
overnight at 37°C. A single colony was picked, and used to inoculate 25 ml of
Luria-Bertani medium (LB; 1% [w/v] bactotryptone, 0.5% [w/v] bacto-yeast
extract [both from Difco], 0.5% [w/v] NaCl) which was then shaken at 225
rpm overnight at 30 °C. Five hundred millilitres of LB medium were
inoculated with 5 ml of this culture and shaken at 150 rpm until the
absorbance of the culture at 600 nm reached 0.5. The culture was placed on
ice water for 2h, and the cells collected by centrifugation at 2500 x g for 15
min at 4°C. The cells were gently resuspended in 20 ml of ice-cold trituration
buffer (100 mM CaCl2, 70 mM MgCl2, 40 mM sodium acetate [pH5.5]) and
the volume was made up to 500 ml with the same solution. The cells were
then incubated on ice for 45 min before being centrifuged at 1800 x g for 10
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min and gently resuspended in 50 ml of ice-cold trituration buffer. 80% (v/v)
glycerol was added to the suspension, dropwise with gentle swirling, to a
final concentration of 15%. The cells were divided into 1ml aliquots, snap-
frozen in an ethanol-dry ice bath and stored at -70 °C.
Purified plasmids were introduced into the cells by a heat-shock
transfection method. Aliquots of competent cells were thawed on ice and 100
pi of cell suspension were pipetted on ice into pre-chilled Falcon 2059 15ml
polypropylene tubes. Purified plasmids (10 ng) were added to the cells on
ice, moving the pipette tip through the cell suspension to mix, and tubes left
on ice for 30 min. Tubes were heated to 42°C for 45 sec, and then placed on
ice again for 2 min. 900 pi of SOC medium (2% [w/v]
bactotryptone, 0.5% [w/v] bacto-yeast extract, 10 mM NaCl, 10 mM MgS04,
10 mM MgCl2, 2.5 mM KC1, 20 mM glucose) was addedAan'd tubes placed at
37°C and shaken at 225 rpm for lh. 100 pi of transformed cells were spread
on LB agar (as LB medium, containing 1.5% [w/v] agar [Difco]) plates,
containing 100 pg/ml ampicillin, 40 pg/ml X-Gal and 500 pM IPTG. Plates
were incubated overnight at 37°C. White recombinant colonies were picked
using a flamed inoculating loop and used to inoculate 5 ml aliquots of LB
medium containing 50 pg/ml ampicillin in sterile Falcon 2059 tubes. The
tubes were incubated for at least 6h at 37°C with shaking at 225 rpm. Cells
were recovered from 1.5 ml of these cultures by centrifugation at 13,000 x g
for 30 sec, and the supernatants discarded. Plasmids were recovered from
the bacteria by resuspension in 110 pi STETL (50 mM Tris [pH8.0], 50 mM
EDTA, 8% [w/v] sucrose, 5% [v/v] Triton X-100, 0.5 mg/ml lysozyme), and
incubated at room temperature for 10 min. The suspensions were boiled for
2 min, and then centrifuged at 13,000 x g for 15 min. The gelatinous pellets
were then removed with sterile pipette tips, and 110 pi isopropanol was
added to the supernatants at room temperature, and the samples were
immediately centrifuged at 13,000 x g for 15 min. The pellets of DNA were
then washed with 70% ethanol, and allowed to dry. After dissolving the
pellets in 30 pi TE buffer (10 mM Tris [pH7.5], 1 mM EDTA), the plasmids
were stored at -20 °C. In order to confirm that clones contained the required
plasmid, plasmid preparations were incubated with the appropriate
restriction enzymes to liberate inserts, and plasmids and restriction digests
were subjected to electrophoresis in 0.8% [w/v] agarose gels containing 1
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pg/ml ethidium bromide, using TAE (40 mM Tris-acetate, 1 mM EDTA) as
the electrode buffer, and visualised under ultraviolet light.
2.2.3.2 Amplification
Positive clones were then grown in large-scale culture. Cells
transformed with plasmids of interest were used to inoculate 25 ml cultures
of LB medium containing 50 gg/ml ampicillin, which were incubated
overnight at 37°C with shaking at 200 rpm. Overnight cultures were used to
inoculate 400 ml cultures of LB medium containing 50 pg/ml ampicillin,
which were incubated at 37°C with shaking at 150 rpm until the absorbance
at 600nm reached 0.8. Chloramphenicol was added to a final concentration of
170 (ig/ml, and cultures were incubated overnight at 37°C with shaking at
150 rpm. Bacteria were pelleted at 3000 x g for 10 min, and plasmids were
purified by an alkaline lysis method, using a commercial kit (Qiagen Maxi
Prep kit, Hybaid). Bacterial pellets were resuspended in 10 ml of a buffer
containing 50 mM Tris, 10 mM EDTA, 100 gg/ml RNase A. Ten ml of 200
mM NaOH containing 1% [w/v] SDS were added, and the suspensions
incubated at room temperature for 5 min. Ten ml of 2.55 M potassium acetate
(pH4.8) were added, suspensions were immediately gently mixed and
centrifuged at 20,000 x g for 30 min at 4°C. Supernatants were removed
promptly, and centrifuged again at 20,000 x g for 10 min at 4°C, to obtain a
clear lysate. Plasmids were purified from lysates by ion exchange
chromatography. Columns (Qiagen tip 500) were equilibrated with 10 ml of
a buffer containing 50 mM MOPS (pH7.0), 750 mM NaCl, 0.15% (v/v) Triton
X-100,15% (v/v) ethanol, and the lysates applied by gravity. Columns were
washed with 3 x 10 ml of a buffer containing 50 mM MOPS (pH7.0), 1M
NaCl and 15% (v/v) ethanol, to remove RNA, protein and other impurities.
Plasmids were eluted from the resin in 15 ml of a buffer containing 50 mM
MOPS (pH8.2), 1.25 M NaCl and 15% (v/v) ethanol, and recovered by
precipitation with 0.7 volumes of isopropanol and centrifugation at 10,000 x
g for 30 min at room temperature. Pellets of plasmid DNA were washed with
10 ml 70% (v/v) ethanol, allowed to dry, and redissolved in TE buffer.
Concentration of plasmids was assessed by spectrophotometry as described
for RNA above, except that for the calculation of concentration, an A26O of 1.0
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was assumed to indicate a concentration of 50 pg/ml double-stranded DNA.
Plasmids were stored at -20°C in TE buffer, at a concentration of 5 mg/ml.
2.2.4 Preparation of 32P-labelled cDNA Probes
cDNA inserts were liberated from purified plasmids by incubation with
restriction enzymes.
The rat P45017a cDNA was restricted with Sst I and Kpn I to generate
fragments of 0.30, 1.142, 1.375 and 3.567 kb. The reaction mixture was
electrophoresed in a 0.8% low melting point agarose TAE gel, and the 1.142
kb fragment was excised from the gel. The excised agarose was weighed and
3 times volume of sterile distilled water was added. The mixture was boiled
for 5 min and then vortexed. The plasmid was stored in 50 ng aliquots at
-20 °C.
The rat 18S rRNA cDNA was restricted with Bam HI to yield a 1.4 kb
fragment which was excised from the gel and treated as described above.
cDNA probes were labelled by random priming using a commercial kit
(Megaprime Kit, Amersham), based on the method of Feinberg and
t/
Vogelstein (1983). Fifty nanograms of purified cDNA was denatured by
boiling for 2 min, and placed on ice. Water was added to give a final reaction
volume of 50 pi, and 10 pi of labelling buffer (unlabelled dGTP, dATP and
dTTP in a buffer containing Tris [pH7.8], MgCl2 and (3-mercaptoethanol), 5
pi random sequence hexamer primers (in a buffer containing BSA) and 50
pCi of [32P]dCTP (specific activity -3000 Ci/mmol, Amersham) were added
on ice in order. Klenow DNA polymerase (2 U) was added, the components
were mixed by gentle passage through a pipette tip, and centrifuged briefly
to the bottom of the tube, and the reaction mixture was incubated at 37 °C for
30 min. Labelled cDNA was separated from unincorporated nucleotides by
chromatography on Sephadex G-50 columns (Nick Columns, Pharmacia) in
TE buffer, and yield of probe was measured by scintillation counting. Probe
was denatured by boiling for 5 min and then placing on ice. Hybridisation
buffer was added to give ~106cpm/ml antisense DNA probe.
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2.2.5 Northern Hybridisation with 32P-labelled Probes
Northern blots were prehybridised by incubation for at least Ih in
hybridisation buffer (5 x SSPE [0.9 M NaCI, 0.05 M sodium phosphate, 0.005
EDTA], 5 x Denhardts [0.1% BSA, 0.1% Ficoll, 0.1% polyvinylpyrrolidone],
0.5% SDS (w/v), 50% formamide, 10 mg salmon sperm DNA) using a
commercial hybridisation oven (Hybaid). Prehybridisation buffer was
replaced with probe solution. Prehybridisation and hybridisation were
carried out at 42°C. Blots were washed twice for 5 min at room temperature
in a large volume of 2 x SSC, twice for 30 min at 65 °C in a large volume of 1 x
SSC and 1% SDS, once for 30 min at room temperature in a large volume of
0.5 x SSC and 1% SDS. Blots were then wrapped in cling film (Saran Wrap,
GRI, Dunmow, Essex), and exposed to X-ray film (Kodak X-Omat AR-5,
Sigma), using two intensifying screens (GRI). Abundance of the -2.0 kb
P45017a transcript was quantified by video densitometry and images were
analysed using the Magiskan computer system (Joyce Loebl, UK). Results are
expressed as the ratio of the P45017a and 18S rRNA autoradiographic signals
in each sample.
2.3 Preparation of Granulosa Cell Conditioned Medium
Granulosa cells from preantral and early antral follicles were harvested
in culture medium as described in chapter 2 section 2.2. The culture wells
were inoculated with replicate 250 |il portions of cell suspension containing
100,000 viable granulosa cells. The granulosa cells were incubated for 48 h in
the presence or absence of 1 IU/ml rh-FSH. The spent culture medium
(granulosa cell conditioned medium) was collected and stored frozen at
-20°C.
2.4 Isolation and culture of thecal/interstitial cells
Thecal/interstitial cell preparations were prepared using the procedure
described in chapter 3, section 2.2. In vitro treatments included hLH (0.1-30
ng/ml), rh-IGF-I (0.1-30 ng/ml) and rh-inhibin-A (0.1-30 ng/ml).
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2.5 Isolation and culture of granulosa cells
Granulosa cells from preantral and early antral follicles were harvested
in culture medium as described in chapter 2 section 2.2 and cultured for 6 h
in the presence of hFSH (30 ng/ml) and 1.0 |iM testosterone (aromatase
substrate).
2.6 Steroid Radioimmunoassays
Oestradiol, androstenedione and androsterone in spent culture medium
were determined by radioimmunoassays as described in Chapter 3, sections
2.4.1, 2.4.2 and 2.4.3.
2.7 Statistics
Statistical analysis was carried out using commercial software (CLR
ANOVA). Analysis of variance with the Newman-Keuls test was used to
analyse differences between experimental and control observations.
Differences assigned a P value of <0.05 were regarded as statistically
significant.
3. Results
3.1 Effect of rh-FSH administration in vivo on whole ovarian
P450C17ocmRNA expression
Treatment of intact animals with rh-FSH (total dose 72 IU) increased the
abundance of the ~2 kb-sized P450C17a mRNA transcript in ovarian total
RNA approximately 5-fold, similar to the positive-control response (15 IU
PMSG) in four of four experiments (Fig. 4.1). Only in over-exposed
autoradiograms could the P450C17a mRNA signal of vehicle-treated control
tissue be discerned (Fig. 4.2). In hypophysectomised animals, P450C17a
mRNA abundance was even lower and the response to rh-FSH was either
weak (<20% of that to 15 IU PMSG, in one of three experiments; Fig. 4.3) or
absent (two of three experiments; Fig. 4.4).
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The dose-dependence of rh-FSH action on ovarian P450C17a mRNA
expression was established in experiments on intact animals (Fig. 4.5). By
Northern analysis using P450C17a mRNA:18S rRNA signal ratios assessed
by video scanning densitometry to account for variable sample loading, a
1.7-fold increase in P450C17a mRNA abundance occurred in response to the
lowest rh-FSH total dose (16 IU), with 1.61-, 2.02- and 4.93-fold increases in
response to 32, 48 and 72 IU rh-FSH, respectively.
3.2 Relative effect of rh-FSH administration in vivo on the
expression of P450C17a mRNA in granulosa and
thecal/interstitial cells
To assess the relative effect of treatment with rh-FSH on expression of
P450C17a mRNA in granulosa and thecal/interstitial cells, Northern
analysis was carried out on RNA extracted from cells isolated from the
ovaries of intact animals 48 h after initiating treatment with 72 IU rh-FSH. As
shown in Fig. 4.6, granulosa cells from control animals did not display a
visible autoradiographic signal corresponding to P450C17a
mRNA and treatment with rh-FSH barely elicited a response. On the other
hand, P450C17a mRNA abundance was high in control thecal/interstitial
cells and increased 4-6-fold by rh-FSH, resulting in a P450C17a mRNA signal
-14 times greater than in rh-FSH-stimulated granulosa cells.
3.3 Effect of r-LH and rh-FSH administration in vivo on whole
ovarian P450C17amRNA expression
Treatment of hypophysectomised animals with r-LH (total dose 10 IU)
increased the abundance of the -2 kb-sized P450C17a mRNA transcript in
ovarian total RNA (Fig. 4.7). Consistent with previous observations,
treatment with rh-FSH (total dose 72 IU) or injection vehicle alone did not
noticeably increase the abundance of the P450C17a mRNA transcript, while
PMSG treatment increased the abundance of the transcript. In the presence
of a fixed dose of rh-FSH (30 IU), r-LH (total dose 1-30 IU) dose-dependently
increased the abundance of the P450C17a mRNA transcript (Fig. 4.7). The
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FIG. 4.1. Effect of rh-FSH administration in vivo on ovarian P450C17amRNA
expression in intact female rats. The animals received four 12-hourly SC injections
of rh-FSH (total dose 72 IU); negative controls received injection vehicle alone;
positive controls received a single injection (15 IU) of pregnant mare's serum
gonadotropin. Ovaries were removed 48 h after the first FSH injection. Total ovarian
RNA was size-fractionated (20 (ig/track) by electrophoresis on a 1.2% agarose-
formaldehyde gel and blotted on to a nylon membrane. Upper panel Northern
analysis using a 32P-labelled (random priming) bovine cytochrome P450C17a
cDNA. Exposure of the autoradiogram to Kodak XAR-5 film was overnight at -70°C
using an intensifying screen. The -2.0 kb-sized cytochrome P450C17a transcript is
arrowed. Lower panel Ethidium bromide stained 18S rRNA, demonstrating
uniformity of sample loading.




FIG. 4.2. Overexposed autoradiogram demonstrating the effect of rh-FSH
administration in vivo on ovarian P450C17amRNA expression in intact female rats.
See Fig. 2.1 for experimental details. Exposure of the autoradiogram to Kodak XAR-
5 film was for 3 days at -70°C using an intensifying screen. The -2.0 kb-sized
cytochrome P450C17a transcript is arrowed. Lower panel Ethidium bromide stained
IBS rRNA, demonstrating uniformity of sample loading.




FIG. 4.3. Effect of rh-FSH administration in vivo on ovarian P450C17amRNA
expression in hypophysectomised female rats. The animals received four 12-hourly
SC injections of rh-FSH (total dose 72 IU); negative controls received injection
vehicle alone; positive controls received a single injection (15 IU) of pregnant mare's
serum gonadotropin. Ovaries were removed 48 h after the first FSH injection. Total
ovarian RNA was size-fractionated (20 (ig/track) by electrophoresis on a 1.2%
agarose-formaldehyde gel and blotted on to a nylon membrane. Upper panel
Northern analysis using a 32P-labelled (random priming) bovine cytochrome
P450C17a cDNA. Exposure of the autoradiogram to Kodak XAR-5 film was
overnight at -70 °C using an intensifying screen. The -2.0 kb-sized cytochrome
P450C17a transcript is arrowed. Lower panel Ethidium bromide stained 18S rRNA,
demonstrating uniformity of sample loading.
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FIG. 4.4. Effect of rh-FSH administration in vivo on ovarian P450C17amRNA
expression in hypophysectomised female rats. Experimental details were as
described in Fig. 2.3. The -2.0 kb-sized cytochrome P450C17a transcript is
arrowed. Lower panel Ethidium bromide stained 18S rRNA, demonstrating
uniformity of sample loading.
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FIG. 4.5. Dose-dependent effect of rh-FSH administration in vivo on ovarian
P450C17a mRNA expression in intact female rats. The animals received four 12-
hourly SC injections of rh-FSH (total dose 16 to 72 IU); negative controls received
injection vehicle alone; positive controls received a single injection (15 IU) of
pregnant mare's serum gonadotropin. Ovaries were removed 48 h after the first FSH
injection. Total ovarian RNA was size-fractionated (20 |ig/track) by electrophoresis
on a 1.2% agarose-formaldehyde gel and blotted on to a nylon membrane. Upper
panel Northern analysis using a 32P-labelled (random priming) bovine cytochrome
P450C17a cDNA. Exposure of the autoradiogram to Kodak XAR-5 film was
overnight at -70 °C using an intensifying screen. The -2.0 kb-sized cytochrome
P450C17a transcript is arrowed. Lower panel Northern analysis using a 3*P-labelled
(random priming) rat 18S rRNA cDNA, to compensate for nonuniform sample
loading. Exposure of the autoradiogram to Kodak XAR-5 film was for 2h at -70 °C
using an intensifying screen.














FIG. 4.6. Relative effect of rh-FSH administration in vivo on granulosa and
thecal/interstitial cell expression of P450C17a mRNA. Intact, immature female rats
received four 12-hourly SC injections of rh-FSH (total dose 72 IU); controls
received injection vehicle alone. Ovaries were removed 48 h after the first FSH
injection for isolation of granulosa and thecal/interstitial cells. Total ovarian RNA
was size-fractionated (20 (ig/track) by electrophoresis on a 1.2% agarose-
formaldehyde gel and blotted on to a nylon membrane. Upper panel Northern
analysis using a 32P-labelled (random priming) bovine cytochrome P450C17a
cDNA. Exposure of the autoradiogram to Kodak XAR-5 film was overnight at -70
°C using an intensifying screen. The -2.0 kb-sized cytochrome P450C17a transcript
is arrowed. Lower panel Ethidium bromide stained 18S rRNA, demonstrating
uniformity of sample loading.
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FIG. 4.7. Effect of r-LH administration in vivo in the presence of a fixed dose of rh-
FSH onovarian P450C17amRNA expression in hypophysectomised female rats.
The animals received four 12-hourly SC injections of rh-FSH (total dose 30 IU)
and/or r-LH (total dose 1, 10 or 30 IU); negative controls received injection vehicle
alone; positive controls received a single injection (15 IU) of pregnant mare's serum
gonadotropin. Ovaries were removed 48 h after the first FSH injection. Total ovarian
RNA was size-fractionated (20 jag/track) by electrophoresis on a 1.2% agarose-
formaldehyde gel and blotted on to a nylon membrane. Upper panel Northern
analysis using a 32P-labelled (random priming) bovine cytochrome P450C17a
cDNA. Exposure of the autoradiogram to Kodak XAR-5 film was overnight at -70
°C using an intensifying screen. The -2.0 kb-sized cytochrome P450C17a transcript
is arrowed. Lower panel Ethidium bromide stained 18S rRNA, illustrating sample
loading.
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interpretation of this experiment must take account of the uneven
sample loading and poor quality ofmRNA used.
To establish whether rh-FSH increased LH-stimulated P45017a mRNA
expression hypophysectomised animals were treated with different
combinations of rh-FSH (0, 30 or 72 IU) and r-LH (0,1 or 10 IU). Treatment
with rh-FSH alone or injection vehicle alone did not noticeably increase the
abundance of the P450C17a mRNA transcript, while PMSG treatment
increased the abundance of the transcript (Fig. 4.8). Recombinant LH alone at
the lowest dose tested (1 IU) increased P45017a mRNA expression. In the
presence of this low dose of LH, rh-FSH (72 IU) increased the abundance of
the P45017a mRNA transcript (Fig. 4.8). Recombinant LH alone at a dose of
10 IU also increased P45017a mRNA expression. In the presence of this dose
of LH, rh-FSH (72 IU) decreased the abundance of the P45017a mRNA
transcript (Fig. 4.8). However, again the interpretation of this experiment
was very difficult due to the uneven sample loading and poor quality of
mRNA used.
3.4 Effect of rh-FSH administration in vivo on thecal/interstitial
cell response to hLH in vitro
Cultured thecal/interstitial cells from the ovaries of intact animals
produced roughly similar amounts of androstenedione and androsterone.
Results were therefore combined and expressed as total androgen
production.
Treatment with hLH in vitro elicited a dose-related increase in androgen
production by cultured thecal/interstitial cells. Maximum response
occurred in the presence of hLH at a concentration of 10 ng/ml, with an
ED50 of ~3 ng/ml. Pretreatment in vivo with rh-FSH (total dose 72 IU)
increased the maximal response to hLH approximately 2-fold without
significantly altering the ED50 (Fig. 4.9A). Composite data from four
experiments on cultured thecal/interstitial cells from the ovaries of intact
animals are shown in Fig. 4.10 A.
Thecal/interstitial cells isolated from control hypophysectomised
animals produced similar amounts of androgen to cells from intact controls
and showed similar sensitivity and responsiveness to hLH in vitro (compare
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FIG. 4.8. Effect of rh-FSH administration in vivo in the presence of fixed doses of r-
LH on ovarian P450C17amRNA expression in hypophysectomised female rats.
The animals received four 12-hourly SC injections of rh-FSH (total dose 0,30 or
72IU) and/or r-LH (total dose 0,1 or f^) IU); negative controls received injection
vehicle alone; positive controls received a single injection (15 IU) of pregnant mare's
serum gonadotropin. Ovaries were removed 48 h after the first FSH injection. Total
ovarian RNA was size-fractionated (20 pg/track) by electrophoresis on a 1.2%
agarose-formaldehyde gel and blotted on to a nylon membrane. Upper panel
Northern analysis using a 32P-labelled (random priming) bovine cytochrome
P450C17a cDNA. Exposure of the autoradiogram to Kodak XAR-5 film was
overnight at -70 °C using an intensifying screen. The -2.0 kb-sized cytochrome
P450C17a transcript is arrowed. Lower panel Ethidium bromide stained 18S rRNA,
illustrating sample loading.








































FIG. 4.9. Effect of rh-FSH administration in vivo on hLH-responsive androgen
production in vitro by thecal/interstitial cells from the ovaries of A. intact female rats
and B. hypophysectomised female rats. Thecal/interstitial cell cultures (40,000 viable
cells per culture well) were incubated for 48 h in serum-free medium containing
increasing doses of hLH (0.1 to 30 ng/ml). Androstenedione+androsterone
accumulation in spent culture medium was determined by radioimmunoassay. Data
from a representative experiment are expressed as mean ± SE (n = 3). Asterisk
denotes significant stimulation by rh-FSH versus untreated control: *P <0.01.
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FIG. 4.10. Effect of rh-FSH administration in vivo on hLH-responsive androgen
production in vitro by thecal/interstitial cells from the ovaries of A. intact female
rats and B. hypophysectomised female rats. Thecal/interstitial cell cultures (40,000
viable cells per well) were incubated for 48 hours in serum-free medium with and
without hLH (10 ng/ml). Androstenedione+androsterone accumulation in the spent
culture medium was determined by radioimmunoassay. Composite data from 4
experiments are expressed as mean ± SE.
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Figs. 4.9A and 4.9B). However, pretreatment of hypophysectomised
animals with rh-FSH (total dose 72 IU) in vivo did not significantly affect
sensitivity or responsiveness to hLH in vitro (Fig. 4.9B). Composite data from
four experiments on thecal/interstitial cells from the ovaries of
hypophysectomised animals are shown in Fig. 4.1OB.
Treatment of cultured thecal/interstitial cells in vitro with rh-FSH at
concentrations up to 100 ng/ml did not significantly increase androgen
production (Fig 3.6), confirming lack of intrinsic 'LH-like' activity.
3.5 Effect of granulosa cell conditioned medium on basal and
hLH-responsive thecal/interstitial cell androgen synthesis in vitro
To obtain in vitro evidence for FSH-stimulated paracrine signalling,
granulosa cells from intact animals were cultured for 48 h in serum-free
medium, with and without rh-FSH (1 IU/ml), and the spent medium was
collected and added to thecal/interstitial cell cultures. Incubation of
thecal/interstitial cells from intact animals in undiluted medium from FSH-
treated granulosa cultures significantly altered androgen production in
response to exogenous hLH (Fig. 4.11), the response to high-dose (30 ng/ml)
hLH being ~25% higher (P<0.01). Medium from granulosa cells not treated
with rh-FSH tended to suppress the response to hLH, although its effect was
not statistically significant.
3.6 Effect of inhibin on basal and hLH-responsive
thecal/interstitial cell androgen synthesis and P450C17amRNA
expression in vitro
To confirm the influence of a putative paracrine factor on
thecal/interstitial androgen synthesis, cells were cultured with recombinant
inhibin in the presence and absence of hLH. Regardless of whether the cells
were obtained from intact or hypophysectomised animals, inhibin (30
ng/ml) alone, had no significant effect on androgen production but
enhanced the stimulatory effect of hLH (10 ng/ml) 2-3 fold. A typical dose-
response is shown in Fig. 4.12.
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FIG. 4.11. Effect of conditioned medium from rh-FSH-stimulated granulosa cells on
LH-responsive androgen production in vitro by thecal/interstitial cells from the
ovaries of intact female rats. Granulosa cell cultures (100,000 viable cells per culture
well) were incubated for 48 h in serum-free medium with or without rh-FSH (1
IU/ml)and the spent medium was collected. Thecal/interstitial cell cultures (40,000
viable cells per culture) were incubated in either serum-free medium, spent medium
from untreated granulosa cell cultures, or spent medium from rh-FSH-treated
granulosa cells. Cultures were for 48 h in the presence of increasing doses of hLH
(0.1 to 30 ng/ml). Androstenedione+androsterone accumulation in spent
thecal/interstitial cell culture medium was determined by radioimmunoassay. Data
from a representative experiment are expressed as mean ± SE (n = 3).
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FIG. 4.12. Effect of inhibin on LH-responsive androgen production in vitro by
thecal/interstitial cells from the ovaries of intact female rats. Thecal/interstitial cell
cultures (40,000 viable cells per culture well) were incubated for 48 h in serum-free
medium with and without hLH (10 ng/ml) and/or inhibin-A (0.1-30 ng/ml).
Androstenedione +androsterone accumulation in spent culture medium was
determined by radioimmunoassay. Data from a representative experiment are
expressed as mean ± SE (n = 3).
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To test the influence of inhibin on P45017a mRNA expression,
thecal /interstitial cells from intact animals were cultured with recombinant
inhibin in the presence and absence of hLH. Messenger RNA was then
extracted and Northern hybridisation was carried out. In four out of ten
experiments inhibin (30 ng/ml) alone, had no significant effect on P45017a
mRNA expression but enhanced the stimulatory effect of hLH (10 ng/ml)
(Fig. 4.13). In six out of ten experiments no clear pattern was observed (Fig.
4.13).
3.7 Effect of IGF-I on basal and hLH-responsive thecal/interstitial
cell androgen synthesis in vitro
To confirm the influence of another putative paracrine factor on
thecal/interstitial androgen synthesis, cells were cultured with recombinant
IGF-I in the presence and absence of hLH. Regardless of whether the cells
were obtained from intact or hypophysectomised animals, IGF-I (30 ng/ml)
alone, only had a significant effect on androgen production at doses of
lOng/ml or above. IGF-I also enhanced the stimulatory effect of hLH (10
ng/ml) by about 50%. A typical dose-response is shown in Fig. 4.14.
3.8 Effect of rh-GH administration in vivo on thecal/interstitial cell
response to hLH in vitro
In an attempt to explain the differences in the effects of rh-FSH
treatment in vivo on LH-responsive androgen production in vitro between
cells from intact and hypophysectomised animals, hypophysectomised
animals were treated in vivo with rh-GH (total dose 400 mlU). This treatment
was sufficient to significantly augment a FSH-stimulated increase in ovarian
weight Fig. 4.15) and increase granulosa cell aromatase activity in vitro,
though this effect was not significant (Fig. 4.16). However, growth hormone
treatment in vivo did not alter basal or LH-responsive androgen production
in vitro by thecal/interstitial cells from untreated or rh-FSH treated
hypophysectomised animals (Fig. 4.17).










FIG. 4.13. Effect of inhibin on LH-responsive androgen production and P45017a
expression in vitro by thecal/interstitial cells from the ovaries of intact female rats.
Thecal/interstitial cell cultures (40,000 viable cells per culture well) were incubated
for 48 h in serum-free medium with and without hLH (10 ng/ml) and/or inhibin-A
(30 ng/ml). Androstenedione +androsterone accumulation in spent culture medium
was determined by radioimmunoassay.Data are expressed as mean ± SE.
Thecal/interstitial cells were removed and total ovarian RNA was size-fractionated
(20 |ig/track) by electrophoresis on a 1.2% agarose-formaldehyde gel and blotted on
to a nylon membrane. Upper panel Northern analysis using a 32P-labelled (random
priming) bovine cytochrome P450C17a cDNA. Exposure of the autoradiogram to
Kodak XAR-5 film was overnight at -70°C using an intensifying screen. The -2.0
kb-sized cytochrome P450C17a transcript is shown. Autoradiographs are
representative of six experiments. Lower panel Northern analysis using a 32P-
labelled (random priming) bovine cytochrome P450C17a cDNA. Exposure of the
autoradiogram to Kodak XAR-5 film was overnight at -70°C using an intensifying
screen. The -2.0 kb-sized cytochrome P450C17a transcript is shown.
Autoradiographs are representative of four experiments.
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FIG. 4.14. Effect of IGF-I on LH-responsive androgen production in vitro by
thecal/interstitial cells from the ovaries of intact female rats. Thecal/interstitial cell
cultures (40,000 viable cells per culture well) were incubated for 48 h in serum-free
medium with and without hLH (10 ng/ml) and/or IGF-I (0.1-30 ng/ml)
Androstenedione +androsterone accumulation in spent culture medium was determined
by radioimmunoassay. Data from a representative experiment are expressed as mean ±
SE (n = 3).













FIG. 4.15. Effect of GH on ovarian weight of hypophysectomised female rats.
Animals were treated with rh-GH (total dose 400 mlU) and/or rh-FSH (total dose 72
IU) or injection vehicle alone (PBS in 0.1% BSA). Ovaries were removed after 48 h
and all extraneous material was dissected. Results are expressed as mean weight of
each ovarian pair ± SE. (n > 6). a is significantly different from b and C (P <0.01), b
is significantly different from c (P <0.01).
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FIG. 4.16. Effect of GH treatment in vivo on hFSH-responsive aromatase activity by
rat granulosa cells in vitro. Granulosa cell cultures (40,000 viable cells per well)
were incubated for 48 h in serum-free medium containing 1.0 |iM testosterone
(aromatase substrate) and hFSH (30 ng/ml). Oestradiol in spent medium was
determined by RIA; values are expressed as mean ± SE (n=3). a is significantly
different from b (P <0.01).
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FIG. 4.17. Effect of growth hormone administration in vivo on hLH-responsive
androgen production in vitro by thecal/interstitial cells from the ovaries of
hypophysectomised female rats. Thecal/interstitial cell cultures (40,000 viable cells
per culture well) were incubated for 48 h in serum-free medium containing hLH (10
ng/ml) and/or IGF-I (30 ng/ml). Androstenedione+androsterone accumulation in
spent culture medium was determined by radioimmunoassay. Data are expressed as
mean ± SE (n=3).There were no significant differences due to GH nor rh-FSH
treatment.
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3.9 Effect of rh-LH administration in vivo on thecal/interstitial cell
response to hLH in vitro
In an attempt to explain the differences in the effects of rh-FSH
treatment in vivo on LH-responsive androgen production in vitro between
cells from intact and hypophysectomised animals, hypophysectomised
animals were treated in vivo with r-LH (total dose 1-30 IU). Treatment of
hypophysectomised animals in vivo with r-LH (total dose 10 IU) in
combination with rh-FSH (total dose 72 IU) restored the ability of rh-FSH to
increase thecal/interstitial responsiveness to LH in vitro (Fig. 4.18). However,
hypophysectomised animals treated in vivo with Pergonal (40 IU of both LH
and FSH) exhibited a lack of LH responsive androgen production (Fig. 4.19).
Treatment in vitro with IGF-I did not affect the levels of basal nor LH-
stimulated androgen production (Fig. 4.19).
To examine the effects of LH in vivo on androgen synthesis in vitro more
closely, hypophysectomised animals were treated with increasing doses of r-
LH (total dose 0, 1 or 30 IU) in the presence of a fixed dose of rh-
FSH (total dose 30 IU). Co-treatment of rh-FSH treated animals with a low
dose of r-LH (1 IU) in vivo increased LH-stimulated androgen production
compared to cells from animals treated with rh-FSH alone (Fig. 4.20).
However, androgen production in the presence of LH + inhibin (30 ng/ml)
was unaffected by r-LH treatment in vivo. Co-treatment of rh-FSH treated
animals with a high dose of r-LH (30 IU) in vivo decreased androgen
production by LH- and LH + inhibin-treated cells to levels seen in
unstimulated cells (Fig. 4.20).
3.10 Effect of DES administration in vivo on thecal/interstitial cell
response to hLH in vitro
To test the influence of oestrogen, another candidate paracrine factor on
thecal/interstitial androgen synthesis, cells from intact animals treated with
DES in vivo were cultured with and without hLH (10 ng/ml). Treatment with
DES in vivo decreased thecal/interstitial cell LH-responsiveness in vitro (Fig.
4.21). Treatment with DES in vivo also rendered thecal/interstitial cells
unresponsive to rh-FSH treatment in vivo (Fig. 4.21).






































FIG. 4.18. Effect of rh-FSH administration in vivo on hLH-responsive androgen
production in vitro by thecal/interstitial cells from the ovaries of hypohysectomised
female rats treated in vivo with A. injection vehicle alone and B. r-LH (1 IU).
Thecal/interstitial cell cultures (40,000 viable cells per well) were incubated for 48
hours in serum-free medium with and without hLH (10 ng/ml).
Androstenedione+androsterone accumulation in the spent culture medium was
determined by radioimmunoassay. Data from a representative experiment are
expressed as mean ± SE (n=3).
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FIG. 4.19. Effect of rh-FSH (72 IU) and Pergonal (40 IU each of FSH and LH)
administration in vivo on hLH-responsive androgen production in vitro by
thecal/interstitial cells from the ovaries of hypophysectomised female rats.
Thecal/interstitial cell cultures (40,000 viable cells per well) were incubated for 48
hours in serum-free medium with and without hLH (10 ng/ml) and or IGF-I (30
ng/ml). Androstenedione+androsterone accumulation in the spent culture medium
was determined by radioimmunoassay. Data from a representative experiment are
expressed as mean ± SE (n=3). Asterisk denotes significant difference due to
Pergonal versus untreated control or rh-FSH: *P <0.01.
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FIG. 4.20. Effect of r-LH administration in vivo on hLH-responsive androgen
production in vitro by thecal/interstitial cells from the ovaries of rh-FSH treated
hypophysectomised female rats. Thecal/interstitial cell cultures (40,000 viable cells
per well) were incubated for 48 hours in serum-free medium with and without hLH
(10 ng/ml) ancj/()r IGF-I (30 ng/ml). Androstenedione+androsterone accumulation in
the spent culture medium was determined by radioimmunoassay. Data from a
representative experiment are expressed as mean ± SE (n=3). a denotes significant
difference due to FSH 30 + LH 1 treatment compared to FSH 30 alone (P <0.01), b
denotes significant difference due to FSH 30 + LH 30 treatment compared to FSH 30
alone or FSH 30 + LH 1 treatment (P <0.01).











































FIG. 4.21. Effect of DES administration in vivo on hLH-responsive androgen
production in vitro by thecal/interstitial cells from the ovaries of intact female rats
treated in vivo with A. injection vehicle alone and B. rh-FSH. Thecal/interstitial cell
cultures (40,000 viable cells per well) were incubated for 48 hours in serum-free
medium with and without hLH (10 ng/ml). Androstenedione+androsterone
accumulation in the spent culture medium was determined by radioimmunoassay.
Data from a representative experiment are expressed as mean ± SE (n=3).
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4. Discussion
Granulosa cells but not thecal/interstitial cells possess FSH receptors,
whereas P450C17a mRNA expression is far higher in thecal/interstitial cells
than granulosa cells (Hedin et al. 1987), therefore the finding that treatment
with rh-FSH in vivo enhances P450C17oc mRNA expression and LH-
responsive androgen synthesis in vitro can be interpreted as direct evidence
that FSH activates granulosa-derived paracrine signalling in the ovary. Since
P450C17a mRNA expression is almost exclusively localised to
thecal/interstitial cells (see Chapter 5), then it can be inferred that any
changes in P450C17a mRNA content of the ovary reflects changes in
thecal/interstitial cell expression of P450C17a mRNA.
Human LH-responsive thecal/interstitial cell androgen synthesis in
vitro was doubled by treatment with rh-FSH in vivo, but sensitivity to hLH
was unchanged. Similarly, treatment of thecal/interstitial cells with hLH in
the presence of conditioned medium from rh-FSH-stimulated
granulosa cells augmented overall response without affecting sensitivity to
hLH. The mechanism of this effect is not known but would be expected to
involve increased activity of enzymes crucial to androgen synthesis.
P450C17a and cholesterol side-chain cleavage (P450scc) ar^ two such
enzymes known to be regulated by LH. In cultured rat thecal/interstitial
cells both enzymic activities are upregulated by insulin-like growth factor I
(IGF-I), a granulosa-derived growth factor previously implicated in the
paracrine regulation of androgen synthesis (Magoffin et al. 1990). As
confirmed here, inhibin (another granulosa-derived protein) also enhances
LH-responsive androgen synthesis (Hsueh et al. 1987). Our data also suggest
that P45017a is a target of inhibin action, though the experiments were not
always reproducible (see Fig. 4.13). Since FSH enhances granulosa cell
production of IGF-I (Adashi et al. 1985a) and inhibin (Bicsak et al. 1986), both
factors are potential intermediaries of FSH action on thecal/interstitial cells.
Further work is required to determine if they actually affect LH-responsive
androgen synthesis in vivo.
Hypophysectomy prevented the stimulatory action of FSH treatment in
vivo on subsequent thecal/interstitial cell responsiveness to hLH in vitro. This
suggests that simultaneous exposure to endogenous LH is necessary to
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facilitate augmentation of thecal/interstitial function by FSH. In other words,
paracrine signalling emanating in FSH-stimulated granulosa cells modulates
the action of LH but cannot substitute for the endocrine role of LH per se. The
finding in vitro that a candidate paracrine factor, inhibin, is unable to directly
stimulate androgen synthesis whereas it potently enhances the action of hLH
in vitro supports this interpretation. The finding that low dose LH treatment
in vivo restored the stimulatory action of FSH treatment in vivo on
subsequent thecal/interstitial cell responsiveness to hLH in vitro further
supports the hypothesis that simultaneous LH exposure is necessary for
FSH-stimulated augmentation of thecal/interstitial function.
Treatment with both FSH and LH is required to stimulate follicular
/
oestrogen synthesis in hypohysectomised rats (Mannaerts et al. 1991) because
androgens produced in LH-stimulated thecal/interstitial cells are essential
aromatase substrates for estrogen synthesis in FSH-stimulated granulosa
j J
cells (Armstrong & Dorrington, 1979; Dorrington et al. 1975; Makris & Ryan,
1975; Fortune & Armstrong, 1977; Baird, 1977; Tonetta & diZerega, 1989). 17-
Hydroxylase and C17-20 lyase activities of P450C17a are rate-limiting in
androgen synthesis (Bogovich & Richards, 1982), and the finding that
thecal/interstitial cell P450C17a mRNA expression is directly enhanced by
treatment with PMSG in vivo is consistent with the fundamental role of LH in
regulating these enzymic activities. Moreover, the reduction in P450C17a
mRNA expression caused by hypophysectomy is explained by withdrawal
of endogenous LH, since replacement therapy with r-LH in low doses
restores P450C17a mRNA expression as well as the ability of rh-FSH in vivo
to augment thecal/interstitial responsiveness to LH in vitro. However, a
generalised metabolic disturbance subsequent to hypophysectomy would
also be expected to influence gonadal steroidogenesis. In particular, adrenal
collapse due to lack of ACTH or absence of circulating liver-derived IGF-I
due to withdrawal of GH could negatively influence thecal androgen
synthesis. Potentially important endocrine and metabolic effects of ACTH on
androgen synthesis were not evaluated in this study. However, this study
has shown that replacement therapy with rh-GH at a dose sufficient to
significantly stimulate ovarian weight in hypophysectomised, immature
female rats does not significantly alter basal or LH-responsive
thecal/interstitial cell androgen production in vitro, effectively ruling out
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both direct and indirect contributions of GH to ovarian androgen synthesis
in this system.
If P450C17a mRNA expression is exclusive to the thecal/interstitial
ovarian compartment, the finding that rh-FSH stimulates granulosa cell
P450C17a mRNA expression as judged by Northern analysis is difficult to
explain. The possibility that the granulosa cells from which RNA was
isolated for Northern analysis were significantly contaminated with
thecal/interstitial cells (see Fig. 4.6) cannot be ruled out. However, a more
probable explanation is that every steroidogenic cell type expresses finite
levels of all steroidogenic enzymes. The characteristic steroid secretory
functions of endocrine glands reflect their histogenetic derivation and the
trophic mechanisms to which specific cell types respond, consistent with the
'unified' concept of steroid hormone formation put forward by Ryan twenty
years ago (Ryan, 1972). Thus FSH-stimulated granulosa cells, being richly
endowed with aromatase, are functionally deficient in 17-hydroxylase and
17-20 lyase while the opposite is true of LH-stimulated thecal/interstitial
cells. Either way, stimulation of granulosa cells with rh-FSH in vivo markedly
enhances thecal/interstitial cell P450C17a mRNA expression which has
implications for oestrogen synthesis as well as androgen synthesis.
The LH surge prior to ovulation leads to a drop in P450C17a mRNA
and bioactivity (Hedin et al. 1987; Eckstein & Tsafriri, 1986). This is consistent
with the finding that high doses of LH in vivo result in a decrease in P45017a
mRNA expression and a loss of LH-responsive androgen production in vitro.
Similarly DES treatment in vivo results in a reduction in LH-responsive
androgen production in vitro consistent with the finding that oestrogens
inhibit LH-stimulated androgen biosynthesis in rat thecal/interstitial cells
(Erickson et al. 1985) by greater than 90%. The mechanism of oestrogen action
in thecal/interstitial cells remains unclear. The inhibitory effects of oestradiol
on thecal/interstitial cell androgen production occur without changes in LH
receptors, LH-stimulated cAMP production or progesterone production
(Erickson et al. 1985) and oestradiol does not cause a direct inhibition of
P450C17a activity in ovarian homogenates (Johnson et al. 1984). These
inhibitory effects of oestrogen may be the mechanism which mediates the
decrease in P450C17a activity that occurs after the LH surge prior to
ovulation in a wide variety of species (Erickson et al. 1985).
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In conclusion, FSH is able to influence ovarian androgen synthesis via a
paracrine mechanism that involves modulation of expression of
thecal/interstitial P450C17a. Further research is required to determine which
locally produced factor(s) mediates this action of FSH. It is likely that
steroids produced by FSH-stimulated granulosa cells modulate androgen
production by thecal/interstitial cells resulting in co-ordinated follicular
steroidogenesis. Oestradiol is a potential candidate since it is able to regulate
androgen synthesis by thecal/interstitial cells in vitro (Erickson et al. 1985).
Other likely candidates are regulatory proteins produced by granulosa cells
responding to direct stimulation by FSH. Such proteins include inhibin
(Hsueh et al. 1987) and IGF-I (Adashi et al. 1985), which dose-dependently
enhance LH-stimulated thecal/interstitial cell androgen synthesis in vitro
and thereby qualify as potential paracrine modulators of androgen
synthesis in vivo.
Chapter 5. Expression of Ovarian P45017a mRNA.
1. Introduction
The previous chapter reported an investigation of the control of
ovarian thecal/interstitial cell function by gonadotrophins and paracrine
factors. This chapter describes a study by in situ hybridisation of the
regulation of P450C17a mRNA expression during follicular development.
Cytochrome P450C17a (17-hydroxylase/Cl7-20 lyase) in thecal/interstitial
cells is the LH-responsive steroidogenic enzyme involved in the conversion
of progestogens to androgens (Bogovich & Richards, 1982), and hence the
provision of aromatase substrates required for oestrogen synthesis in FSH-
stimulated granulosa cells (reviewed by Erickson et al. 1985). To-date there
has been no published report of the expression of P450C17a as studied by in
situ hybridisation.
Thecal/interstitial cells are major sites of androgen biosynthesis in the
ovary (Erickson et al. 1985). P450C17a is the single microsomal enzyme that
catalyses steroid 17-hydroxylase and C17-20 lyase activities (Zuber et al. 1986).
These activities reside in the thecal/interstitial cells of the ovary (Erickson et
al. 1985) and are absent from granulosa cells (Richards et al. 1987). Granulosa
cells are therefore incapable of de novo androgen synthesis and depend on
the theca to supply extracellular androgen for use as oestrogen precursor
consistent with the two-cell, two-gonadotrophin mechanism of oestrogen
synthesis (Armstrong & Dorrington, 1979). Like P45017a activity, P450C17a
mRNA and protein have been detected exclusively in the thecal/interstitial
cells (Hedin et al. 1987; Eckstein & Tsafriri, 1986). LEI promotes
differentiation of thecal/interstitial cells and the induction of P450C17a in
developing follicles (Bogovich et al. 1981). Throughout this process of
follicular development P450C17a mRNA, protein content and bioactivity
increase (Hedin et al. 1987). The LH surge leads to a drop in P450C17a
mRNA, protein content and bioactivity to levels below those seen in small
antral follicles (Hedin et al. 1987; Eckstein & Tsafriri, 1986).
As well as primary endocrine regulation by LH, thecal/interstitial
P450C17a activity is likely to be subject to a secondary level of regulation by
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factors produced by granulosa or thecal/interstitial cells. In vitro studies
suggest many steroidal (e.g. oestradiol) and non-steroidal regulatory factors
(e.g. inhibin and related peptides) could have a role in such a system. This
study investigates the regulation of P450C17a mRNA expression by 'pure'
(i.e. recombinant) gonadotrophins and intraovarian modulators of
gonadotrophin action.
2. Materials and Methods
2.1 Animals and in vivo treatments
All animals and in vivo treatments have been described previously in
Chapter 2, section 2.1.
2.2 Determination of stage of oestrous cycle
Four month old adult female Wistar rats were tracked by daily vaginal
smearing to ascertain the stage of oestrous cycle that they had reached. The
rat oestrous cycle was considered to consist of four stages; dioestrus 1,
dioestrus 2, pro-oestrus and oestrus. A plastic stirring rod (Sarstedt,
Beaumont Leys, Leicester) was dipped in saline and then a vaginal smear
was taken and spread onto a glass slide containing a drop of saline solution.
The smears were then viewed under phase contrast microscopy at a
magnification of x 100. The animal was considered to be in dioestrus if the
smear contained polymorpho-nucledr lymphocytes (PMNL) which are small,
perfectly rounded cells. If the smear contained clumps of larger, round or
oddly shaped cells then the animal was considered to be at the pro-oestrus
stage of the cycle. The presence of clumps of angular cells in the complete
absence of any PMNL was regarded as definitive for oestrus. Only animals
that completed two regular 4 day cycles were used in the experiment.
2.3 Tissue preparation
Ovaries were fixed overnight at 4°C in 4% (w/v) paraformaldehyde
(Sigma) dissolved in PBS. This was followed by sequential dehydration
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treatments with PBS for 30 min at 4°C; 0.85% (w/v) NaCl dissolved in PBS
for 30 min at 4°C; 0.85% (w/v) NaCl dissolved in PBS: ethanol (1:10) for 15
min at room temperature; 70% (v/v) ethanol for 15 min at room temperature;
70% (v/v) ethanol for 30 sec at room temperature. The tissue was then
automatically processed overnight (Shandon Scientific Ltd) through graded
ethanol solutions, followed by xylene, 1:1 xylene-paraffin, then paraffin wax.
Prepared tissues were then placed in moulds containing melted paraffin,
which was then allowed to solidify. Tissue embedded in paraffin wax is
stable for several years without loss of hybridisability of target RNAs or
deterioration ofmorphology.
2.4 Slide preparation and tissue sectioning
Slides were cleaned and coated to help tissue section retention. Firstly
slides were dipped in 10% (v/v) HC1 in 70% (v/v) ethanol for 10 sec. This
was followed by a 10 sec rinse in distilled water, then the slides were dipped
in 95% (v/v) ethanol. The slides were placed in an oven at 150°C for 5 min.
Once the slides had cooled they were twice dipped in a 2% (v/v) solution of
TESPA in acetone for 10 sec, followed by two 10 sec washes in acetone. The
slides were then rinsed in distilled water then baked dry at 42 °C.
Using a standard rotary microtome (American Optical Corporation)
tissue was sectioned at 5|im thickness to produce a ribbon of sections. This
ribbon was floated on the surface of distilled water heated to 45 °C in a water
bath. Sections were mounted by inserting a coated slide into the water bath
near the sections at a 45 ° angle to the water surface, touching an edge of the
ribbon to the slide and slowly withdrawing the slide from the bath. Slides
were placed in an oven overnight at 40 °C to ensure sections had adhered to
the slide.
2.5 Plasmid preparation
Plasmid containing cDNA encoding the rat Cytochrome P450C17a (17-
hydroxylase/Cl7-20 lyase) (Fevold et al. 1989) was generously donated by Dr.
J. Ian Mason, University of Texas Southwestern Medical Center, Dallas,
Expression ofOvarian P45017a mRNA 149
Texas. From a clone containing a 1.88 kb insert, a 1.143 kb segment was
excised (nucleotides 251-1394) using Kpn I and Sst I. This was then blunted
with feenow fragment of E. coli DNA polymerase I (Promega Ltd) and
inserted into the Sma I site of pGEM-3Z vector (Promega Ltd). The
orientation of the insert was such that SP6 RNA polymerase could be used to
to transcribe antisense RNA probes and T7 RNA polymerase to transcribe
sense probes. Templates were prepared using Pvu II to generate an antisense
template of 564 bp and Sea I to generate a sense template of 536 bp. A
plasmid map is shown in Fig. 5.1.
Plasmid containing cDNA encoding the rat P450 aromatase (P450arom)
(Hickey et al. 1990) was generously donated by Dr. J.S. Richards, Baylor
College of Medicine, Houston, Texas. From a clone containing a 1047 bp
insert the full insert was excised using Eco RI. This was blunted as above and
inserted into the Sma I site of pGEM-3Z vector (Promega Ltd, UK). The
orientation of the insert was such that SP6 RNA polymerase could be used to
to transcribe antisense RNA probes and T7 RNA polymerase to transcribe
sense probes. Templates were prepared using Acc III to generate an
antisense template of -300 bp and Bam HI to generate a sense template of
-400 bp.
Plasmid containing cDNA encoding the rat LH receptor (LH-R) (LaPolt
et al. 1990a) was generously donated by Dr. A.J.W. Hsueh, Stanford
University School of Medicine, Stanford, California. The LH-R clone
corresponding to bases 249 to 849 of the rat LH-R cDNA was subcloned into
pGEM-3Z at Eco RI. The orientation of the insert was such that SP6 RNA
polymerase could be used to to transcribe sense RNA probes and T7 RNA
polymerase to transcribe antisense probes. Templates were prepared using
Bgl II to generate an antisense template of 408 bp and Bam HI to generate a
sense template.
Plasmids were transfected and amplified, as described in chapter 4,
sections 2.2.3.1 and 2.2.3.2.













Rat P45017alpha cDNA insert
FIG. 5.1. Restriction map of pGEM3Zf(+) rat P45017 alpha showing orientation of
insert cDNA in relation to SP6 and T7 DNA polymerases.
Expression ofOvarian P45017a mRNA 151
2.6 Probe preparation and labelling
P45017a DNA templates were prepared by digestion of plasmid with
Pvu II (to generate an antisense probe) or Sea I (to generate a sense probe to
be used as a control for probe specificity). In order to ensure that plasmid
was fully linearised, restriction digestion was carried out overnight at 37°C.
A small aliquot of digested DNA was analysed by agarose gel
electrophoresis and visualised under UV light. A single band of DNA was
observed, indicating that plasmid was fully linearised, and its concentration
was estimated by comparison with standards of known concentration.
Template DNA was precipitated with 0.1 volume of 3M sodium acetate (pH
7.0) and 2 volumes of ethanol at -20°C for at least lh, and centrifuged at
13,000g for 10 min. The DNA pellet was redissolved in TE buffer to give a
concentration of ~1 mg/ml. Transcription of RNA from the Pvu II template
using SP6 RNA polymerase results in synthesis of RNA probes
complementary to the portion of mRNA encoding the conserved P45017a
and Ozols tridecapeptide regions of P45017a protein (Fevold et al. 1989). In
vitro transcription was carried out using a commercial kit (Riboprobe Gemini
System II, Promega). One microgram of template DNA was added to a tube
containing 40 mM Tris (pH7.5), 10 mM NaCl, 6 mM MgCl2, 2 mM
spermidine, 26 mM DTT, 20 U ribonuclease inhibitor (RNasin, Promega),
unlabelled ATP, GTP and CTP at 0.33 mM each.Fifty microcuries of
35S-labelled UTP (specific activity > 1000 Ci/mmol; final concentration, 6(iM,
Amersham), and 20 U SP6 (antisense) or T7 (sense) RNA polymerase were
added, the components were mixed gently by passage through a pipette tip
and brought to the bottom of the tube by brief centrifugation, and the
reaction was allowed to take place for 30 min at 37 °C. A further 20 U SP6
(antisense) or T7 (sense) RNA polymerase were added and the reaction was
allowed to continue for 3 h at 37°C. Incorporation of labelled nucleotide and
specific activity of probe were measured by adsorption of RNA to charged
paper filters (DE81, Whatman). Duplicate lpl aliquots of the reaction mixture
were spotted onto DE81 filters and allowed to dry. One filter was washed
four times for 5min in ~200ml 0.5M Na2HP04 (pH 7.0), then rinsed in 70%
ethanol and allowed to dry. Both filters were placed in scintillation vials with
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4ml of scintillation fluid, and radioactivity bound to the filters was measured
by liquid scintillation counting. Counts bound to the washed filter
represented rUTP incorporated into RNA, and those on the unwashed filter
represented the total input of rUTP. Incorporation and specific activity were
calculated to be >70% and ~106cpm/ng respectively (assuming
approximately equal proportions of all four nucleotides in the template
sequence). Template DNA was removed by incubation with 2 U RNase-free
DNase (RQ1 DNase, Promega) and lOmg/ml tRNA for 10 min at 37°C. This
was followed by extraction with 1 volume of TE-saturated phenol, vortexing
thoroughly and centrifugation at 12,000 x g for 2 min. The upper, aqueous
phase was transferred to a fresh tube and 1 volume of phenol/chloroform
was added. This mixture was vortexed and then centrifuged at 12,000 x g for
2 min. Again the upper, aqueous phase was transferred to a fresh tube and 1
volume of chloroform was added. This mixture was vortexed and then
centrifuged at 12,000 x g for 2 min. Unincorporated nucleotides were
removed from the labelled probe by ethanol precipitation; 0.2 volumes of 10
Manmonium acetate was added to the RNA sample and mixed. Three
volumes of ethanol were added and the RNA was precipitated at -20 °C for at
least 1 h. The mixture was centrifuged at 12,000 x g for 20 min at 4°C and the
supernatant was removed. The pellet was washed in 80% (v/v) ethanol and
spun for 10 min at 12,000 x g. The supernatant was carefully removed and
the pellet was vacuum dried. The pellet was then suspended in sufficient
50mM DTT to yield a final concentration of RNA of 5 ng/pi and stored at
-70 °C.
The DNA templates for LH-R and aromatase were prepared in the
same way using the appropriate restriction enzymes as described above.
2.7 Prehybridisation
Tissue sections were deparaffinised and rehydrated by immersing
slides in two changes of xylene for 10 min each time. The slides were then
passed sequentially, for 2 min each, through 100%, 100%, 90% (v/v), 75%
(v/v), 50% (v/v), and 30% (v/v) ethanol then 5 min in each of 0.85% (w/v)
NaCl in PBS and PBS. This was followed by 20 min in 4% (w/v)
paraformaldehyde in PBS, then two changes of PBS for 5 min each. Sections
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were digested in 20 gg/ml proteinase K in 50 mM Tris, 5mM EDTA for 7.5
min. To stop the proteinase K reaction slides were dipped in PBS for 5 min,
4% (w/v) paraformaldehyde in PBS for 10 min, PBS for 5 min, sterile
distilled water for 10 sec and triethanolimine (TEA) buffer for 30 min. To
reduce electrostatic binding of probe, sectionsK^re acetylated at their amino
groups by 0.25% (v/v) acetic anhydride in TEA for two changes of 10 min
each. The slides were then dehydrated through sequential solutions of PBS
for 5 min, 0.85% (w/v) NaCl for 5 min then 1 min in each of 30% (v/v), 50%
(v/v), 75% (v/v) and 90% (v/v) ethanol, followed by two 5 min periods in
100% ethanol. Slides were allowed to air dry for 2 h.
2.8 Hybridisation
Probe (5 ng/ml) was diluted to the required concentration (0.3
ng/ml/kb probe) using a hybridisation mix as diluent. The hybridisation
mix consisted of 10 mM Na2HPC>4 (pH 6.8), 5 mM EDTA (pH 8), 10 mM Tris-
HC1 (pH 7.5), 0.02% each BSA, Ficoll and polyvinyl pyrollidine, 0.3 M NaCl,
50% formamide, 500 mg/ml yeast tRNA, 100 mM DTT and 50% dextran
sulphate. The probe and hybridisation mix were mixed at 80 °C for 2 min and
then cooled on ice. The hybridisation mixture was then added to pretreated
slides at a volume of 10-20 pi per slide. Sections were then covered with a
coverslip to produce a thin and constant layer of probe over the sections.
Slides were stored in a plastic box containing tissue soaked in 50%
formamide, 5 x SSC to stop sections drying out. Closed boxes were sealed
into a plastic bag containing soaked tissue and were stored overnight at 55 °C
to allow hybridisation.
Unhybridised probe was removed by sequential washes in 5 x SSC, 10
mM DTT for 30 min at 55°C; 50% formamide, 2 x SSC, 0.1 M DTT for 30 min
at 65 °C; and 0.5 M NaCl, 10 mM Tris, 5 mM EDTA (NTE buffer, pH 7.5) for
three 10 min changes at 37°C. Non-specifically bound probe was hydrolysed
with 40 pg/ml RNase in NTE for 30 min at 37°C. The slides were washed in
NTE for 15 min at 37°C then 50% formamide, 2 x SSC, 10 mM (3-
mercaptoethanol for 20 min at 65 °C. To increase the stringency of the washes
the slides were washed in decreasing salt solutions; 2 x SSC for three changes
of 10 min each at room temperature, then 0.1 x SSC for three changes of 10
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min each at room temperature. The sections were dehydrated by passing
through successively increasing alcohol solutions containing 0.3 M
ammonium acetate to prevent denaturation of in situ hybrids; 1 min in each
of 30% (v/v), 50% (v/v), 75% (v/v) and 90% (v/v) ethanol, followed by two
5 min periods in 100% ethanol. Slides were allowed to air dry for 2 h.
2.9 Autoradiography
Kodak NTB-2 (Kodak) emulsion was melted in a 40 °C water bath in a
dark room illuminated by a safelight. Once liquefied the emulsion was
diluted with an equal volume of distilled water and thoroughly mixed, then
poured into a slide dipping chamber (Amersham). The emulsion was
allowed to sit for 10-15 min to let any bubbles rise and then bubbles on the
surface were removed by dipping several blank slides. Slides carrying
hybridised sections were dipped in the emulsion twice, for about 2 sec each
time. The bottom edges were blotted with a paper towel and the back of the
slide was cleaned to remove the emulsion. Slides were placed on a foil-
covered hot plate to dry. Once dry, the slides were placed in dessicant-filled,
light-proof plastic boxes which were subsequently wrapped in foil and left
at 4°C for 2 weeks.
2.10 Developing
The foil-wrapped box was allowed to stabilise at about 15 °C while still
sealed to avoid condensation on the slides which would reduce grain
density. Slides were developed in D19 developer for 4 min. Development
was stopped in distilled water and then the slides were fixed in
Kodafix:distilled water (1:4) for 4 minutes and then rinsed in distilled water.
All solutions were kept at the same temperature, 15°C, to prevent the
emulsion cracking and flaking.
2.11 Staining and Mounting
Slides were stained by sequential dipping in haematoxylin, water, acid
alcohol, water, Scotts tap water and water for optimal times to achiswe,
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optimal visualisation. Slides were then dehydrated through successively
increasing alcohol solutions ; 1 min in each of 30% (v/v), 50% (v/v), 75%
(v/v), 90% (v/v) and 100% ethanol followed by 5 min in xylene. Coverslips
were mounted using Eukitt, and were then allowed to dry for 4 h.
2.12 Photography
Slides were examined under bright and darkfield optics, using a Zeiss
photomicroscope and a yellow daylight filter at a magnification of x 10 or x
25. Kodakcolour II, 200 ASA film was used.
3. Results
3.1 In situ hybridisation of P450arom mRNA by
hypophysectomised rat ovaries
The expression and localisation of P450arom mRNA was studied by in
situ hybridisation. Control ovaries contained only small immature follicles in
which P450arom mRNA was undetectable (Fig. 5.2A and B). Treatment with
rh-FSH (total dose 72 IU) stimulated the development of antral follicles
containing granulosa cells that clearly expressed P450arom (Fig. 5.2C and D).
The P450arom mRNA signal was most intense in the mural cell layers and
not discernible in any other cell type other than granulosa cells. FIMG
treatment (total dose 40 IU of both FSH and LH) also stimulated follicular
growth and and granulosa cell P450arom mRNA formation (Fig. 5.2E and F).
There was no evidence of P450arom mRNA expression above background
levels (sense probe; Fig. 5.2G) in any other ovarian cell type.
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FIG. 5.2. Bright- (left hand column) and darkfield (right hand column) views of in
situ hybridisation with hypophysectomised rat ovaries using a P450arom cRNA
probe. Bar = lOOfim. A and B Section from an untreated rat ovary showing no
hybridisation above background. C and D Section from a rh-FSH treated (total dose
72 IU) rat ovary showing intense hybridisation of the P450arom cRNA probe to
predominately mural granulosa cells of antral follicles. E and F Section from a
HMG treated (total dose 40 IU of both LH and FSH) rat ovary showing hybridisation
to granulosa cells but not thecal/interstitial cells. G Sense cRNA probe illustrating
specificity of antisense probe.
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3.2 In situ hybridisation of LH receptor mRNA by
hypophysectomised rat ovaries
The expression and localisation of LH receptor mRNA was studied by
in situ hybridisation. LH receptor mRNA was detectable in control ovaries,
but only in thecal/interstitial cells (Fig. 5.3A and B). The administration of
rh-FSH (total dose 72 IU) induced LH receptor mRNA in the granulosa cells
of large follicles without having any clear effect on thecal/interstitial cells
(Fig. 5.3C and D). Granulosa cell LH receptor mRNA was also induced by
HMG treatment (total dose 40 IU of both FSH and LH). This response to
HMG was often more marked than that to rh-FSH but there was
considerable follicle-to-follicle variation (Fig. 5.3E and F). The probe
specificity was demonstrated by the use of a sense probe (Fig. 5.3G).
3.3 Evidence for thecal/interstitial cell-specific expression of
P450C17amRNA
The site of P45017a mRNA expression was studied by in situ
hybridisation. In-situ hybridization with antisense 32P-labelled P450C17a
cRNA demonstrated that P450C17a mRNA expression was confined to
thecal cells at all stages of follicular development, persisting in secondary
interstitial tissue within the stroma (Fig. 5.4). Expression beyond background
levels (sense probe; Fig. 5.4G) was not observed in any other ovarian cell
type.
3.4 Effect of diethylstilboestrol treatment vivo on expression of
P450C17ocmRNA by ovaries from intact animals
The effect of oestrogen in vivo on ovarian P45017a mRNA expression
was tested by the use of DES implants for four days prior to removal of
ovaries. P450C17a mRNA was detectable in control ovaries, but only in
thecal/interstitial cells (Fig. 5.5A and B). The administration of rh-FSH (total
dose 72 IU) had no clear effect on thecal/interstitial cell expression of
P450C17a mRNA (Fig. 5.5E and F). The administration of
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FIG. 5.3. Bright- (left hand column) and darkfield (right hand column) views of in
situ hybridisation with hypophysectomised rat ovaries using a LH receptor cRNA
probe. Bar = 100p.m. A and B Section from an untreated rat ovary showing
hybridisation is limited to thecal/interstitial cells. C and D Section from a rh-FSH
treated (total dose 72 RJ) rat ovary showing hybridisation of the LH receptor cRNA
probe to granulosa cells as well as thecal/interstitial cells. E and F Section from a
HMG treated (total dose 40 IU of both LH and FSH) rat ovary showing increased
hybridisation signal intensity above that achieved with rh-FSH alone. G Sense cRNA
probe illustrating specificity of antisense probe.
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FIG. 5.4. Bright- (left hand column) and darkfield (right hand column) views of in
situ hybridisation with adult rat ovaries at the proestrous stage of the oestrous cycle
using a P450C17a cRNA probe. Bar = 100|im. A and B Section of a preovulatory
follicle. The distribution of labelling indicates that P450C17a expression is
predominately located in the thecal/interstitial cell layer. C and D Higher
magnification of the same follicle section. The distribution of labelling indicates that
P450C17a expression is predominately located in the thecal/interstitial cell layer and
is not found in the granulosa cell layer. E and F Section of a corpus luteum showing
little hybridisation above background levels. G Sense cRNA probe illustrating
specificity of antisense probe.
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FIG. 5.5. Bright- (left hand column) and darkfield (right hand column) views of in
situ hybridisation with intact rat ovaries using a P450C17a cRNA probe. Bar =
100p.m. A and B Section from an untreated rat ovary showing hybridisation is
limited to thecal/interstitial cells. C and D Section from a DES treated rat ovary
showing decreased hybridisation of the P450C17a cRNA probe to thecal/interstitial
cells.
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FIG. 5.5. (contd.) Bright- (left hand column) and darkfield (right hand column)
views of in situ hybridisation with intact rat ovaries using a P450C17a cRNA probe.
Bar = 100pm. E and F Section from a rh-FSH treated (total dose 72 IU) rat ovary
showing hybridisation is limited to thecal/interstitial cells at a similar intensity to that
found in untreated ovaries. G and H Section from a DES and rh-FSH treated (total
dose 72 IU) rat ovary showing decreased hybridisation of the P450C17a cRNA
probe to thecal/interstitial cells relative to untreated ovaries or ovaries treated with
rh-FSH or DES alone. I Sense cRNA probe illustrating specificity of antisense
probe. For corresponding control, see Fig. 5.5 A and B.
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DES treatment decreased intensity of P450C17a mRNA expression both in
the presence and absence of rh-FSH (Fig. 5.5C, D, G and H). The probe
specificity was demonstrated by the use of a sense probe (Fig. 5.51).
3.5 In situ hybridisation of P450C17amRNA by intact rat ovaries
The expression of ovarian P45017a mRNA in pituitary intact animals
was studied by in situ hybridisation. P450C17a mRNA was detectable in
control ovaries, but only in thecal/interstitial cells (Fig. 5.6A and B).
Treatment with rh-FSH (total dose 72 IU) stimulated the development of
antral follicles but showed no clear effect on thecal/interstitial cell
expression of P450C17a mRNA (Fig. 5.6C and D). HMG treatment also
stimulated follicular growth and increased thecal/interstitial cell expression
of P450C17a mRNA (Fig. 5.6E and F) over that found in untreated ovaries.
There was no evidence of P450C17a mRNA expression above background
levels (sense probe; Fig. 5.6G) in any other ovarian cell type.
3.6 In situ hybridisation of P450C17amRNA by
hypophysectomised rat ovaries
The expression of ovarian P45017a mRNA in hypophysectomised
animals was studied by in situ hybridisation. P450C17a mRNA was
detectable in control ovaries, but only in thecal/interstitial cells (Fig. 5.7A
and B). Treatment with rh-FSH (total dose 72 IU) stimulated the
development of antral follicles and decreased the overall expression of
P450C17a mRNA (Fig. 5.7C and D) though it was unclear whether this was
due to a true decrease in levels of expression or the same levels of expression
distributed over a larger area. HMG treatment (total dose 40 IU of both FSH
and LH) also stimulated follicular growth and increased thecal/interstitial
cell expression of P450C17a mRNA (Fig. 5.7E and F) over that found in
untreated ovaries. There was no evidence of P450C17a mRNA expression
above background levels (sense probe; Fig. 5.7G) in any other ovarian cell
type.
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FIG. 5.6. Bright- (left hand column) and darkfield (right hand column) views of in
situ hybridisation with intact rat ovaries using a P450C17a cRNA probe. Bar =
100|im. A and B Section from an untreated rat ovary showing hybridisation is
limited to thecal/interstitial cells. C and D Section from a rh-FSH treated (total dose
72 IU) rat ovary showing a similar intensity of hybridisation of the P450C17a cRNA
probe to thecal/interstitial cells relative to untreated ovaries. E and F Section from a
HMG treated (total dose 40 IU of both LH and FSH) rat ovary showing increased
hybridisation signal intensity above that achieved with rh-FSH alone. G Sense cRNA
probe illustrating specificity of antisense probe.
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FIG. 5.7. Bright- (left hand column) and darkfield (right hand column) views of
situ hybridisation with hypophysectomised rat ovaries using a P450C17a cRNA
probe. Bar = 100pm. A and B Section from an untreated rat ovary showing
hybridisation is limited to thecal/interstitial cells. C and D Section from a rh-FSH
treated (total dose 72 IU) rat ovary showing decreased intensity of hybridisation of
the P450C17a cRNA probe to thecal/interstitial cells relative to untreated ovaries. E
and F Section from a HMG treated (total dose 40 IU of both LH and FSH) rat ovary
showing increased hybridisation signal intensity above that observed in untreated
ovaries. G Sense cRNA probe illustrating specificity of antisense probe.
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3.7 Establishment of dose-dependence of rh-FSH action on
P450C17amRNA expression by hypophysectomised rat ovaries
The dose-dependence of rh-FSH action on ovarian P450C17a mRNA
expression was established in insitu hybridisation experiments on
hypophysectomised animals (Fig. 5.8). P450C17oc mRNA was detectable in
control ovaries, but only in thecal/interstitial cells (Fig. 5.8A and B). The
administration of a total dose of 3 IU rh-FSH (Fig. 5.8C and D) had no
discernible effect on the expression of P450C17a mRNA. The administration
of a total dose of 10 IU rh-FSH (Fig. 5.8E and F) or 30 IU rh-FSH (Fig. 5.8G
and H) decreased expression of P450C17a mRNA compared to levels of
expression found in untreated ovaries. The administration of a total dose of
100 IU rh-FSH (Fig. 5.81 and J) further decreased the intensity of P450C17a
mRNA expression. HMG treatment (total dose 40 IU of both FSH and LH)
increased thecal/interstitial cell expression of P450C17a mRNA (Fig. 5.8K
and L) over that found in untreated ovaries. There was no evidence of
P450C17a mRNA expression above background levels (sense probe; Fig.
5.8M) in any other ovarian cell type.
3.8 Effect of r-LH administration vivo on expression of
P450C17amRNA by hypophysectomised rat ovaries
The effect of r-LH administration on expression of P450C17a mRNA
expression in the presence and absence of rh-FSH was tested (Fig. 5.9).
P450C17a mRNA was detectable in control ovaries, but only in
thecal/interstitial cells (Fig. 5.9A and B). The administration of a total dose of
10IU (Fig. 5.9N and O) increased intensity of expression of P450C17a mRNA
over levels found in control ovaries. In the presence of a total dose of 30 IU
rh-FSH the administration of a total dose of 1 IU r-LH (Fig. 5.9J and K) or 10
IU (Fig. 5.9P and Q) increased intensity of expression of P450C17a mRNA
over levels found in ovaries treated with 30 IU rh-FSH alone (Fig. 5.9C and
D). In the presence of a total dose of 72 IU rh-FSH the administration of a
total dose of 1 IU r-LH (Fig 8L and M) or 10 IU (Fig. 5.9R and S) increased
intensity of expression of P450C17a mRNA
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FIG. 5.8. Bright- (left hand column) and darkfield (right hand column) views of in
situ hybridisation with hypophysectomised rat ovaries using a P450C17a cRNA
probe. Bar = 100|im. A and B Section from an untreated rat ovary showing
hybridisation is limited to thecal/interstitial cells. C and D Section from a rh-FSH
treated (total dose 3 IU) rat ovary showing a similar intensity of hybridisation of the
P450C17a cRNA probe to thecal/interstitial cells compared to untreated ovaries. E
and F Section from a rh-FSH treated (total dose 10 IU) rat ovary showing decreased
intensity of hybridisation of the P450C17oc cRNA probe to thecal/interstitial cells
relative to untreated ovaries.
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FIG. 5.8. (contd.) Bright- (left hand column) and darkfield (right hand column)
views of in situ hybridisation with hypophysectomised rat ovaries using a P450C17a
cRNA probe. Bar = 100p.m. G and H Section from a rh-FSH treated (total dose 30
IU) rat ovary showing further decreased intensity of hybridisation of the P450C17a
cRNA probe to thecal/interstitial cells relative to untreated ovaries. I and J Section
from a rh-FSH treated (total dose 100 IU) rat ovary showing further decreased
intensity of hybridisation of the P450C17a cRNA probe to thecal/interstitial cells
relative to untreated ovaries. K and L Section from a HMG treated (total dose 40 IU
of both LH and FSH) rat ovary showing increased hybridisation signal intensity
above that observed in untreated ovaries. M Sense cRNA probe illustrating
specificity of antisense probe. For corresponding control, see Fig. 5.8 A and B.
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FIG. 5.9. Bright- (left hand column) and darkfield (right hand column) views of in
situ hybridisation with hypophysectomised rat ovaries using a P450C17oc cRNA
probe. Bar = 100|im. A and B Section from an untreated rat ovary showing
hybridisation is limited to thecal/interstitial cells. C and D Section from a rh-FSH
(total dose 30 IU) and no r-LH treated rat ovary rat ovary showing decreased
intensity of hybridisation of the P450C17a cRNA probe to thecal/interstitial cells
relative to untreated ovaries. E and F Section from a rh-FSH (total dose 72 IU) and
no r-LH treated rat ovary showing further decreased intensity of hybridisation of the
P450C17a cRNA probe to thecal/interstitial cells relative to untreated ovaries. G
Sense cRNA probe illustrating specificity of antisense probe.
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FIG. 5.9. (contd.) Bright- (left hand column) and darkfield (right hand column)
views of insitu hybridisation with hypophysectomised rat ovaries using a P450C17a
cRNA probe. Bar = 100p.m. H and I Section from a r-LH treated (total dose 1 IU)
rat ovary showing amount of hybridisation is similar to untreated ovaries (for
corresponding control, see Fig. 5.9 A and B). J and K Section from a rh-FSH (total
dose 30 IU) and r-LH (total dose 1 IU) treated rat ovary rat ovary showing increased
intensity of hybridisation of the P450C17a cRNA probe to thecal/interstitial cells
relative to rh-FSH (total dose 30 IU) treated ovaries (for corresponding control, see
Fig. 5.9 C and D). L and M Section from a rh-FSH (total dose 72 IU) and r-LH
(total dose 1 IU) rat ovary showing increased intensity of hybridisation of the
P450C17a cRNA probe to thecal/interstitial cells relative to rh-FSH (total dose 72
IU) treated ovaries (for corresponding control, see Fig. 5.9 E and F).
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FIG. 5.9. (contd.) Bright- (left hand column) and darkfield (right hand column)
views of in situ hybridisation with hypophysectomised rat ovaries using a P450C17a
cRNA probe. Bar = lOOjim. N and O Section from a r-LH treated (total dose lolU)
rat ovary showing increased hybridisation limited to thecal/interstitial cells relative
to untreated ovaries (compare with 5.9 H and I). P and Q Section from a rh-FSH
(total dose 30 IU) and r-LH (total dose 10 IU) treated rat ovary rat ovary showing
increased intensity of hybridisation of the P450C17a cRNA probe to
thecal/interstitial cells relative to rh-FSH (total dose 30 IU) treated ovaries in the
presence or absence of 1 IU total dose r-LH (compare with 5.9 J and K). R and S
Section from a rh-FSH (total dose 72 IU) and r-LH (total dose 10 IU) rat ovary
showing increased intensity of hybridisation of the P450C17a cRNA probe to
thecal/interstitial cells relative to rh-FSH (total dose 72 IU) treated ovaries in the
presence or absence of 1 IU total dose r-LH (compare with 5.9 L and M). T and U
Section from a HMG treated (total dose 40 IU of both LH and FSH) rat ovary
showing increased hybridisation signal intensity above that observed in untreated
ovaries.
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over levels found in ovaries treated with 72 IU rh-FSH alone (Fig. 5.9E and
F). In the absence of r-LH the administration of 30 IU rh-FSH (Fig. 5.9C and
D) or 72 IU rh-FSH (Fig. 5.9E and F) decreased intensity of P450C17a mRNA
expression compared to levels of expression found in untreated ovaries (Fig.
5.9A and B). Interestingly, in the presence of 1 IU r-LH (Fig. 5.9H to M) or 10
IU r-LH (Fig. 5.9N to U) the administration of rh-FSH did not decrease levels
of P450C17a mRNA expression and possibly increased the expression. There
was no evidence of P450C17a mRNA expression above background levels
(sense probe; Fig. 5.9G) in any other ovarian cell type.
4. Discussion
The finding that P450C17a mRNA expression is confined to
thecal/interstitial cells confirms a basic requirement of the two cell, two
gonadotrophin mechanism of follicular oestrogen synthesis (Whitelaw et al.
1992). This is the first time that P450C17a mRNA distribution in the ovary
has been studied by in-situ hybridisation. The message is apparently absent
from granulosa cells but abundantly expressed in thecal cells throughout
preantral and antral follicular development, consistent with thecal cells being
primary sites of androgen synthesis in the ovary. The significance of the
observation that P45017a expression occurs in clusters or pockets of cells is
not known. It is possible that this indicative of cell lineage. In other words,
cells within the same pocket, whether it be labelled or unlabelled, could be
derived from the same parent cell.
Therehjobeen no published in situ hybridisation study of P45017a
mRNA expression in the ovary despite the fact that the technology has been
available for some time. A possible explanation for this could be that there
has been some difficulty due to the region of mRNA chosen that is
complementary to the probe used. In this study the probes were
complementary to the portion of the mRNA encoding the conserved P45017a
sequence and Ozols tridecapeptide regions of the P45017a protein. It is
po ssible that the probe must be complementary to one or both regions for
adequate hybridisation to P45017a mRNA.
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Using a combination of hypophysectomised rats and recombinant FSH
this study presents a convincing demonstration that FSH acts directly in the
absence of endogenous sex steroids and LH to induce granulosa cell
aromatase expression in vivo. This induction occurred without a par allel
increase in oestradiol secretion (Chapter 2, Table 2.2). This finding supports
the two-cell, two-gonadotrophin hypothesis which requires simul taneous
LH activation of androgen synthesis by thecal/interstitial cells for oestrogen
synthesis (Armstrong & Dorrington, 1979). Aromatase mRNA expression
was always confined to granulosa cell layers and absent from
thecal/interstitial cells confirming another basic requirement of the two cell,
two gonadotrophin mechanism of follicular oestrogen synthesis (Whitelaw et
al. 1992).
In contrast to aromatase mRNA, LH receptor mRNA was expressed in
the thecal/interstitial cells of control animals not treated with FSH.
Treatment with FSH induced an increase in granulosa cell LH receptor
mRNA expression, in parallel with its effect on aromatase expression. Again
this induction occurred without a paf illel increase in oestradiol secretion
providing evidence that oestrogen is not required for the induction of LH
receptor by FSH in contrast to a previous report (Richards et al. 1987). This
finding however does not exclude the possibility that oestradiol is capable of
modulating FSH action (Richards et al. 1987).
In untreated ovaries P450C17a mRNA is constitutively expressed
whilst aromatase mRNA expression does not occur until it is induced by
FSH. The observation that P450C17a mRNA in thecal/interstitial cells is
expressed before aromatase mRNA in granulosa cells implies an interaction
between these two cell types. Androgens induce rat granulosa cell aromatase
in the presence of FSH by an androgen receptor mediated mechanism
(Hillier & deZwart, 1982).
Oestrogens inhibit LH-stimulated androgen biosynthesis in rat
thecal/interstitial cells (Erickson et al. 1985) by greater than 90%. The
mechanism of oestrogen action in thecal/interstitial cells remains unclear.
The inhibitory effects of oestradiol on thecal/interstitial cell androgen
production occur without changes in LH receptors, LH-stimulated cAMP
production or progesterone production (Erickson et al. 1985) and oestradiol
does not cause a direct inhibition of P450C17a activity in ovarian
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homogenates (Johnson et al. 1984). These observations coupled with our
finding that DES decreases P450C17a mRNA expression suggest a selective
inhibitory block to transcription or translation of the P450C17a gene. These
inhibitory effects of oestrogen may be the mechanism which mediates the
decrease in P450C17a activity that occurs after ovulation in a wide variety of
species (Erickson et al. 1985). P450C17a mRNA expression is found in low
levels in the corpus luteum of the rat ovary. This finding is consistent with
the low androgen levels, and consequently oestradiol, found in the corpus
luteum which is primarily a progesterone-producing structure.
The complete withdrawal of gonadotrophins by hypophysectomy had
no effect on the overall levels of P450C17a expression despite the high levels
of atresia induced by such treatment. This suggests that P450C17a is
expressed constitutively. Treatment of hypophysectomised animals with
FSH resulted in a dose-dependent decrease in P450C17a mRNA expression.
This decrease could be due to an expanding thecal cell layer caused by FSH-
stimulated granulosa cell proliferation. The expanded thecal cell layer may
express the same levels of P45017a mRNA, but the expression is spread over
a greater area, giving the impression of decreased intensity. However, the
same treatment in intact animals did not notk&iibly alter the level of
P450C17oc mRNA expression. These results suggest that FSH, in the absence
of LH (i.e. hypophysectomised animal), is able to negatively regulate the
expression of P450C17a mRNA. Since thecal /interstitial cells do not possess
FSH receptors it is implied that this negative regulation is via a paracrine
mechanism. Factors produced by FSH-stimulated granulosa cells include
IGF-I (Hernandez et al. 1989), TGF(3 (Kim & Schomberg, 1989), activin and
inhibin (Meunier et al. 1988). TGFP, in the presence of IGF-I, is capable of
inhibiting basal androgen production by thecal/interstitial cells (Hernandez
& Adashi, 1988). IGF-I and inhibin augment LH-stimulated androgen
synthesis by thecal/interstitial cells but are unable to affect basal androgen
synthesis by these cells (IGF-I: Adashi et al. 1985a; inhibin: Hsueh et al. 1987).
\jT
Activin inhibits LH-stimulated androgen synthesis (Hsueh et al. 1987). It is
therefore possible that the discrepency between the effects of FSH on
P450C17a mRNA expression in hypophysectomised and intact animals may
be explained by the actions of these factors. It may be hypothesised that FSH
treatment stimulates the production of IGF-I, TGF|3, activin and inhibin by
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granulosa cells. In the hypophysectomised animal the inhibin and activin
would have no effect, due to the absence of LH, but TGF[3 in the presence of
IGF-I would decrease the expression of P450C17a mRNA. In the previous
chapter it was shown that there is a requirement for LH to facilitate the
actions of inhibin and IGF-I. In the intact animal there is endogenous LH
present which therefore would enable inhibin or IGF-I produced by
granulosa cells to overcome the combined effect of TGF(3 and IGF-I and
thereby increase LH-stimulated androgen production. If the granulosa cells
are predominantly immature they will not be ready for aromatase substrate
and will produce activin which inhibits LH-stimulated androgen production.
Once the granulosa cells are mature enough for aromatisation they produce
inhibin which augments LH-stimulated androgen production. These results
are consistent with the physiological situation where early in development
theca cells are progesterone producing and do not need to express P45017a
activity. Thus, FSH may down regulate any thecal cell function until the
granulosa cells are ready for aromatase substrate.
LH dose-dependently stimulated an increase in P450C17a mRNA
expression in the absence of any other gonadotrophic stimulation and
reversed the inhibitory effect of FSH alone on P450C17a mRNA expression.
This finding supports the two-cell, two-gonadotrophin hypothesis which
requires the presence of LH for activation of androgen synthesis by
thecal/interstitial cells for normal oestrogen synthesis (Armstrong &
Dorrington, 1979).
In conclusion this study has shown that FSH induces the expression of
aromatase mRNA exclusively in granulosa cells. FSH also directly increases
granulosa cell LH receptor mRNA but thecal/interstitial cell LH receptor
mRNA is expressed constitutively. The induction of both these enzymes by
FSH is independent of LH or locally produced oestrogen. These results
provide evidence that P450C17a is expressed constitutively in a cell-specific
manner and is subject to hormonal regulation by both FSH and LH and
steroidal regulation by oestradiol. FSH is able to influence the expression of
P450C17a mRNA by paracrine signalling. Further research is required to
determine which locally produced factors mediate these actions of FSH.
Candidates include factors produced by granulosa cells under the
stimulation of FSH. Such proteins include inhibin, activin and IGF-I which
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dose dependently enhance LH-stimulated thecal /interstitial cell androgen
production and TGF|3 which inhibits basal androgen production in the
presence of IGF-I. These actions suggest paracrine roles for these factors in
the modulation of P450C17a mRNA expression. The next chapter tests the
hypothesis that inhibin is a granulosa cell-derived paracrine factor that
enhances thecal cell androgen production.
Chapter 6. Rat Ovarian Follicle Culture
1. Introduction
The results of the previous chapters provide evidence for a FSH-
stimulated paracrine enhancement of ovarian thecal/interstitial cell
androgen synthesis. Thus factors produced by FSH-stimulated granulosa
cells may act as paracrine signals in vivo. The results of the previous chapters
also suggest that likely paracrine modulators include inhibin. This chapter
describes a study of the intraovarian function of inhibin in follicular
development using an in vitro rat ovarian follicle culture system.
Gonadal inhibin serves a classic endocrine function in the regulation of
pituitary FSH secretion (see Ying, 1988 for a review). A local role for inhibin
in the control of follicular oestrogen production has also been proposed,
based on evidence that (1) inhibin is produced by FSH-stimulated rat (Bicsak
y \y
et al. 1986) and human (Hillier et al. 1991a) granulosa cells, and (2) treatment
with inhibin augments LH-stimulated androgen production by
thecal/interstitial cells in vitro (Hsueh et al. 1987; Hillier et al. 1991c). Since
thecal androgen is vital as an aromatase substrate in the two-cell, two-
gonadotrophin mechanism of oestrogen synthesis (Armstrong & Dorrington,
1979), augmentation of LH-stimulated androgen synthesis by locally
produced inhibin would therefore be expected to enhance follicular
production of oestradiol (Hillier, 1991b).
Direct evidence that a substance exerts a paracrine function in vitro
requires use of a physiological model in which normal follicular growth and
differentiation can occur. Detailed investigations of the mechanisms of
paracrine signalling within the ovarian follicle have been restricted by the
lack of a defined culture system capable of sustaining normal follicular
development. Monolayer culture systems of individual cell types have
contributed greatly to the understanding of follicular development but they
suffer from the disadvantage that follicular integrity is disrupted meaning
that normal intra-follicular interactions cannot occur. Antral follicle cultures
have mainly involved short-term incubation of large antral follicles for
v y
measuring steroid secretion (Bogovich & Richards, 1982; Laufer et al. 1982;
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Carlsson et al. 1985; Tsafiri et al. 1989b). To test if inhibin has a
physiologically significant paracrine action within the intact follicle we have
turned to a whole follicle culture system initially developed for mouse
ovarian follicles (Boland et al. 1993). Whole follicle culture has the advantage
that normal communication between follicular cell types is maintained such
that paracrine factors remain active at or near their site of production. Here
we exploit this model to examine the consequence of immunoneutralisation
of inhibin on follicular steroidogenesis.
Steroidogenesis is dependent upon the integrity of the follicle and
cooperation of the two cell types found in the ovary. This interdependence of
granulosa and thecal cells for rat ovarian follicular oestrogen production was
clearly demonstrated by Falck in 1959 when it was shown that neither cell
type could produce oestrogens alone. The "two-cell theory" (Short, 1962),
based upon assays of endogenous steroid levels in the mare follicle and
corpus luteum, proposed two types of cell in the ovary with different steroid
producing capacities. In 1975, using a hamster ovarian model, Makris and
Ryan established a clear-cut synergism of granulosa and thecal cells for
oestrogen production, whereby the theca produced androgen which the
v
granulosa aromatised to oestrogen. Dorrington et al. (1975) provided
evidence that FSH regulates oestrogen biosynthesis in granulosa cells but not
s/
thecal cells. Fortune and Armstrong (1977) showed that the theca, under LH
regulation, was the site of follicular androgen secretion by rat ovarian
follicles and suggested that the theca provides the androgen precursor
needed for follicular oestradiol synthesis. These results led to the proposal of
the "two cell, two gonadotrophin" hypothesis (Armstrong and Dorrington,
1979). According to this model, LH stimulates the biosynthesis of androgen
from cholesterol or granulosa-derived progesterone in the theca cell layer.
Androgens diffuse across the lamina basalis and are converted to oestrogens
by FSH-stimulated granulosa cells. In this study withdrawal of inhibin by
immunoneutralisation was expected to suppress thecal androgen synthesis
and hence granulosa cell oestrogen synthesis, thereby confirming the
paracrine inhibin hypothesis.
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2. Materials and Methods
2.1 Animals
Immature female Wistar rats were killed by CO2 asphyxiation at 21
days of age and ovaries were aseptically removed for follicle isolation.
2.2 Follicle isolation
Ovaries were placed in Leibovitz L-15 medium (Gibco-BRL, Irvine,
UK.) supplemented with 3mg/ml BSA fraction V (Sigma, Dorset, UK.) and
immediately transported to the dissection laboratory. Initially, each ovary
was teased into 4-8 pieces. Individual preantral follicles, 186 pm to 400 gm in
diameter (excluding theca cell layer), were then micro-dissected from ovaries
in watchglasses using two fine 28G needles attached to 1ml syringes
(Steriseal, Worcester, UK.). Visualisation was at x40 magnification using a
stereo dissecting microscope (Carl Zeiss Jena Ltd., Hertfordshire, UK.) fitted
with a pre-calibrated ocular micrometer. Care was taken to leave a small
clump of theca cells attached to the basement membrane, as the presence of
this tissue has previously been shown to be vital to follicle development
(Erickson et al. 1985). Follicles with a central, spherical oocyte and no signs of
damage were cultured.
2.3 Preparation of culture dishes.
Ninety-six V-well, microtitre plates (Bibby Sterilin Ltd., Staffordshire,
UK.) were silicone coated (Sambrook et al. 1989) by placing in a dessicator
containing a beaker with 2ml of silicone (Repelcote™, Sigma). The dessicator
was evacuated and left overnight. The plates were then rinsed in sterile
water followed by ethanol the following day. Sterilisation was assured by
ultra-violet irradiation for 5 h. The silicone coating prevented follicular cells
from becoming attached and spreading on the V-well surface and thus an
intact follicular structure was maintained throughout the culture period.
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2.4 Follicle culture
Follicles were cultured individually in 20 fil droplets of a Minimum
Essential Medium (a-MEM) (Gibco-BRL) under 50 |il mineral oil (Sigma;
d=0.84g/ml) in 5% CO2 in air at 37°C for 5 days. Medium was supplemented
with 10 |lg/ml human transferrin (Sigma), llU/ml human FSH (hFSH;
biological potency = 1683 IU FSFl/mg [2nd IRP HMG]; LH contamination
147 IU LH/mg [1st IRP 68/40]; generously donated by Dr. S. Raiti, National
Hormone and Pituitary Program, Bethesda, MD., USA.) and 5% serum from
immature rats. Serum was obtained from 21 day old rats and prepared by
centrifugation after being allowed to clot at room temperature for about 10
min. The inhibin antiserum was raised in an ovariectomised Scottish
Blackface ewe (McNeilly et al. 1989) using as the immunogen a peptide
comprising the N-terminal 1-26 amino acid sequence of the a-subunit of
porcine 32 kDa inhibin (Rivier et al. 1986) conjugated to ovalbumin. This
antiserum was previously shown to neutralise the suppressive effect of
inhibin on FSH production by dispersed sheep pituitary cells in vitro (Mann
et al. 1989a). Non-immune sheep serum was obtained from an untreated
Scottish Blackface ewe. Recombinant human inhibin-A (Mason, 1988) was
from Genentech Inc. and androstenedione was from Sigma. All control and
test treatments were done in replicate (n=12) and the main experiments were
repeated at least twice, as summarised in Table 6.1.
After each successive 24 h period of culture, follicles were removed
from their wells in a minimum volume of medium using a fine glass
micropipette, and transferred to fresh culture medium. Follicle diameters
were measured daily with a precalibrated ocular micrometer at x 40
magnification in medium at 37°C. Spent culture medium was stored at -20°C
for steroid assay.
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TABLE 1: Summary of Experiments.
Treatment
Expt. Control Test
I non-immune serum( 1.0%) inhibin antiserum (0.1%)
inhibin antiserum(1.0%)
II non-immune serum( 1.0%) inhibin antiserum(0.1%)
inhibin antiserum(1.0%)
III no serum non-immune serum( 1.0%)
IV non-immune serum( 1.0%) inhibin antiserum(1.0%)
inhibin antiserum(1.0%)+inhibin(50ng/ml)
V no serum inhibin antiserum( 1.0%)
inhibin antiserum( 1,0%)+inhibin(50ng/ml)
VI no serum inhibin antiserum(1.0%)
inhibin antiserum(1.0%)+androstenedione (l|iM)
In every experiment, each control and test treatment comprised 12 follicles cultured
individually.
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2.5 Preparation of Follicle Sections
On day 5 of culture follicles were fixed overnight at 4°C in 4% (w/v)
paraformaldehyde (Sigma) dissolved in PBS. This was followed by
sequential dehydration treatments at room temperature with 85% (v/v)
ethanol for 1 h; 95% (v/v) ethanol for 1 h; three treatments with 100% (v/v)
ethanol for 1 h each; two treatments with xylene for 30 min each and then a
third treatment with xylene overnight at room temperature. Tissue was then
treated with paraffin i wax for two successive 1 h periods at 60 °C. Prepared
tissues were then placed in molds containing melted paraffin, which was
then allowed to solidify.
Slides were cleaned and coated to help tissue section retention as
described previously (Chapter 5, section 2.4). Tissue was sectioned and
mounted as described in Chapter 5, sections 2.4 and 2.11.
Slides were stained by sequential dipping in haematoxylin, water, acid
alcohol, water, Scotts tap water, water, eosin and water for optimal times to
achive optimal visualisation. Slides were then dehydrated through
successively increasing alcohol solutions ; 1 min in each of 30% (v/v), 50%
(v/v), 75% (v/v), 90% (v/v) and 100% ethanol followed by 5 min in xylene.
Coverslips were mounted using Eukitt which was then allowed to dry for 4
h.
Slides were examined under brightfield optics, using a Zeiss
photomicroscope and a yellow daylight filter at a magnification of x 10.
Kodakcolour II, 200 ASA film was used.
2.6 Steroid Assays
Oestradiol, progesterone, androsterone and androstenedione in spent
culture medium were determined by RIA using standard procedures and
antisera as described previously (Chapter 2, sections 2.5.1, 2.5.2 and 2.5.3,
and Chapter 3, section 2.4.3). The inter- and intraassay precision for each
steroid was less than 15%. Steroid accumulation is expressed as picomoles
steroid per follicle per 24 h.
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2.7 Statistics
Statistical analysis was carried out using commercial software (CLR
ANOVA). Analysis of variance with the Newman-Keuls test was used to
analyse differences between experimental and control observations.
Differences assigned a P value of <0.05 were regarded as statistically
significant.
3. Results
3.1 Follicle growth and morphology
3.1.1 Follicle size at the start of culture
Previous studies have shown in the mouse that factors influencing
growth of follicles in vitro include how often medium is changed, number of
follicles per well, species and age of serum donor and follicle size at the start
of culture (Nayudu & Osborn, 1992). Thus follicles of varying starting
diameters (186 [im to 400 (im) were compared for their growth in culture
under optimal conditions (Fig. 6.1). The most rapidly growing folfcles (240
pm) increased by approximately 45 pm a day to an average size of 470 pm
which is comparable with sizes of 500 - 750 pm reported in vivo (Freeman,
1988). The growth profile of this starting size of follicle best represented the
physiological growth of a primary follicle through to a preovulatory follicle.
If the follicle starting size was too small the follicle was usually dissected
without an intact theca layer and as such failed to proceed through antral
development. Follicles too large were generally atretic due to the lack of
circulating gonadotrophins in vivo to rescue them from this fate. All cultures
described in the following results started with follicles of 244 ± 10 pm
diameter.
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Day of culture
FIG. 6.1. Growth rates of rat follicles of differing starting sizes cultured individually
in vitro for 5 days in medium without inhibin antiserum. Results are expressed as
mean.
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3.1.2 Follicle growth and steroidogenesis in vitro
Preantral follicles cultured in medium containing FSH grew from a
mean (± SE) diameter of 244 ±10 )im to 470 ± 28 gm during the 5 day culture
period (Fig. 6.2). Antrum formation began on Day 2. By the end of the
culture period follicles had attained preovulatory size and Graafian
morphology (Fig. 6.3).
Oestradiol production by follicles cultured in medium containing FSH
was significantly elevated on Day 2 (Fig. 6.4), coincident with the onset of
antrum formation. The rate of oestradiol production increased steadily
throughout culture. Progesterone production also increased on Day 2 but
peaked on Day 3 and then declined on Days 4 and 5 (Fig. 6.4). Androgen
accumulation during the culture period was not measurably changed (Table
6.2).




DAY 1 1.20 ±0.56 0.88 ±0.52 0.96 ±0.24 0.88 ±0.40
DAY 2 1.52 ±0.68 0.88 ±0.32 1.16 ± 0.48 0.96 ± 0.40
DAY 3 1.08 ±0.68 0.84 ±0.28 0.88 ±0.28 1.24 ±0.32
DAY 4 1.32 ±0.64 1.20 ±0.60 1.08 ±0.52 0.84 ±0.52
DAY 5 0.80 ±0.56 0.64 ± 0.40 0.80 ±0.16 0.96 ± 0.64
Table 6.2. Androsterone accumulation (pmol/follicle/24h) by follicles cultured
individually in vitro for 5 days in medium containing homologous serum and FSH (1
IU/ml). Treatments were inhibin antiserum (1.0 %), inhibin (50 ng/ml) and
androstenedione (1 pM). Where measured androstenedione accumulation was below
the minimal detectable dose of the RIA (<0.025 pmol). Composite data from 3
experiments is expressed as mean ± SE.
3.2 Effect of addition of inhibin antiserum to follicle cultures
To test the effect of lack of inhibin during follicular development
follicles were cultured in the presence of inhibin antiserum. Follicles cultured
in the presence of the inhibin antiserum or non-immune serum
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FIG. 6.2. Growth rates of rat follicles cultured individually in vitro for 5 days in
medium with or without inhibin antiserum (0.1% and 1%). Composite data from six
experiments (mean ± SE).
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FIG. 6.3. Morphology of a preovulatory follicle stained with haemotoxylin and
eosin. Follicles were cultured individually in vitro for 5 days in medium without
inhibin antiserum. Follicle diameter at end of culture was 440p.m.
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FIG. 6.4. Steroid production in vitro by individual rat follicles. Whole follicles were
incubated for 5 days in culture medium without inhibin antiserum. Each 24 h of
culture, follicles were removed from their wells using a fine glass micropipette, and
transferred to fresh culture medium. Steroid accumulation in spent culture medium
was determined by radioimmunoassay. Composite data from experiments III, V and
VI (mean ± SE, n=36). *P <0.01 compared with steroid accumulation on Day 1.
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grew at a similar rate to follicles cultured in the absence of antiserum during
the 5 day culture period (Fig. 6.2).
Treatment with antiserum at a concentration of 1.0% (v/v) reduced
oestradiol production on Days 2-5 to levels that were not significantly higher
than those found on the first day of culture (Fig. 6.5). Progesterone
accumulation in the presence of the antiserum was significantly raised on
Day 2 and increased steadily throughout the period of culture (Fig. 6.6).
Treatment with non-immune serum did not significantly alter steroid
production relative to untreated controls (Figs. 6.5 and 6.6). The effects of the
inhibin antiserum on steroidogenesis were dose-dependent with significant
suppression of oestradiol and enhancement of progesterone at a
concentration of 0.1% (v/v) (Fig. 6.7). Androgen production was not
measurably affected by the addition of inhibin antiserum (Table 6.2).
3.3 Effect of supplementing antiserum-treated culture medium
with inhibin
To test the effect of replacing 'neutralised' inhibin antiserum-treated
follicles were cultured in the presence of exogenous inhibin. Follicles
cultured with 50 ng/ml recombinant human inhibin in the presence of the
inhibin antiserum (1.0%) showed a significant increase in oestradiol levels on
Day 1 over those seen in the presence of antiserum alone (Fig. 6.8a) or no
treatment at all (Fig. 6.4). This higher level of oestradiol production was
maintained throughout the period of culture. Progesterone production (Fig.
6.8b) was also initially increased by the addition of exogenous inhibin on
Day 1, unaffected at Day 2, and remained suppressed relative to treat .ment
with antiserum alone at Days 3-5.
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• Inhibin antiserum (1.0%)
o Non-immune serum (1.0%)
Day of culture
FIG. 6.5. Effect of inhibin antiserum compared with A. non-immune serum and B.
untreated follicles on oestradiol accumulation in vitro by rat follicles. Whole follicles
were incubated for 5 days in medium with inhibin antiserum (1.0%) or non-immune
serum (1.0%). Each 24 hours of culture, follicles were removed from their wells
using a fine glass micropipette, and transferred to fresh culture medium. Steroid
accumulation in spent culture medium was determined by radioimmunoassay.
Composite data from experiments I and II (A) or V and VI (B) (mean ± SE, n=24).
*P <0.01 compared with control.
Rat Ovarian Follicle Culture 190
Day of culture
FIG. 6.6. Effect of inhibin antiserum compared with A. non-immune serum and B.
untreated follicles on progesterone accumulation in vitro by rat follicles. Whole
follicles were incubated for 5 days in medium with inhibin antiserum (1.0%) or non¬
immune serum (1.0%). Each 24 hours of culture, follicles were removed from their
wells using a fine glass micropipette, and transferred to fresh culture medium.
Steroid accumulation in spent culture medium was determined by
radioimmunoassay. Composite data from experiments I and II (A) or V and VI (B)
(mean ± SE, n=24). *P <0.01 compared with control.




Non-immune 0.1% antiserum 1.0% antiserum
serum (1.0%)
Non-immune 0.1% antiserum 1.0% antiserum
serum (1.0%)
FIG. 6.7. Dose-dependent effect of inhibin antiserum on A. oestradiol and B.
progesterone accumulation in vitro by rat follicles on Day 5 of culture. Whole
follicles were incubated for 5 days in medium with inhibin antiserum (0.1% and
1.0%). Each 24 hours of culture, follicles were removed from their wells using a fine
glass micropipette, and transferred to fresh culture medium. Steroid accumulation in
spent culture medium was determined by radioimmunoassay. Composite data from
experiments I and II (mean ± SE, n=24). P <0.01 compared with non-immune serum
treated control.
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Day of culture
Day of culture
FIG. 6.8. Effect of exogenous inhibin on A. oestradiol and B. progesterone
accumulation in vitro by antiserum-treated rat follicles. Whole follicles were
incubated for 5 days in medium with inhibin antiserum and 50 ng inhibin /ml. Every
24 hours in culture, follicles were removed from their wells using a fine glass
micropipette, and transferred to fresh culture medium. Steroid accumulation in spent
culture medium was determined by radioimmunoassay. Composite data from
experiments IV and V (mean ± SE, n=24). *P <0.01 compared with antiserum
treatment.
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3.4 Effect of supplementing antiserum-treated culture medium
with androstenendione
In an attempt to bypass the block to androgen synthesis caused by the
removal of inhibin, antiserum-treated follicles were cultured in the presence
of an aromatisable androgen, androstenedione. Oestradiol production in the
presence of inhibin antiserum was significantly increased on Day 1 by the
addition of androstenedione to antiserum-treated medium (Fig. 6.9a).
Oestradiol production increased steadily throughout the culture and was
greater than in the absence of any treatment (Fig. 6.4). Progesterone
accumulation in the presence of androstenedione and antiserum was
significantly raised on Day 1 (Fig. 6.9b) and increased steadily throughout
the period of culture.
4. Discussion
These results represent the most direct evidence to-date of a paracrine
function for inhibin in the regulation of follicular oestrogen synthesis.
Treatment of intact follicles with an antiserum directed against the inhibin a-
subunit markedly suppressed FSH-stimulated oestradiol secretion. Although
androstenedione levels were not measurably affected, simultaneous
treatment with exogenous androstenedione restored oestrogen secretion by
anti-inhibin treated follicles. It therefore seems most likely that inhibin
promotes follicular oestrogen formation via a paracrine mechanism
involving increased production of aromatase precursor in thecal/interstitial
cells.
The FSH preparation used in this study was significantly (8.7 %)
contaminated with LH, which would explain its ability to promote follicular
oestrogen synthesis in the absence of additional LH. Both the original "two-
cell" theory of steroid synthesis (Short, 1962) and the contemporary "two-cell,
two-gonadotrophin" model of follicular oestrogen synthesis (Armstrong &
Dorrington, 1979) appear to operate in the rat follicle. Previously we showed
that inhibin dose-dependently
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350- • Antibody (1.0%) + Androstenedione (1 |JM)
Day of culture
FIG. 6.9. Effect of exogenous androstenedione on A. oestradiol and B. progesterone
accumulation in vitro by antiserum-treated rat follicles. Whole follicles were
incubated for 5 days in medium with inhibin antiserum and 1 mM androstenedione.
Every 24 hours in culture, follicles were removed from their wells using a fine glass
micropipette, and transferred to fresh culture medium. Steroid accumulation in spent
culture medium was determined by radioimmunoassay. Data from experiment VI
(mean ± SE; n=12). *P <0.01 compared with antiserum treatment. Data for
antiserum + androstenedione on day 3 excludes one outlier (oestradiol = 51 nmol;
progesterone = 1200 nmol) and therefore n=ll.
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enhances LH-stimulated thecal/interstitial cell androgen synthesis in
vitro (Chapters 3 and 4). This led us to propose that FSH may influence
ovarian androgen synthesis via a paracrine mechanism arising in FSH-
stimulated granulosa cells. According to the Armstrong and Dorrington
model, withdrawal of such FSH-dependent paracrine signalling would bring
about decreased androgen synthesis, and hence reduced oestrogen
production. Selective inhibition of androgen synthesis in this way would
then be expected to cause the build up of granulosa-derived progesterone,
which is a thecal androgen precursor (Short, 1962). Since treatment of
isolated thecal :interstitial1, cells with inhibin potently stimulates androgen
synthesis without affecting progesterone (Hillier et al., 1991c), all the data
point to an action at the level of Cytochrome P450C17a (17-hydroxylase/Cl7-
20 lyase), which is the rate limiting steroidogenic enzyme in androgen
synthesis (Bogovich & Richards, 1982).
To rule out non-specific effects of the inhibin antiserum we added
exogenous inhibin or androstenedione to antiserum-treated follicle cultures.
The addition of inhibin restored a measure of oestradiol production and
decreased progesterone accumulation. This suggests that inhibin
immunoneutralisation causes selective inhibition of androgen synthesis and
is further consistent with action at the level of P450C17a. Addition of the
aromatisable androgen androstenedione to antiserum-treated follicle
cultures fully overcame the block to oestradiol synthesis, confirming the
crucial role of thecal androgen as an aromatase precursor. The stimulatory
effect of exogenous androstenedione on progesterone accumulation in
antiserum-treated follicles agrees with the proposed paracrine role of
androgen in augmenting C21 steroid synthesis in FSH-stimulated granulosa
cells (Armstrong and Dorrington, 1976). Interestingly, oestradiol production
by inhibin antiserum-treated follicles cultured with FSH in the presence of
exogenous inhibin or androstenedione increased more rapidly than follicles
treated with FSH alone. This observation suggests that the inductive action
of FSH on granulosa cell inhibin production (hence androgen production) is
a rate-limiting factor in initiation of oestrogen secretion by the preovulatory
follicle.
Presumably androgen production and aromatase activity each limit tire
rateof oestrogen synthesis in the preovulatory follicle. As the aromatising
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capacity of the preovulatory follicle increases a commensurate increase in
thecal androgen synthesis is required to sustain the rising oestradiol
production rate. The attendant rapid turnover of androgen to oestrogen is
probably the main reason why androgen does not accumulate at a
measurable level in cultures of FSH-treated whole follicles.
The dramatic effects on steroidogenesis of the inhibin antiserum
treatment were surprising though it must be remembered that the system of
follicle culture is a fragile one and thus any imbalance of the normal
hormonal environment is likely to be detrimental to normal steroidogenesis.
Nevertheless, previous observations in vitro (Chapters 3 and 4) have shown
that inhibin is able to augment LH-stimulated androgen production by up to
4-fold. Since androgen accumulation appears to be the rate-limiting step in
oestrogen synthesis in this culture system then it may be presumed that
oestradiol production would be increased by a comparable amount due to
this effect of inhibin. Therefore the selective removal of inhibin would be
expected to decrease oestradiol production by up to 75% in the absence of
any other intraovarian modulation of androgen synthesis. It should not be
forgotten though that other factors such as IGF-I can augment LH-stimulated
androgen synthesis 1.5-fold (Hernandez et al. 1988b; Magoffin & Erickson,
1988a) and thus mask some of the effects of inhibin immunoneutralisation.
Therefore it was unexpected to observe that the selective removal of inhibin
decreased oestradiol synthesis to 15% of levels seen in the absence of
antiserum. This discrepancy may be explained by the negative effects of
activin and possibly TGF(3 which both inhibit LH-stimulated androgen
synthesis (Activin: Hsueh et al. 1987; TGF{3: Magoffin et al. 1989) and are
produced by FSH-stimulated granulosa cells (Activin: Woodruff et al. 1987;
\/
TGF(3: Kim & Schomberg, 1989). It has also been reported that inhibin can
neutralise the inhibitory effects of activin on LH-induced androgen synthesis
(Hillier et al. 1991b). It may be postulated that the removal of inhibin
increases the activin:inhibin ratio and therefore decreases LH-stimulated
androgen production, and hence oestradiol synthesis. Activin also increases
progesterone production by GC (Miro et al. 1991). TGF(3 selectively decreases
P45017a activity (Hernandez et al. 1990a) and therefore androgen
production, as well as increasing progesterone production by FSH-
\/ ^
stimulated granulosa cells (Dodson & Schomberg, 1987; Knecht et al. 1987)
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and LH-stimulated theca cells (Magoffin et al. 1989; Hernandez et al. 1990a).
These effects of activin and TGF(3 are consistent with our finding that inhibin
immunoneutralisation decreases oestradiol synthesis and increases
progesterone accumulation. Follistatin is known to decrease FSH-stimulated
aromatase activity, and increase granulosa cell progesterone production
J V
(Xiao et al. 1990; Xiao & Findlay, 1991). It is expressed in increasing amounts
with development of the follicle and thus may be also contributing to the
enhanced progesterone and decreased oestradiol production rates.
It has been previously reported that an intrabursal injection of inhibin
influences folliculogenesis by causing growth of follicles into the recruited
(350 - 500 |im) size class (Woodruff et al. 1990). Follicular growth was also
enhanced by intrabursal gonadotrophin treatment, and inhibin was capable
of augmenting this effect. However, removal of inhibin by antiserum
treatment does not significantly affect growth rate nor alter follicular
diameter after 5 days in culture. The combined results of both studies
suggest that FSH exerts the major control over follicular growth, whilst
inhibin though not essential, can augment FSH-stimulated folliculogenesis.
In conclusion, we have used a whole follicle culture system to evaluate
the influence of inhibin on gonadotrophin stimulated growth and oestrogen
secretion. Immunoneutralisation of inhibin selectively suppressed FSH-
stimulated oestrogen synthesis without retarding follicular growth. The
inhibitory action of inhibin withdrawal on oestrogen synthesis was fully
compensated by replacement therapy with exogenous inhibin or
androstenedione. These results support our hypothesis that locally produced
inhibin exerts a physiologically significant paracrine function in the
regulation of follicular oestrogen synthesis in vivo.
Chapter 7. General Discussion
1. Introduction
Paracrine control within the endocrine system involves local cellular
production of hormones, which diffuse out of the cell and exert their actions
on neighbouring target cells. The term "paracrine" was first applied to the
local production of gut peptides that mediate cell-cell interactions in the
digestive tract (Van Noorden & Polak, 1979). The significance of paracrine
control to the coordination of ovarian follicular development has attracted a
great deal of interest in recent years.
The 'two-cell, two-gonadotrophin' theory of preovulatory oestrogen
synthesis provides a model for paracrine signalling within the ovarian
follicle (Armstrong & Dorrington, 1979). This model requires that granulosa
cells exclusively express receptors for FSH, while thecal cells express LH
receptors (Hsueh et al. 1984). FSH action is accomplished by receptor-
mediated cAMP intracellular signalling mechanisms that increase the
expression of differentiated functions, such as LH receptor and aromatase
(Chapter 5), the enzyme crucial for oestrogen synthesis. LH receptors are
also coupled to steroidogenesis via cAMP, the major steroidogenic enzyme
under LH control being P45017a (Chapters 4 and 5). This enzyme is crucial
for follicular androgen synthesis, and hence the provision of aromatase
substrate for FSH-stimulated granulosa cells. Granulosa cells do not express
significant amounts of P45017a (Chapters 4 and 5), whereas thecal cells do
not express aromatase (Chapter 5). While every follicle is exposed to the
same gonadotrophin profile during the ovarian cycle, they all react
differently due to local modulation of the actions of gonadotrophins.
2. Evidence for Paracrine Signalling in the Ovary
The overall objective of the studies described in this thesis was to
investigate the local modulation of gonadotrophin action in the ovary.
Firstly, the relative contributions of FSH and LH to follicular development
were investigated. It was found that FSH is required for normal follicular
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development, however this is unlikely to be entirely a direct effect of the
hormone. This study demonstrates that FSH is capable of stimulating the
rate of granulosa cell proliferation in vivo, but not in vitro (Chapter 2). This
suggests that the growth stimulating effects of FSH are mediated through
another factor(s). Factors that potentially mediate this effect of FSH include
oestrogens, TGFa and IGF-I. Oestrogens increase ovarian weight in
hypophysectomised rats (Louvet et al. 1975), although it has been reported
that thecal/interstitial cells are required to induce granulosa cell DNA
synthesis (Bley et al. 1991), thereby implicating factors of thecal cell origin in
the mediation of this effect (Bendell & Dorrington, 1991). TGFa, of thecal cell
origin, promotes granulosa cell proliferation, but inhibits granulosa cell
differentiation and thecal cell androgen production (May & Schomberg,
1989). IGF-I augments the responses of ovarian cells to gonadotrophins
(Chapters 2, 3 and 4) and is believed to be involved in the stimulation of
granulosa cell proliferation (Giudice, 1992). These factors therefore qualify as
potential paracrine mediators of the growth stimulatory effects of FSH.
As well as promoting follicular growth, FSH was shown to stimulate
granulosa cell expression of differentiated functions, such as progesterone
and oestradiol synthesis, both in vivo and in vitro (Chapter 2). Androgens of
thecal cell origin, as well as acting as a substrate for aromatase, enhance FSH-
stimulated progesterone and oestradiol synthesis, but block oestradiol
enhancement of LH-responsiveness in granulosa cells (Chapter 2). These
results show that FSH can exert a direct action upon granulosa cell
maturation, but also that androgens, of thecal cell origin, are capable of
augmenting these effects of FSH. Therefore androgens can also act as
paracrine signals during follicular maturation.
According to the 'two-cell, two-gonadotrophin' theory, both FSH and
LH are required for normal oestrogen synthesis. This study shows that FSH
alone is incapable of eliciting an increase in plasma levels of either oestradiol
or androgen in the complete absence of LH (Chapter 2). However, once LH
was restored, FSH dose-dependently increased plasma levels of both
steroids. This observation implies that cell-cell communication is necessary




In summary, these results suggest that FSH is the primary stimulus to
oestradiol synthesis and follicular growth, but that LH is essential to support
these actions of FSH. Paracrine communication is important for mediating
the actions of FSH and LH to ensure coordinated follicular development.
Administration of FSH in vivo enhances P45017a mRNA expression and
LH-responsive androgen synthesis in vitro (Chapter 4). Granulosa cells but
not thecal/interstitial cells possess FSH receptors, whereas P45017a
expression, and hence the capability for androgen synthesis, is far higher in
thecal/interstitial cells than granulosa cells (Chapter 4). Therefore, these
findings can be interpreted as direct evidence that FSH activates granulosa-
derived paracrine signalling in the ovary. Hypophysectomy impedes this
stimulatory action of FSH, but replacement therapy with LH restores the
ability of FSH to enhance thecal cell function. Therefore simul taneous
exposure to endogenous LH is necessary to facilitate augmentation of
thecal/interstitial function by FSH. It is likely that factors produced by FSH-
stimulated granulosa cells modulate androgen production by
thecal/interstitial cells resulting in coordinated follicular steroidogenesis. A
candidate for this role is inhibin, which dose-dependently enhances LH-
stimulated thecal/interstitial cell androgen synthesis in vitro (Chapters 3 and
4).
To test the hypothesis that inhibin exerts a physiologically significant
paracrine function within the intact follicle, a whole follicle culture system
was used (Chapter 6). Withdrawal of inhibin by immunoneutralisation
during culture of individual follicles in vitro provided the most direct
evidence to-date of a paracrine function for inhibin in the regulation of
follicular oestrogen synthesis. Immunoneutralisation of inhibin selectively
suppressed FSH-stimulated oestrogen synthesis without affecting follicular
growth. These results support the hypothesis that inhibin promotes follicular
oestrogen synthesis via a paracrine mechanism involving increased
production of aromatase precursor in thecal/interstitial cells.
In summary this thesis has shown that FSH exerts primary control over
follicular development while LH supports and augments the regulatory
function of FSH during folliculogenesis. It also provides direct evidence that
FSH can influence LH-responsive thecal/interstitial androgen production in
vivo and suggests similar potentials for inhibin, IGF-I and oestradiol of
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granulosa origin in mediating this action of FSH. However, while potential
roles have been demonstrated for these factors, the physiological relevance
of these findings has not yet been discussed.
3. Physiological relevance of paracrine signalling
For normal follicular function, the ovary must be exposed to the correct
gonadotrophin stimulus. The central control of ovarian development is via
the hypothalamic control of pituitary gonadotrophin secretion (Knobil, 1980),
but the precise control and coordination cannot be exercised by
gonadotrophins alone. There are several events in ovarian follicular
development which occur without adequate changes in gonadotrophin
levels to explain their occurence. Such events include recruitment, selection
and dominance of follicles, and atresia. It is highly probable that these events
are mediated by the local modulation of gonadotrophin action. Indeed, local
communication is necessary for the functional coordination of ovarian cell
types to ensure normal follicular development and oestrogen synthesis. This
section will attempt to assign some physiological relevance to the findings of
this thesis.
Once the selection of antral follicles from the preantral pool has
occurred, the ovary must choose which one(s) will attain dominance and
eventually ovulate. This dominance is exerted despite a decrease in
gonadotrophin support, and therefore an important consideration in the
selection of a dominant follicle is a high rate of oestradiol and inhibin
synthesis for negative feedback to decrease pituitary FSH production.
Equally important is the role of local intraovarian factors in modifying the
response to gonadotrophins to favour the dominant follicle. The FSH-
induced acquisition of LH receptors on mature granulosa cells enables these
cells to respond to tonic levels of LH in the same way that they would
respond to FSH. In this way LH can stimulate intracellular cAMP
accumulation and substitute for the lowered levels of FSH. Therefore follicles
that have a low threshold for FSH due to a high aromatase activity and
acquisition of LH responsiveness are more likely to survive the lower FSH
levels and are preferentially selected.
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Factors implicated in the attainment of dominance include inhibin and
IGF-I. Both factors are of granulosa cell origin and augment LH-stimulated
androgen production by thecal cells (Chapters 3 and 4). This enables a high
level of oestrogen secretion because of the provision of aromatase substrate
and the augmentative action of androgen on FSH-stimulated oestrogen
synthesis. Oestradiol in rats increases inhibin-a and -[3b (inhibin) subunit
mRNA expression but does not affect inhibin-PA (activin) subunit mRNA
expression (Turner et al. 1989). In this way oestradiol can modulate the
relative rates of granulosa cell inhibin/activin synthesis by favouring inhibin
synthesis later in follicular development.
These actions are potentially important in the attainment of dominance
during the mid-follicular phase when aromatase activity, LH receptor
content of granulosa cells, and IGF-I and inhibin production reach critical
levels. The LH receptor, being coupled to cAMP-mediated post-receptor
signalling, like the FSH receptor, stimulates granulosa cells to produce
inhibin and IGF-I and thus sensitises thecal cells to LH. Similarly thecal cell
androgen increases aromatase activity, and inhibin and IGF-I production.
Since both these factors increase LH-stimulated androgen production by
thecal cells, there is a reciprocal mechanism to increase oestradiol synthesis.
Thus in the situation of declining FSH stimulation, the non-dominant
follicles are unable to survive as growth is restricted. The dominant follicle(s)
survives becaues&inhibin and IGF-I increase the sensitivity of follicles to both
FSH and LH, and thereby compensate for the low FSH levels. In this way the
high levels of oestradiol synthesis that are normally associated with the
dominant preovulatory follicle are facilitated. Therefore, the modulation of
LH action by FSH-stimulated granulosa cell paracrine signalling can
determine the fate of the follicle.
4. Future prospects
Undoubtably there are many other processes in ovarian follicular
development where paracrine communication is important. For instance it
has been proposed that the prevention of oocyte maturation potentially
involves inhibin (O et al. 1989), whereas TGF(3 stimulates meiotic maturation
(Tsafriri et al. 1989b). However, immature follicles with arrested oocytes have
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no inhibin, and the development-related expression of TGFP has yet to be
determined. Thus the situation is obviously very complex and there are
probably a combination of factors involved in this process.
The hypothesis that inhibin and IGF-I exert a physiologically significant
role in ovarian follicular development is based solely on the demonstration
of potential actions of these factors on ovarian cells. However, many of these
actions still need to be verified in vivo and the hypothesis tested and
confirmed. It is important to remember that we should not assign status to
any one factor and ignore the others. The emerging situation is one whereby
modulators of gonadotrophin action form complex interactions during
follicular development, and variations in the availability of one or more
factors at various stages of development can alter the response of follicles to
the same gonadotrophin stimulus.
In order for a candidate paracrine factor to be considered for a potential
action it must satisfy certain standard criteria (Franchimont, 1986), It must be
produced locally, be received locally and exert its action locally. All the
factors mentioned in this thesis satisfy these basic criteria, but once they are
met there must be rigorous testing to demonstrate a more meaningful role in
vivo. Specifically, final proof of in vivo relevance requires evidence of
indispensability by means of selective neutralisation of the candidate factor.
Although this study has provided some evidence of the indispensability of
inhibin by immunoneutralisation, a more thorough experiment would
involve transgenic technology. By this technique the potential relevance of
the intraovarian actions of inhibin, as assessed by its dispensability to
ovarian functon, could be determined. This would overcome the problem
that by their very nature, paracrine factors are found in small quantities and
act within a discrete area, and thus are difficult to block in vivo by
immunoneutralisation. However, it must be remembered that since local
modulation of gonadotrophin action involves complex interactions, then the
removal of one factor may upset the normal balance resulting in an
unnatural hormonal environment. The fact that some paracrine factors have
other roles in ovarian physiology must also be considered. For example,1/
inhibin exerts an endocrine control over pituitary function (Ying, 1988), and
thus the removal of inhibin will upset the feedback regulation of
gonadotrophin secretion. Similarly, it has been shown recently that the
GeneralDiscussion 204
selective removal of the inhibin-a gene in transgenic mice leads to the
development of gonadal stromal tumours (Matzuk et al. 1992). The gene for
inhibin-a is thought to be a tumour suppressor gene, and inhibin a tumour
suppressor protein, as well as exerting its other endocrine and paracrine
actions. It therefore seems that in the future a major challenge to ovarian
physiologists will be to demonstrate meaningful intraovarian mechanisms
regulating gonadotrophin action by approaches that do not upset the normal
hormonal balance. These will give important new insights into alterations of
normal physiology that cause syndromes such as infertility and polycystic
ovary syndrome.
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